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Abstract 
 
One of the main groups of organic compounds containing nitrogen in both cyclic systems and 
straight chains is the alkaloids. Indole is perhaps the single most common heterocycle in all of 
chemistry and it is embodied in a myriad of natural products, pharmaceutical agents and a 
growing list of polymers. This dissertation presents method for the synthesis of substituted 
indoles bearing aryl substituents onto the 2- and 3- position as well as 2,3-fused indoles. The 
route for the synthesis of the aryl substituted indoles starts from the indole nucleus which was 
protected using the phenylsulfonyl group because it was found that the group is easy to remove 
and does not require harsh conditions. After successful protection of the indole nucleus NH as N-
phenylsulfonyl, bromine was introduced at the 3-position of the indole nucleus while iodine was 
introduced at the 2-position of the indole nucleus. The bromination of the indole nucleus was not 
easily achieved because the reaction of molecular bromine with indole resulted in the formation 
of 2,3-dibromoindole while activated 5-methoxyindole gave an insoluble 2,3,4-tribromoindole. 
However, this problem was solved by refluxing indole with molecular bromine in the presence of 
sodium methoxide while activated 5-methoxyindole was refluxed with N-bromosuccinimide in 
the presence of catalytic benzoyl peroxide.  2-Iodoindoles were synthesized using directed ortho 
metallation, where isopropyl magnesium chloride was used in the presence of catalytic amount 
of diisopropylamine. Using standard aqueous Suzuki-Miyaura cross-coupling in the presence of 
sodium carbonate as a base, 2-aryl, 3-aryl as well as 2,3-diaryl substituted indoles were 
synthesized in good to excellent yields. The synthesis of 2,3-fused indoles was achieved in poor 
yields starting from 1-(phenylsulfonyl)indole which was alkylated using allyl bromide at the 2-
position and formylated at the 3-position of the indole nucleus to the cyclization of the alcohols 
using mercury acetate.  
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Chapter 1: Introduction 
 
1.1 Alkaloids 
 
One of the main groups of organic compounds containing nitrogen in both cyclic systems and 
straight chains is the alkaloids. Alkaloids are nitrogenous bases which occur naturally in plants 
and other living organisms. They nearly always contain their nitrogen as part of a heterocyclic 
system with few exceptions and are often complex in structure; however there is no very sharp 
distinction between alkaloids and many other naturally occurring nitrogenous compounds. In 
addition, the alkaloids usually show specific pharmacological activity1. As in the case of other 
classes of natural products, no uniform system of nomenclature has so far been devised for 
alkaloids. The name of the alkaloid in most cases is derived from the plant or organism name, 
usually the systematic name. 
 
Alkaloids, with few exceptions,  are weak bases that usually occur in plants as salts of the 
inorganic or organic acids. The crude alkaloid salt is often separated from the powdered plant 
material by extraction with water, dilute acid or alcohol. Some material may be neutralized with 
alkali and the organic bases extracted with organic solvent. The crude mixture is often purified 
by fractional distillation of sparingly soluble salts such as hydrohalide, sulfate, oxalate, 
perchlorate, nitrate and others2. In “working up” the plant material for the isolation of alkaloids, 
various extraction and concentration steps have to be carried out during which solvents, acids, 
and bases are brought into contact with the crude plant material3.  
 
It is believed that plants, animals and microorganisms produce alkaloids for specific purposes.  
Many alkaloids show biological activity. For example, some alkaloids show antifungal activity 
such as aporphine alkaloid, liriodenine (1), which displays a broad activity spectrum against 
fungi such as the yeast Candila albicans, Trichophyton mentagrophytes, and has high activity 
against phytopathogenic fungi, this provides a plausible reason for the synthesis of the compound 
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in terms of the plant’s survival strategy. (–)-Senecionine (2) (Figure 1), a pyrrolizidine alkaloid 
can be regarded as a feeding deterrent where it is taken in by herbivores from plants and safely 
stored in the body as N-oxides which are nontoxic and rapidly transformed into toxic form when 
required4. 
 
N
O
O
O
                            
N
O
O
H
O
O
HO
 
      1 Liriodenine                                                  2 (–)-Senecionine 
Figure 1 
 
Some alkaloids have remarkable structural similarities to neurotransmitters in the central nervous 
system of humans. Examples include dopamine (3), serotonin (4) and acetylcholine (5) (Figure 
2). The amazing effect of these alkaloids on humans has led to the development of powerful 
medications and “spiritual” drugs5. 
 
NH2HO
HO
3 dopamine
            
NH2
N
H
HO
4 serotonin
    
O N+
O
5 acetylcholine
 
Figure 2 
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Alkaloids also form the basis of many drugs which are useful in treating diseases and pain, while 
other drugs such as cocaine, heroin and morphine can be harmful if abused but are believed to be 
helpful medicines6.  Among the alkaloids in Figure 2, only (4) is an indole derivative. There are 
over 1200 naturally occurring indole alkaloids and many of them have biological applications7.  
 
Some of the known naturally occurring indoles include, as mentioned above, serotonin (4) a 
monoamine neurotransmitter synthesized in serotonergic neurons in the central nervous system 
and enterochromaffin cells in the gastrointestinal tract8, tryptophan (6) which is an essential 
amino acid7,  and reserpine (7), a more complicated derivative which is used for the treatment of 
high blood pressure, as well as being a tranquilliser9 (Figure 3). 
 
   
N
H
N
H
H
H
H3CO2C
OCH3
O
O
7 reserpine
OMe
OMeMeO
NH2
N
H
O
OH
6 tryptophan
 
Figure 3 
 
Many reviews have been written on indole and its derivatives10, 11. Indole is perhaps the single 
most common heterocyclic system in all of chemistry. It is embodied in a myriad of natural 
products, pharmaceutical agents and a growing list of polymers. In addition to the hundreds of 
well-known indole plant alkaloids, the indole ring is present in an array of other structures. The 
central importance of the indole derivatives in living organisms has inspired chemists to design 
and synthesize indole-containing compounds12, 13, 14. The following sections cover some of these 
aspects. 
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1.2 Indole: Discovery, Synthesis and Reactivity 
 
Indole is a benzopyrrole in which the benzene and pyrrole rings are fused through the 2-and 3- 
positions of the pyrrole nucleus. The indole ring is also found in many natural products such as 
the indole alkaloids, fungal metabolites and marine natural products15. The first preparation of 
indole dates from 1866 but the Fisher indole synthesis, which remains one of the most versatile 
methods for preparing indoles, was first reported in 188316.  
 
The principal commercial source of indole is extraction from coal tar, although the feasibility of 
industrial synthesis from starting materials such as aniline, ethylene glycol and others has also 
been demonstrated16. Indole (9) itself was first obtained by Adolf Baeyer by pyrolysis of 
oxindole (8) with zinc dust in 1886. Oxindole (8) was obtained from the reduction of isatin (10) 
which was obtained from oxidizing the natural insoluble dark blue dye called indigo (11) 
(Scheme 1)17.  
 
N
H
H
N
O
O
N
H
O
O
N
H
O
N
H
Oxidation
R
eduction
Pyrolysis
1110
8 9 1
2
345
6
7
 
Scheme 1 
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Although the main source of indole is extraction from coal tar, many researchers have reported 
synthetic methods for the preparation of various substituted indoles from readily available 
starting materials owing to their importance in natural products synthesis and pharmaceutical 
chemistry. One of the most widely used methods as mentioned previously is the Fischer indole 
synthesis. This method involves heating phenylhydrazine (12) with aldehyde or ketone (13) in 
acetic acid, forming phenylhydrazone (14) which subsequently rearranges with the loss of 
ammonia to give indole or 2- and 3-substituted indoles (9 and 15) as outlined in Scheme 2.  
 
 
N
H
NH2
12
13
14 9 R = R1 = H
15 R = R1 = 
alkyl, aryl
ZnCl2
170 oC
O
R
R1
HN N
R
R1
N
H
R1
R
 
Scheme 2 
 
Other methods include the Grandberg synthesis, Reissert synthesis, Leimgruber-Batcho 
synthesis, Madelung synthesis and Bischler synthesis to name a few. Both the Reissert and 
Leimgruber-Batcho syntheses depend on the acidity of methyl group ortho to an aromatic nitro 
group while Madelung synthesis proceeds via a Wittig-type reaction18. The Reissert synthesis is 
suitable for the preparation of 2-substituted indoles. For example, when 1-methyl-2-nitrobenzene 
(16) is treated with dimethyl oxalate (17) in the presence of sodium methoxide as a base it gave 
methyl 3-(2-nitrophenyl)-2-oxopropanoate (18), which upon catalytic hydrogenation (H2, Pd-C) 
reduced the nitro group to an amino group followed by a spontaneous cyclodehydration to give 
indole-2-carboxylic acid methyl ester (19) (Scheme 3)19. 
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NO2
O
COOMe
NO2 NH
COOMeNaOMe
OMeO
O OMe
16
17
18 19
H2, Pd-C
-3H2O
 
Scheme 3 
 
On the other hand, the Leimgruber-Batcho synthesis is particularly suitable for the synthesis of 
indoles with substituents on the benzene ring but is unsubstituted on the pyrrole moiety. In this 
method, substituted 1-methyl-2-nitrobenzene (20) is treated with N,N-dimethylformamide 
dimethyl acetal (21) to give substituted 1-dimethylamino-2-(o-nitrophenyl)ethene (22), which on 
reductive cyclization yielded substituted indole (23) (Scheme 4). Madelung synthesis (not 
illustrated) is essentially confined to the preparation of 2-alkylindoles due to the vigorous 
reaction conditions, while Bischler synthesis (not illustrated) is particularly suitable for 2-and 3-
disubstituted indoles19. 
R
NO2 N
OMe
MeO
R
NO2
N
N
H
RH2, Pd-C
20
21
22
23
 
Scheme 4 
 
Up until now the methods discussed in the synthesis of indole have nitrogen atom bonded 
directly to an arene. Only a few indole syntheses make use of building blocks in which the 
nitrogen atom is not directly bonded an arene. The Nenitzescu synthesis is an example of this 
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type. In this synthesis, 1,4-quinone (24) is condensed with (E)-methyl 3-aminobut-2-enoate (25) 
by a Michael addition to give (E)-methyl 3-amino-2-(2,5-dihydroxyphenyl)but-2-enoate (26). 
When (26) was subjected to oxidation, it gave (E)-methyl 3-amino-2-(3,6-dioxocyclohexa-1,4-
dienyl)but-2-enoate (27) which was followed by a cyclodehydration to give methyl 2-methyl-5-
oxo-5H-indole-3-carboxylate (28) and the reduction of (28) furnished 2,3-disubstituted indole, 
methyl 5-hydroxy-2-methyl-1H-indole-3-carboxylate (29) (Scheme 5)19. This method provides a 
rapid means of preparing functionalized 5-hydroxyindoles from simple, readily accessible 
starting materials10, and the hydroxyl group can also be introduced onto the indole nucleus20. 
H2N
COOMe
H
O
O
+
OH
HO
COOMe
NH2
O
O
COOMe
NH2
N
O
COOMe
N
H
HO
COOMe
oxidation
-2H
-H2O
reduction
+2H
24 25
26
27
2829
 
Scheme 5 
 
Indole undergoes electrophilic substitution mainly on position 3 of the nucleus when the 
hydrogen on the indole nitrogen atom is substituted or when a strong magnesium base is used. 
This is because indole nitrogen is the most reactive towards reactions with electrophiles followed 
by position 3 of the indole nucleus. When both positions 1 and 3 of the indole nucleus are 
occupied by substituents other than hydrogen, position 2 is the most reactive one and when 
position 2 is occupied the electrophile occupies a position on the benzene ring21.  
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1.3 2-Substituted Indoles: Synthesis and Biological Importance 
 
1.3.1 Synthesis 
 
The synthesis of indoles is currently the object of wide investigations owing to their central role 
as useful building blocks in the synthesis of alkaloids and in the design of therapeutic agents and 
this would include the topic of this section, 2-substituted indoles. Some general methods for 
preparing 2-substituted indoles were discussed in the preceding section, but several more specific 
methods are described below. 
 
As the 2-alkynylphenylamine derivatives (30) are easily available by established synthetic 
procedures, the syntheses of 2-substituted indoles with these compounds as starting materials are 
some of the most useful procedures. Both base-promoted and electrophilic cyclization reactions 
of (30) to furnish 2-substituted indoles have been developed. For example, when (30) was treated 
with gold salts such as sodium chloroaurate (NaAuCl4) as a catalyst, it yielded 2-substituted 
indoles (31) in reasonable yields. This procedure is compatible with a variety of functional 
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groups on the benzene ring of (30) as illustrated in Scheme 6, where the R group can be 
hydrogen, alkyl, aryl or a variety of substituted aryls22. 
 
Cl
Cl
N
H
R
NaAuCl4.2H2O
EtOH, rt,
65-83%30 31
Cl
Cl R
NH2
 
Scheme 6 
 
2-Substituted indoles can also be synthesized by the previously discussed methods for indole 
synthesis. Fischer indole synthesis methodology can be generally employed. For example, 
treating acetophenone (32) with phenylhydrazine (12) in the presence of acetic acid in ethanol at 
80 °C as illustrated in Scheme 7 gave 2-phenylindole (33) in good yield23.  
O
+
HN
NH2
N
H
AcOH
EtOH, 80 oC.
80-90%
32 12 33
 
Scheme 7 
 
Indole can also be halogenated at the 2-position but this has proved to be a difficult reaction if 3-
position is not substituted. Powers reported the synthesis of 2-haloindoles (34 and 35) with 
phosphorus oxyhalides through a Vilsmeyer salt.  This was performed using oxindole (8) as a 
source of the indole moiety but these compounds have limited stability as they cannot be stored 
for long without decomposing24, 90. 
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There is other methodology for introducing substituents at the 2-position of indole. This 
methodology employs the ortho-metallation of N-protected indoles. The most commonly used N-
protecting groups are phenylsufonyl (PhSO2), p-toluenesulfonyl (4-MeC6H4SO2 or Ts) and tert-
butoxycarbonyl (Boc). The N-protecting groups like these are required to effect metal 
stabilization at the 2-postion of the indole nucleus by lone pair donating properties of the 
“protecting” group to allow for what is called directed ortho metallation (DOM). For instance, 
when 1-phenylsulfonylindole (36) is treated with a strong base like lithium diisopropylamide 
(LDA) at low temperatures, it gives a regioselective 2-lithiation product (37) which can be 
quenched with various electrophiles including halogen sources to afford 2-substituted indoles 
(38)25 (Scheme 9). 
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Scheme 9 
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When the electrophile is a halogen as in (35), this can also allow C-C bond formation through the 
now well-developed catalytic cross-coupling reactions. Most frequently, palladium cross-
coupling reactions are used for the formation of C-C bonds. One of the most commonly used 
methods is the Suzuki-Miyaura cross-coupling reaction which employs palladium(0) under basic 
conditions, usually with aryl or heteroaryl boronic acids or esters to effect C-C bond formation26.  
 
Apart from the regioselective lithiation of N-protected indoles at the 2-position with strong bases 
such as LDA, the hydrogen at the 2-position of (36) can also be replaced by magnesium metal. 
Kondo et al. devised a methodology of replacing the hydrogen at the 2-position of (36) with 
magnesium using magnesium amide bases. When hydrogen is replaced by magnesium in (36), it 
acts much like lithiated (37) but this reaction can be achieved at room temperature while 
lithiation is achieved at lower temperatures due to the instability of lithiating reagents27. This 
methodology was modified by using Grignard reagents in the presence of a catalytic amount of 
amines instead of using magnesium amide bases and this showed improved yields28.  
 
The direct C-arylation of free (NH) indole holds a significant synthetic potential as it eliminates 
the need for introducing the protecting groups and reactive functionalities prior to C-C 
formation, thereby enabling direct access to valuable heteroaromatic compounds29. 2-Arylindoles 
in particular are important structures that serve as key components of variety of biologically 
active molecules. Many traditional approaches to these compounds have involved cross-coupling 
between 2-functionalized indole and functionalized arene derivative, a strategy that often 
requires more than one step. Recently, methodology has been developed to affect C-2 arylation 
of indoles without protecting the NH group or the requirement of the introduction of a halogen or 
boronic acid. For instance, treating (9) with phenyliodonium tetrafluoroborate (Ph2I+BF4-) in the 
presence of 1,3-bis(2,4,6-trimethylphenyl)imidazo-2-ylidene palladium acetate (IMesPd(OAc)2) 
as a catalyst afforded (33) in good yield at room temperature and this methodology is compatible 
with a diverse selection of electron-donating and electron-withdrawing substituents on indoles 
without competing N-arylation or other undesirable side reactions30. 
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Scheme 10 
 
1.3.2 Biological importance 
 
2-Substituted indoles can have complex structures and interesting biological activities, but not all 
compounds having the indole skeleton have biological importance. For example, compound (39) 
and compound (40) both possessing a substituents at the 2-position of the indole nucleus were 
both tested for in vitro cytotoxic effects as well as in vivo cytotoxic effects. They were used on 
human melanoma cell line A2058 using an MTS cell proliferation assay. Compound (39) showed 
a mean GI50 value of 0.38 µM while compound (40) showed a mean GI50 value of 0.182 µM, 
indicating that these compounds have the potential for use as highly potent broad-spectrum 
anticancer compounds to inhibit the growth of a variety cancer cell lines31.  
 
When compounds (39) and (40) were tested for in vivo cytotoxic effects, they both showed 
intraperitoneal (ip) plus subcutaneous (sc) scores of larger than 20. If ip plus sc scores are larger 
than 20, the compounds are considered to be active and have potential as an antitumour or 
anticancer drug candidates. The in vivo test results showed that compounds (39) and (40) had 
total scores of 22 and 30 respectively. Another example is compound (41), again a 2-substituted 
indole, and this was tested for the inhibition of the cleavage activity of restriction endonuclease 
BamHI. The experimental results showed that compound (41) inhibits BamHI digestion and this 
is because it can bind to the DNA more efficiently31. 
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Figure 4 
 
In another example, evaluation of the growth-inhibitory properties of the novel quinol (42) 
shown in Figure 5 was undertaken in two human colon cancer cell lines (HCT 116 and HT 29). 
The valuation results show that 4-(1-phenylsulfonyl-1H-6-fluoroindol-2-yl)-4-
hydroxycyclohexa-2,5-dienone (42) was the most potent against the cell lines with the mean GI50 
value of 16 nM and mean LC50 value of 2.2 µM32. Finally in this section, compound (43) was 
examined for in vitro inhibitory effects towards the lipid peroxidation induced by free radicals in 
a rat brain homogenate and their scavenging activity towards DPPH (1,1-diphenyl-2-
picrylhydrazyl) radicals and it showed antioxidative  activity33 while bis(1H-2-
indolyl)methanone (44) caused a strong inhibition of PDGF receptor activity with IC50 value of 1 
µM34. 
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1.4 3-Substituted Indoles: Synthesis and Their Biological Importance 
 
1.4.1 Synthesis 
 
As stated earlier in this dissertation, indole undergoes electrophilic substitution mainly on 
position 3 when the indole nitrogen is protected. The widespread natural occurrence and 
importance of indoles has stimulated the continuing development of new methods for their 
preparation. There are attractive reactions but only few directly produce indoles by annulation of 
commercially available N-aromatic precursors, as in the Fischer-indole synthesis. However, 
despite recently developed methodologies, the classical Fischer indole synthesis remains one of 
the most important approaches to 3-substituted indoles. In the traditional Fischer indole 
synthesis, the required hydrazone is generated via the condensation of the corresponding 
carbonyl compound with a hydrazine derivative. 
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The desire for broad substrate scope, more accessible starting materials, improved 
regioselectivity, milder reaction conditions, and functional group tolerance has also spawned 
several transition metal-promoted route to indoles, most of which are intramolecular reactions 
that require a substituted N-aromatic precursor. When ntirosobenzene (45) and phenylacetylene 
(46) were heated together in the presence of [CpRu(CO)2]2 as a catalyst with carbon monoxide in 
benzene, at 170 oC and 750 psi, it produced regioselectively the 3-substituted indole, 3-
phenylindole (47), in good yields and some small traces of aniline and azoxybenzene (48) but no 
trace of 2-phenylindole was detected35. 
 
NO
+
[CpRu(CO)2]2 
170 oC, 750 psi
benzene, 62%
CO
N
H
45
46
47
N+
O-
N
+
48
Ph
 
Scheme 11 
 
Recently, Odom and co-workers reported an elegant atom-economical methodology of indole 
synthesis based on intermolecular titanium amide-catalyzed hydroamination reaction of alkynes 
with hydrazine derivatives followed by a cyclization employing Zinc chloride (ZnCl2). This 
methodology uses Fischer indole synthesis strategy, with the formation of a hydrazone 
intermediate. The method employs the inexpensive Lewis-acid titanium tetrachloride (TiCl4) as a 
precatalyst and amine like tert-butylamine (tBuNH2) to transform hydrazines and unsymmetrical 
alkynes into indoles. For example, 1,1-disubstituted hydrazine (49) is treated with unsymmetrical 
alkyne (50) in the presence of TiCl4 and tBuNH2 to afford 1,3-diubstituted indole (51) as 
depicted in Scheme 1236.  
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Scheme 12 
 
Recently, methodology which employs the inexpensive bismuth(III) trifluoromethanesulfonate 
(triflate) (Bi(OTf)3 which can be easily prepared on multi-gram scale in the laboratory from 
bismuth(III) oxide and triflic acid has been used to synthesize 3-substituted indoles. It was found 
that treating indole (9) with quinone (52) in the presence of Bi(OTf)3 as a catalyst in acetonitrile 
at room temperature gave exclusively 3-indolyhydroquinones (53 and 54) (Scheme 13).This 
method is clean and free from chlorinated side products that are usually observed under protic 
acid conditions and is applicable to both electron-rich and electron-deficient indoles37. 
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Scheme 13 
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C-Glycosides, wherein a carbon atom replaces the glycosidic oxygen have attracted considerable 
attention in carbohydrate and biological chemistry owing to their stability towards enzymatic and 
acidic hydrolysis. Indole C-glycosides are model compounds for the synthesis of nucleosides of 
9-deazapurines and are believed to exist in biological systems. Indole C-glycosides are usually 
synthesized in the presence of Lewis acids such as zinc chloride (ZnCl2), mixture of boron 
trifluoride and diethyl ether (BF3-Et2O) or trimethylsilyl trifluoromethanesulfonate (TMSOTf) 
but these usually give unsatisfactory results with low stereoselectivity. Recently, the use of InCl3 
to perform such reactions has been evaluated due to its water stability. When indole (9) is treated 
with acetobromoglucose (55) in the presence of indium trichloride (InCl3) as a catalyst in 
dichloromethane at room temperature, afforded exclusively 3-substituted-C-glycoside indole 
(56) in poor yields and high stereoselectivity as outlined in Scheme 1438.  
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Scheme 14 
 
C-Alkylation of indoles is one of the most common methods used to introduce substituents onto 
the 3-position but this methodology usually gives mixtures of products. The methodology 
employs metals like zinc and magnesium. Recently organometallic reactions have found a wide 
application in organic synthesis including C-alkylation of indoles and pyrroles. Organozinc 
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reagents are especially owing to their compatibility with other functional groups, stability, 
reactivity and selectivity; and they also exhibit low nucleophilicity, thus permitting 
chemoselective transformations of groups with similar reactivity.  
 
Here preparation of 3-allylindole (58) through the zinc-mediated Barbier-type reaction is 
illustrated. Indole (9) was treated with allyl bromide (57) in the presence of zinc in 
tetrahydrofuran (THF) at room temperature to give 3-allylindole (58) in good yield and high 
regioselectivity. The methodology can also be used with crotyl, prenyl bromides and substituted 
indoles39. 
 
N
H
N
H
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85%
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Scheme 15 
 
The development of effective asymmetric entries to indole architecture constitutes an important 
research field. Some catalytic enantioselective additions of indoles to unsaturated carbonyl 
compounds, in particular Friedel-Crafts (F-C) alkylations, have been of particular recent interest. 
A number of highly selective metal-catalyzed F-C reactions of bidentate chelating carbonyls 
have been developed. Here efficient asymmetric organocatalytic addition of indoles to simple 
enones is demonstrated, a general and trivial protocol that allows rapid access to a broad range of 
highly enantioenriched 3 -indolyl derivatives. The method uses iminium ion activation strategy 
with enone substrates, based on catalytic use of an amine salt in which both the cation and the 
anion are chiral. Indole (9) was reacted with (E)-4-phenylbut-3-en-2-one (59) in the presence of 
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chiral amine catalyst salt (60) to give 4-(1H-indol-3-yl)-4-phenylbutan-2-one (61) in good yield 
and with >90% ee. This method shows a significant tolerance towards steric and electronic 
demands of the β -olefin substituents40 (Scheme 16).  
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Scheme 16 
 
Electrophilic aromatic bromination is one of the older reactions known to organic chemists. Aryl 
halides are important synthetic intermediates for a variety of transformations that range from 
formation of functionalized aromatic compounds to aryl organometallic reagents that are used in 
other reactions. Despite the many halogenation methods available, regioselective reaction of 
activated aromatic compounds such as 5-methoxyindole still remains a problem. Although 
bromination of indole gives mostly 3-bromoindole, sometimes it gives mixture of products 
where bromination can take place on the electron-rich benzene ring. However, there are a 
handful of selective bromination procedures. For example, the procedure outlined below proved 
to be selective with high yields. Treatment of indole (9) with n-butyllithium and trimethyltin 
chloride followed by the addition of bromine at –78 °C gave 3-bromoindole (62) with no sign of 
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other brominated indole product and this method worked well with activated 5-methoxyindole41 
(Scheme 17). 
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Scheme 17 
 
The 3-arylindole structure represented is some of the biologically active indole containing 
compounds. Among the arylated indole compounds, 3-phenylindole is an antimicrobial 
compound active towards many fungi and Gram-positive bacteria42.  
 
3-Arylated indoles have been prepared by ring closure synthesis or by introducing protecting 
groups on heterocyclic nitrogen atom and introducing functionalities prior to C-C formation. For 
example, N-protected 3-bromoindoles allow C-C bond formation through the developed catalytic 
cross-coupling reactions. One of the most commonly used methods is the Suzuki-Miyaura cross-
coupling reaction26. C-3 Arylation of indoles containing an unprotected heterocyclic nitrogen 
atom is also possible with a highly specific palladium catalyst as illustrated here. When indole 
(9) was treated with 1-bromo-4-nitrobenzene (63) in the presence of the exotic catalyst (64) 
abbreviated a POPd, it gave 3-(4-nitrobenzene)indole (65) in good yield and selectivity. 
Palladium-phosphinous acid complex abbreviated (POPd) (64) has been found to be a superior 
catalyst in this type of cross-coupling reactions due to its air-stability42 (Scheme 18). 
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Scheme 18 
 
1.4.2 Biological Importance 
 
Many indoles substituted at C-3 have also been found to be biologically active. Most of the 
active 3-C substituted indoles were found to be anticancer agents and kinase inhibitors. Many 
have been synthesized but some are also found in Nature. For example, compound (66) was 
found to have strong potency against vessel growth in vivo chick embryo assay with 82% 
inhibition of vessel area after 24 hours incubation by application of 10 µg per pellet and it was 
also found to be active against the kinase involved in the angiogenic process resulting in in vivo 
activity43. Angiogenesis, the formation of new capillaries from preexisting blood vessels, is 
essential in several physiological situations, including embryo development, female reproductive 
cycle, and wound healing during which angiogenesis is under strict control. The angiogenic 
process is regulated by a variety of endogenous molecules including vascular endothelial growth 
factor (VEGF), basic fibroblast growth factor (bFGF), transforming growth factors (TGF) and 
cytokines interleukin IL-2 and Il-845. 
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Figure 6 
 
Uptake into the presynaptic neuron is the principal mechanism for the rapid inactivation of 
released biogenic amines in the neural synapse. The tricyclic antidepressant agents inhibit to a 
varying extent the uptake of noradrenaline (NA) and 5-hydroxytryptamine (5-HT). 
Clomipramine was the most selective inhibitor of 5-HT uptake in vitro, but the selectivity was 
greatly reduced in vivo due to the biotransformation into chlordesipramine, an NA uptake 
inhibitor. In more detailed in vivo studies, indalpine (67) was shown to be the most potent and 
the most selective inhibitor of 5-HT and it was found to be the most active 5-hydroxytryptophan 
(5-HTP) potentiator44. 
 
It was found that indole-3-carbinol (68) inhibits the proliferation and tube formation, an in vitro 
maker of angiogenesis of phorbol myristate acetate (PMA) activated EA hy926 endothelial cells,  
a potential angiogenesis stimulator and such suppression is associated with decrease in secretion 
of VEGF and matrix metalloproteinase (MMP-2 and MMP-9)45. Indole-3-carbinol (68) is a 
naturally occurring anticancer agent and has entered clinical trials for cancer prevention. It (68) 
is a dietary component found in exclusively in cruciferous vegetables and it is known to suppress 
proliferation and induce apoptosis of various cancer cells, including breast, ovarian, lung, 
cervical, colon, prostate and liver.  
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Compound (68) was able to selectively inhibit activation of Akt in the tumor-derived MDA-MB-
468 breast and PC-3 prostate cancer cell lines, but not in nontumorigenic human HBL100 breast 
and CRL2221 prostate epithelial cells46. Adrenaline or noradrenaline are prominent in the 
cardiovascular system, acting through α- and β-adrenergic receptors, which exist as a number of 
subtypes. The interaction of effects from these receptors is quite complex. Many common drugs 
are simple carbocyclic analogues of adrenaline but few of the important compounds are 
heterocyclic. One of them is indoramin (69) which is used for the treatment of hypertension and 
benign prostatic hypertrophy47.  
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Figure  
 
1.5 2- and 3-Disubstituted Indoles: Synthesis and Biological Importance 
 
1.5.1 Synthesis 
 
2-and 3-Disubstituted indoles can be synthesized from either 3-substituted indoles by introducing 
substituents onto the 2-position, from 2-substituted indole by introducing substituents onto the 3-
position or by cyclization reactions using starting materials that already bear the substituents that 
will occupy 2-and 3-positions of the indole nucleus. They can be formed from α-halogenated or 
Chapter 1                                                Introduction 
 
24 
 
α-hydroxy ketones with arylamines in the presence of halogen acid. For example, treating 2-
bromo-1,2-diphenylethanone (70) with aniline gave 1,2-diphenyl-3-(phenylamino)propan-1-one 
(71). Heating (71) with aniline in the presence of hydrochloric acid for several hours under a 
nitrogen atmosphere gave 2,3-diphenylindole (72) in excellent yield48.  
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Scheme 19 
 
The simplest way of building the indole skeleton with substituents at the 2-and 3-postions would 
be through intermolecular reaction between aminoarene and C2 fragments. The problem is that 
these types of reaction are usually carried out over a heterogeneous catalyst under very severe 
reaction conditions and at high temperatures. The ruthenium-catalyzed reactions between 
aminoarenes and glycols have paved a way for homogeneous transition metal catalysis at 
reduced reaction temperatures. It has been shown that aniline reacted smoothly with 1-
phenylbutane-1,2-diol (73) in the presence of catalytic amount of ruthenium complex with the 
spontaneous hydrogen evolution to give 2-ethyl-3-phenylindole (74) in good yield49. 
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Scheme 20 
 
Bischler indole synthesis is one the classical indole synthesis methods and it involves the 
reaction of aniline with α-haloketones. Its use has been limited by the low accessibility of α-
haloketones. A Bischler-type indole synthesis that would avoid the use of haloketones, thereby 
making it a halogen-free reaction, has been used for the preparation of 2,3-disubstituted indoles. 
The reaction is based on the intermolecular addition of anilines to terminal alkynes and is 
efficiently catalyzed by a commercially available ruthenium carbonyl/additive mixture. As 
described in the literature, aniline was reacted with pent-1-yn-3-ol (75) in the presence of 
ruthenium carbonyl as a catalyst and ammonium hexafluorophosphate (NH4PF6) as an additive to 
give 3-ethyl-2-methylindole (76) in good yield50. 
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1.5.2 Biological Importance  
 
Indoles substituted at both the 2-and 3-positions are also of biological importance. The biological 
activities depend on the type of groups in these positions and the substituents can be aromatic, 
straight chains and non-aromatic rings. Indomethacin (77), a 5-methoxy indole ring which 
contains an acetic acid moiety at position 3 and a methyl substituent at position 2 has shown 
biological activities. Position 1 is occupied by 4-chlorobenzoyl group which also contributes to 
the observed properties. Indomethacin is a potent non-steroidal anti-inflammatory agent used 
primarily in the treatment of rheumatoid arthritis and has potential for use in uveitis, a common 
disease responsible for blindness. Indomethacin may also be used in the management of cystoid 
macular edema (CME), a disease characterized by a build-up of serous fluid in the extracellular 
space in the retina caused by a disruption of the blood-retinal barrier51. Nonsteroidal anti-
inflammatory drugs (NSAIDs) remain among the most widely prescribed drugs worldwide for 
the treatment of inflammation including pain-releasing, antipyretic and rheumatoid arthritis. The 
mechanism of action is through their inhibition of prostaglandin biosynthesis via the enzyme 
cyclooxygenase-2 (COX-2). An example of a synthetic NSAID is 2-phenyl-3-
phenylsulfonamide-1H indole (78), which was found to be more potent and selective against 
COX-2 than COX-152. 
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Current drugs effective against the HIV-1 reverse transcriptase (RT) are classified according to 
their structure as nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTIs and 
NNRTIs, respectively). NRTIs interfere with the enzyme activity following metabolic activation 
to the triphosphate forms and incorporation into the growing DNA strand, which causes chain 
termination. On the other hand, NNRTIs do not require preliminary phosphorylation and are less 
toxic than NRTIs because they do not affect the activity of cellular polymerases and they give 
rise to the rapid emergence of drug-resistance strains which are cross-resistance of other 
inhibitors within the class. 
 
5-Bromo-3-(3,5-dimethylphenylsulfonyl)indole-2-carboxamide (79) was tested against HIV-1 in 
acutely infected MT-4 cells. It showed to be very potent and selective anti-HIV-1 activity not 
only on wild type strains, but also against mutants carrying NNRTI-resistance mutations53. 
Compounds that interfere with the microtubule-tubulin equilibria in cells are useful in the 
treatment of human disease.  [2-(3-Hydroxy-4-methoxyphenyl)-6-methoxy-indol-3-yl](3,4,5-
trimethoxyphenyl)methanone (80) was showed good activity as tubulin polymerase inhibitors 
and was further evaluated for inhibitory effect on the binding of [3H]colchicine to tubulin and 
cytotoxicity against MCF-7 human breast carcinoma cells. However, (80) was found to be less 
potent than combretastatin A-4 (CA-4) as an inhibitor of [3H]colchicine binding to tubulin and as 
cytotoxins against MCF-7 human breast carcinoma cells and its cytotoxicity was less compared 
to CA-454. 
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1.6 Fused indoles: Synthesis and Biological Importance of Carbazoles 
 
1.6.1 Synthesis 
 
Carbazoles (benzo[b]indole) are natural products of medicinal and biochemical importance55. 
They display a range of biological activities that make them attractive compounds to synthetic 
and medicinal chemists. Many methods exist for their preparation in our laboratories. Synthetic 
methodology has been developed for the synthesis of indolocarbazoles employing a light-and 
base-assisted cyclization reaction. Starting from N-methyl-2-bromoindole-3-carbaldehyde (81) 
and treating it with 1,4-dimethoxy-3-methylnaphthalen-2-ylboronic acid (82) under aqueous 
Suzuki-Miyaura cross-coupling reaction conditions afforded the desired compound (83) in good 
yield. Compound (83) was then exposed to potassium tert-butoxide and light in 1,2-
dimethylformamide (DMF) at 80 °C to give the naphtho-fused carbazole (84) in fair yield and 
(84) was further oxidized with ceric(IV) ammonium nitrate (CAN) to afford (85) (Scheme 22)56. 
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Scheme 22 
 
Many natural occurring compounds such as granulatimide (86) and isogranulatimide (87) 
isolated from the ascidian Didemnum granulatum (Figure 10) contain a maleimide unit attached 
to the carbazole. Their biological activity is linked to their capacity to interfere with the G2 
checkpoint in cell growth, which represents a promising target for the development of new 
chemotherapeutic anticancer agents.  
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Other related compounds have also been assembled. For example, there is a new family of 
isogranulatimide analogues in which the imidazole moiety is replaced by a pyrrole heterocycle. 
In the synthesis of these examples, indole (9) was selectively brominated to give 3-bromoindole 
(62) which was then reacted with pyrrole (88) at room temperature in the presence of 
trifluoroacetic acid in dichloromethane which led to 2-(pyrrol-2-yl)indole (89). Reaction of (89) 
with pyrrole-2,5-dione (90) in the presence of stannous chloride gave the Michael adduct (91) in 
good yield. When (91) was treated with palladium black in nitrobenzene as a solvent at 200 °C 
followed by elimination of the solvent by filtration over silica afforded the isogranulatimide 
analogue (92) in good yield57. 
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A very large number of indole alkaloids belong to a class in which an unrearranged secologanin 
unit (93) can be recognized in combination with either tryptamine (94) or tryptophan (6).  For 
example, tryptamine (94) was condensed with secologanin (93), catalyzed by the enzyme 
strictosidine synthetase which controls C-ring closure mechanism, resulting in the formation of 
strictosidine (95) (Scheme 24)58. 
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Scheme 24 
 
1.6.2 Biological Importance 
 
The indolo[2,3-a]carbazole (96) framework contains an embedded indole unit and is found in 
many natural products which have a broad range of potent biological activities, such as 
antifungal, antimicrobial, antitumor, and antihypertensive activity. These carbazoles can be 
potent inhibitors of protein kinase C59. For example, staurosporine (97) and Gö 6976 (98) both 
contain the indolo[2,3-a]carbazole nucleus. Staurosporine (97) has interesting biological 
activities including cytotoxic, antimicrobial, inhibition of protein kinase C, and platelet 
aggregation inhibition. Staurosporine (83) was also found to be one of the best ATP competitive 
kinase inhibitors with IC50 values in the nanomolar range for the serine kinases, protein kinase C, 
CDK2, CDK4, and CDK660.  Gö 6976 (98), a non-glycosidic indolo[2,3-a]carbazole, exhibits 
selective inhibition of protein kinase C and also acts as an antagonist of human 
immunodeficiency virus 1 (HIV-1) (Figure 11)59.  
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Figure 11 
 
Rebeccamycin (99) is an antitumor secondary metabolite isolated from cultures of Saccharothrix 
aerocolonigenes. Rebeccamycin (99) was found to have significant activity against P388 
leukemia, L1210 leukemia and B-16 melanoma implanted in mice and inhibited the growth of 
human lung adenocarcinoma cells. It was found that (99) produces single-strand breaks in DNA 
and in a modified form, it is currently being considered for clinical evaluations as a potential 
treatment for cancer in humans61. On the other hand, fascaplysin (100), a red pigment isolated 
from the Fijian sponge Fascaplysinopsis Bergquist sp. was reported to inhibit the growth of 
several microbes including Staphylococcus aureus, Escherichia coli, Candida albicans, 
Saccharomyces cerevisiae and was also found to suppress proliferation of mouse leukemia cells 
L-1210 while its analogue, cryptolepine (101) has been demonstrated to efficiently intercalate 
into DNA and to act as a potent topoisomerase II inhibitor62. 
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1.7 Aims of the Project 
 
In this MSc project we wished to develop methodology to synthesize 2- and 3-substituted 
indoles, specifically with aryl substituents at those positions. The first part of the MSc project 
was to synthesize 2-arylsubstituted indoles using, as a key step, Suzuki reactions and conditions. 
Alternative methodology to the Suzuki-Miyaura coupling for introducing aryl substituents at C-2 
was developed. For the second part of the project we focused on synthesizing 3-aryl substituted 
indoles with general formula 3-arylindole. In order to place aryl substituents in the 3-position, 
the method we wished to use was the Suzuki-Miyaura coupling reaction, which requires an 
aromatic halide as one component and an aromatic boronic acid as the other. Once these 2-
arylindoles and 3-arylindoles were synthesized, they would be subjected to a range of biological 
screens. After we finished synthesizing 2- and 3-arylindoles, we turned our attention to fused 
indoles. We wished to explore the methodology to synthesize indolo fused pyrans and this was 
achieved by using mercury acetate as a key reagent for ring closure. 
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Chapter 2: Results and Discussion 
 
2.1 Protection and halogenations of the  indole nucleus 
 
In this section we will outline the synthesis of halogenated 2- and 3-substituted indole 
precursors. We required these precursors for the introduction of aryl substituents at both of these 
positions using a variety of different procedures that will be discussed later. However, initially 
we needed to protect the indole nitrogen such that it can also act as a directed ortho metallation 
(DOM) group, but this group needed to be readily removed once the required 2- and 3-
arylindoles were synthesized. 
 
2.1.1 Synthesis of 1-(phenylsulfonyl)-1H-indole (23) and 5-methoxy-1-(phenylsulfonyl)-1H-
indole (104) 
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Scheme 25 
 
Gribble et al. have described procedures for introducing the phenylsulfonyl group at low 
temperatures. The method employs air and water sensitive chemicals namely, n-butyllithium at –
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78 °C 63. Some of recently developed methodologies involve sodium hydroxide as base which is 
not sensitive to either air or water and the reaction takes place at 0 °C to room temperature as 
compared to –78 °C. In this project, commercially available indole (9) or 5-methoxyindole (102) 
was treated with sodium hydroxide and phenylsulfonyl chloride (103) in the presence of a 
catalytic amount of tetrabutylammonium bromide to afford 1-(phenylsulfonyl)indole (36) and 5-
methoxy-1-(phenylsufonyl)indole (104) in excellent yields of 100%60. Compound (36) was 
obtained as a cream white solid, with the melting point 75-78 °C and the literature reported (36) 
isolated as colourless needles with melting point 76.5-77 °C 64. The 1H NMR spectra of both 
compounds showed the disappearance of the NH signal. The 1H NMR spectrum of (36) was also 
characterized by the appearance of a doublet (J = 7.50) at 7.87 ppm integrating for two 
hydrogens which belonged to two equivalent hydrogens on the phenylsulfonyl group and other 
three hydrogens are embedded in the multiplet. This was also evident from the increased number 
of hydrogens in the aromatic region due to the introduction of the phenylsulfonyl group. The 13C 
NMR spectrum of (36) showed two peaks at 129.66 and 127.14 ppm each accounting for two 
equivalent carbons bearing a hydrogen of the phenyl ring of (36).  
 
N
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N
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Figure 14  
 
Compound (104) was isolated as white solid with melting point 96-99 °C. The literature reported 
that (104) was isolated as colourless crystals34, 63 with melting point 97-98 °C34.On the other 
hand, the 1H NMR of compound (104) also showed two doublets at 7.83 (J = 7.51) and 7.40 (J = 
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7.89) ppm each integrating for two hydrogens which belonged to the four hydrogens on the 
phenylsulfonyl group. The 13C NMR spectrum showed two distinct peaks at 129.61 and 127.06 
ppm belonging to the four carbons on the phenylsulfonyl group.  
 
2.1.2 Synthesis of 2-iodo-1-(phenylsulfonyl)-1H-indole (105) and 2-iodo-5-methoxy-1-
(phenylsulfonyl)-1H-indole (106) 
 
As a next step we needed to use methodology to introduce halogens at the 2-position of the 
indole nucleus for the proposed Suzuki coupling reaction. 
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Scheme 26 
 
Encouraged by the good yields obtained for compounds (36) and (104), we decided to attempt 
the next step, i.e. iodination at the 2-position of the indole nucleus. The iodination of these 
compounds proved not to be straight forward. The first method attempted was using lithium 
diisopropylamine as a base at –78 °C as described in the literature65 but this method failed. We 
attempted numerous methods without success until we tried a method developed in our 
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laboratories. The method was mainly used on pyrroles to introduce substituents onto the 2-
position28, and is an extension of a procedure by Kondo et al. for introducing substituents at the 
2–position of indole using magnesium amide bases27. Both compounds (36) and (104) were 
dissolved in THF and treated with isopropylmagnesium chloride and a catalytic amount of 
diisopropylamine, after which the reaction was left to stir at room temperature for 16 hours. 
After this time, the reaction mixture was treated with iodine and left to stir for 1 hour before 
being quenched by the aqueous solution of ammonium chloride as a part of the work up. 
Products (105) and (106) were obtained in yields of 79% and 85% respectively. Compound (105) 
was isolated as a cream white solid with melting point 95-98 °C. The literature reported the 
isolation of (105) as colourless solid27 and tan crystalline solid65 with melting point 96-98 °C66. 
The 1H NMR spectrum of (105) showed a distinctive singlet at 6.99 ppm integrating for one 
hydrogen. This signal belongs to the 3-position, showing that the 2-position is occupied by a 
substituent. The 13C NMR spectrum showed a distinctive quaternary carbon at 121.85 ppm that 
did not appear in the 13C NMR spectrum of (36). Compound (106) was isolated as a cream white 
solid with the melting point 127-130 °C. The 1H NMR spectrum of (106) also showed the similar 
distinctive singlet at 6.89 ppm integrating for one hydrogen for the 3-position of indole nucleus 
(106).  
 
2.1.3 Synthesis of 3-bromo-1-(phenylsulfonyl)-1H-indole (107) 
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Scheme 27 
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The next step for this project was to introduce a halogen at the 3-position of the indole nucleus. 
There are many different methods for preparing (107) described in the literature. One of the 
methodologies involves using reagents such as n-butyllithium and trimethyltin chloride followed 
by addition of bromine in order to convert (9) to 3-bromoindole (62)41 (Scheme 17). Compound 
(62) was then treated with phenysulfonyl chloride in the presence of potassium hydroxide to 
afford (107) but the problem with this method was the instability of compound (62) 68. 
Compound (36) can also be brominated using molecular bromine at room temperature using the 
correct number of equivalents of bromine67. In our case, a mixture of (36) and sodium acetate in 
acetic acid was treated with bromine. The overall mixture was the refluxed for 18 hours over 
which time it turned from brown to light yellow. After being allowed to cool to room 
temperature, the reaction mixture was filtered to remove sodium acetate and the acetic acid 
removed under reduced pressure. This was followed by water work up to give (107) as a white 
solid with a melting point of 120-124 °C, literature reported (107) as a white solid with a melting 
point 122-124 °C68. The 1H NMR spectrum of (107) showed a distinctive singlet at 7.62 ppm 
integrating for one hydrogen belonging to the hydrogen at the 2-position of (107) and 
disappearance of a doublet at about 6.50 ppm due to the hydrogen at the 3-position when 
compared to the 1H NMR spectrum of (36).  
 
2.1.4 Synthesis of 2,3-dibromo-1-(phenylsulfonyl)-1H-indole (108) 
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Scheme 28 
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We also wished to assemble indoles containing aryl substituents at the 2- and 3-positions. If we 
wished to use Suzuki coupling methodology we required a substituted indole such as (108) with 
halogens in both the 2- and 3-position. There are also many different routes for the synthesis of 
(108). One can first synthesize (107) and subsequent bromination of (107) will yield (108)69. In 
our laboratories, (36) was dissolved in carbon tetrachloride and treated with 1.1 eq of bromine at 
room temperature and the reaction left to stir overnight. After this time, the reaction mixture was 
poured into a saturated solution of aqueous sodium hydrogen carbonate and washed successively 
with water, aqueous solution of sodium metabisulfate and brine to remove excess bromine. This 
resulted in a cream white solid in 47% yield with melting point 140-145 °C while the literature 
reported (108) was isolated as white crystals with melting point 141-143 °C70. When the 1H 
NMR spectrum of (108) was examined, there was no indication of the doublet at about 6.50 ppm 
for one hydrogen due to presence of both 2-and 3-position hydrogens. Neither was there the 
singlet at about 6.99 ppm that result when 2-position is occupied nor the singlet at about 7.62 
ppm indicating that the 3-position is occupied was observed. Examination of 13C NMR spectrum 
revealed two distinctive quaternary carbons at 120.52 and 107.13 ppm showing that positions 2-
and 3- are occupied by substituents other than hydrogen. The chemical shifts indicated that most 
likely a halogen occupied both of these positions. 
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2.1.5 Synthesis of 3-bromo-5-methoxy-1-(phenylsulfonyl)-1H-indole (109) 
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Scheme 29 
 
Once the synthesis of indole (108) was complete we turned our attention to the same set of 
reactions starting from 5-methoxyindole (104) also protected as the N-phenylsulfonyl derivative. 
However, the bromination of (104) proved not to be straightforward as compared to bromination 
of a (36). When (104) was brominated under the same conditions as for (36) (Br2, CCl4), the less 
soluble tribromide (110) was identified instead of the monobromo product (109). This was 
confirmed by mass spectroscopy with the M+ at 523.85 for 79Br isotope and 525.81 for 81Br 
isotope. It has been shown that bromination of (104) with molecular bromine as shown in 
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Scheme 29 does not afford (109) as required but usually affords (111) although not detected in 
this case and for one to obtain (109) under these conditions, one must be very careful in 
conducting this reaction56. Bromination of the benzene ring of the indole is occurring due to the 
activation of the benzene ring by the methoxy group.  
 
To resolve this problem, indole (104) was dissolved in dry carbon tetrachloride and mixed with 
N-bromosuccinimide and a catalytic amount of benzoyl peroxide at room temperature. The 
reaction mixture was then refluxed overnight after which excess succinimide was filtered off. 
Trace amounts succinimide were removed by washing with 5% solution of aqueous sodium 
hydroxide and water. This resulted in a cream white solid (109) being obtained with the melting 
point 129-132 °C while the literature reported a white solid 131-133 °C56. When 1H NMR 
spectrum of (109) was examined, a singlet integrating for one hydrogen at 7.58 ppm was 
observed. This singlet belonged to the proton at the 2-position and this showed that 3-position of 
the indole nucleus was occupied. Examination of 13C NMR spectrum of (109) showed the 
presence of a quaternary carbon at 98.69 ppm belonging to the carbon at the 3-postion. 
 
2.2 Synthesis of 2-arylindoles and 3-arylindoles 
 
As the desired halogenated substrates (105)-(109) had now been synthesized, this section will 
deal with the synthesis of 2-arylindoles and 3-arylindoles from these precursors. The key step 
used in this section is the aqueous Suzuki-Miyaura cross-coupling of haloindoles and arylboronic 
acids, mediated by palladium catalyst.  
 
2.2.1 Synthesis of boronic acids 
 
The other precursors required for the coupling reactions, the boronic acids, were prepared from 
the requisite halogenated aryl compounds using traditional methodology, i.e treatment with n-
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butyllithium, followed by trimethyl borate and then converting the boronic ester into the required 
boronic acid by treating each intermediate with 10% aqueous hydrochloric acid. The boronic 
acids obtained in this way are difficult to purify and hence they were used in the subsequent 
reactions as crude materials. The boronic acids synthesized and used in this project were 
phenylboronic acid (112), o-tolylboronic acid (113), 1-naphthylboronic acid (114), p-
methoxyphenylboronic acid (115) and 3,4,5-trimethoxyphenylboronic acid (116) (Scheme 30). 
Although some of these are also commercially available. Table 1 below lists the approximate 
yields of the crude boronic acids. 
 
Ar-Br
BuLi, B(OMe)3, THF,
-78 oC, 1 h, 10% HCl
Ar-B(OH)2
112, 113, 114, 115 and 116
 
Scheme 30 
Table 1: % Yields of boronic acids 
Ar Boronic 
acid 
% yield 
Phenyl 112 88 
o-Tolyl 113 92 
1-Naphthyl 114 70 
p-Methoxyphenyl 115 81 
3,4,5-Trimethoxyphenyl 116 80 
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The other boronic acids used in this project were 2-formylphenylboronic acid (117) and 2-
acetylphenyboronic acid (118), which are commercially available (Figure 15) and were bought 
for this project. 
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117 118
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Figure 15 
 
2.2.2 Suzuki-Miyaura cross-coupling of iodoindoles (105) and (106) followed by 
deprotection 
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Scheme 31 
 
The next step in this synthesis was to perform the Suzuki-Miyaura cross-coupling of either 
indole (105) or methoxyindole (106) with the boronic acids (112)-(116). The two iodoindoles 
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(105) and (106) were exposed to the boronic acids (112)-(116) in the presence of catalytic 
amounts of [Pd(PPh3)4] and aqueous sodium carbonate and dimethoxyethane/ethanol under 
reflux to afford the desired cross-coupling products (119), (121), (123), (125) and (127) for R = 
H while for R = OMe, the products obtained were (120), (122), (124) and (126) in fair to 
excellent yields (Table 2). 
 
Table 2: The % yields of cross-coupling of iodoindoles (105) and (106) with the boronic acids 
(112)-(116) 
R = Ar Boronic 
acid 
Product % yield δ3-H 
ppm 
Melting point °C 
H Phenyl 112 119 82 6.52 100-104 lit. 104-
10564 
OMe Phenyl 112 120 60 6.48 Oil 
H o-Tolyl 113 121 44 6.46 Oil 
OMe o-Tolyl 113 122 78 6.32 Oil 
H 3,4,5-Trimethoxyphenyl 114 123 56 6.40 Oil 
OMe 3,4,5-Trimethoxyphenyl 114 124 77 6.48 Oil 
H p-Methoxyphenyl 115 125 60 6.53 209-212 
OMe p-Methoxyphenyl 115 126 61 6.33 Oil 
H 1-Naphthyl 116 127 60 6.52 Oil 
 
 
The formation of all products was confirmed by 1H and 13C NMR spectroscopy. The 1H NMR 
spectra of (119)-(127) showed distinct singlet at ~6.00-6.55 ppm (Table 2) integrating for one 
Chapter 2                                                     Results and Discussion 
47 
 
hydrogen, suggesting that the 2-position of each compound is occupied by a substituent other 
than hydrogen. The 1H NMR spectra of (121) and (122)  showed further two singlets at 2.19 and 
2.13 ppm respectively each accounting for three hydrogens, thereby suggesting the presence of 
methyl groups. The 1H NMR spectra of (123) and (124) were further characterized by two 
singlets. Compound (123) showed a singlet at 3.85 ppm accounting for nine hydrogens while 
compound (124) showed two singlets at 3.94 ppm accounting for three hydrogens and 3.87 ppm 
accounting for six hydrogens, hence indicating the presence of methoxy substituents in the 
compounds. The examination of 1H NMR spectra of (125) and (126) also revealed some useful 
information. Their spectra showed one singlets each at 3.80 and 3.79 ppm respectively each 
integrating for three hydrogens, suggesting the presence of methoxy substituents in the 
compounds. The examination of 1H NMR spectrum of (127) showed an increase in number of 
hydrogens in the aromatic region suggesting the presence of an aromatic system, and in our case, 
the presence of naphthalene moiety.  
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Figure 16 
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The 13C NMR spectra of these compounds further confirmed the results obtained. The 13C NMR 
spectra of (119) and (120) showed two quaternary carbons at 115.79 and 131.72 ppm 
respectively, indicating that the 2-position of the two compounds is occupied and further showed 
two carbon signals at 114.19 and 103.22 ppm respectively suggesting that the 3-position of the 
two compounds is bonded to a hydrogen atom. On the other hand, the 13C NMR spectra of (121) 
and (122) showed one carbon signal each at 20.89 and 20.87 ppm respectively, suggesting the 
presence of methyl substituents of these compounds. The 13C NMR  spectra of (123) and (124) 
showed  two carbon signals each, 62.38 and 57.63 ppm for (123), 60.39 and 55.58 ppm for (124), 
all indicating the presence of methoxy groups in these compounds while the 13C NMR spectra of 
(125) and (126) showed one carbon signals each at 55.75 and 55.26 ppm respectively indicating 
the presence of methoxy groups of these compounds and overall the 13C NMR spectra of all 
compounds showed an increase in the number of aromatic carbons compared to those observed 
for starting materials (105) and (106). 
 
The next step was the removal of the phenylsulfonyl protecting group of the compounds (119)-
(127) discussed above. This was done by treating the solution of the compounds (119)-(127) in 
methanol with potassium carbonate under reflux followed by treatment with 10% hydrochloric 
acid solution and subjection to column chromatography to afford the unprotected compounds 
(128)-(136) (Scheme 32).  The envisaged unprotected compounds (128)-(136) were produced in 
good to excellent yields (Table 3), and their structures were confirmed by spectroscopy.  
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Scheme 32 
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Table 3: The % yields of unprotected indoles (139)-(147) 
R = Ar Product % yield δNH 
ppm 
Melting point °C 
H Phenyl 128 78 8.36 182-186 lit. 182-
18479 
OMe Phenyl 129 61 8.21 162-165 
H o-Tolyl 130 82 8.04 81-85, lit. 92-
9380 
OMe o-Tolyl 131 67 8.03 Oil 
H 3,4,5-Trimethoxyphenyl 132 51 8.42 206-209, lit. 
205-206.581 
OMe 3,4,5-Trimethoxyphenyl 133 86 8.38 152-155 
H p-Methoxyphenyl 134 52 11.40 228-230, lit. 
227-23182 
OMe p-Methoxyphenyl 135 51 10.22 116-120 
H 1-Naphthyl 136 52 8.19 96-100, lit. 99-
10283 
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Figure 17 
 
The 1H NMR spectra of all compounds (128)-(136) showed a decrease in number of protons in 
the aromatic region, suggesting that the phenylsulfonyl group was no longer present. The spectra 
further confirmed the results by showing the appearance of a new peak integrating for one 
hydrogen between 8.00 and 11.50 ppm (Table 3), suggesting the presence of NH groups of the 
indole. The examination of 13C NMR spectra of compounds (128)-(136) showed a decrease in 
number of carbon signals in the aromatic region, also suggesting that the phenylsulfonyl group 
was no longer present.  A further confirmation of these results was also made through infrared 
spectroscopy. The infrared spectroscopy of compounds (128)-(136) showed medium to strong 
broad peak at a range of 3300-3450 wavenumbers, suggesting the presence of NH group in these 
compounds. 
 
2.2.3 Suzuki-Miyaura cross-coupling of bromoindoles (107) and (109) followed by 
deprotection 
 
After the successful synthesis of 2-arylindoles, the next step was to synthesize 3-arylindoles. 
This was achieved because compounds (107) and (108) were successfully synthesized and 
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characterized as discussed previously. To achieve the synthesis of 3-aryindoles, the two 
compounds (107) and (109) were exposed to the boronic acids (112)-(116) and the other two 
boronic acids (117) and (118) as shown in Figure 15 in the presence of catalytic amounts of 
[Pd(PPh3)4] and aqueous sodium carbonate and dimethoxyethane/ethanol under reflux to afford 
the desired cross-coupling products (150)-(161). The products obtained for R = H were (137), 
(139), (141), (143), (145) and (147) while the ones obtained for R = OMe were (138), (140), 
(142), (144), (146) and (148) and they were obtained in good to excellent yields (Table 4). The 
structures are shown in Figure 18. 
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Scheme 33 
 
Table 4: The % yields of cross-coupling of (107) and (109) with boronic acids (112)-(118) 
R = Ar Boronic 
acid 
Product % yield δ2-H 
ppm 
Melting point °C 
H Phenyl 112 137 81 7.70 139-142, lit. 
141-14364 
OMe Phenyl 112 138 85 7.65 Oil 
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H o-Tolyl 113 139 64 7.87 Oil, lit. Oil56 
OMe o-Tolyl 113 140 86 7.41 111-114, lit. 
127-12856 
H 3,4,5-Trimethoxyphenyl 114 141 65 7.67 Oil 
OMe 3,4,5-Trimethoxyphenyl 114 142 72 7.47 132-136 
H p-Methoxyphenyl 115 143 79 7.63 132-137, lit Oil84 
OMe p-Methoxyphenyl 115 144 72 7.58 Oil 
H 2-Formylphenyl 117 145 72 7.68 Oil 
OMe 2-Formylphenyl 117 146 94 7.59 129-132 
H 2-Acetylphenyl 118 147 92 7.46 Oil 
OMe 2-Acetylphenyl 118 148 82 7.42 105-109 
 
 
Compounds (137)-(148) were characterized and the identity confirmed by spectroscopic 
techniques. Examination of the 1H NMR spectra of compounds (137)-(148) showed a distinctive 
singlet for the hydrogens at C-2 between 7.00 and 7.80 ppm, suggesting that the 3-position in the 
compounds was a substituent other than hydrogen. The spectra further showed an increase in 
number of hydrogens in the aromatic region, suggesting the presence of extra aromatic signals in 
comparison with the starting materials (107) and (109). The 1NMR spectrum of (137) showed a 
singlet at 7.69 ppm and a distinct doublet at 7.60 ppm due to the presence of phenyl ring at the 3-
position of (137) while that of (138) showed a singlet at 7.65 ppm and a distinct doublet at 7.57 
ppm also due to the presence of the phenyl at the 3-position of (138). The 1H NMR spectra of 
(139) and (140) showed one distinct singlet each at 2.21 ppm for (139) and 2.19 ppm for (140), 
each accounting for three hydrogens, suggesting the presence of a methyl substituent in the 
compounds (139) and (140). Further examination of the 1H NMR spectra of (141) and (142) 
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revealed a singlet at 6.80 ppm for (141) integrating for two hydrogens and a singlet at 3.91 ppm 
accounting for nine hydrogens indicating the presence of three methoxy substituents of (141) 
while that of (142) revealed a singlet at 6.77 ppm accounting for two hydrogens and further 
showed an additional two singlets at 3.91 ppm, accounting for six hydrogens and 3.90ppm 
accounting for three hydrogens, both indicating the presence of the extra three methoxy 
substituents of (142).  
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Figure 18 
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The 1H NMR spectra of (143) and (144) showed two singlets each, accounting for one hydrogen 
at 7.63 ppm for (143) and 7.58 ppm for (144) suggesting that the 3-position of the compounds 
was occupied and they further showed two singlets at 3.85 ppm for (143) and 3.86 ppm for (144) 
each integrating for three hydrogens, suggesting the presence of methoxy substituents in the 
compounds. The 1H NMR spectra of (145) and (146) showed two singlets at 9.90 and 9.87 ppm 
respectively, each accounting for one hydrogen, suggesting the presence of aldehydes of the 
compounds and the 1H NMR spectra of (147) and (148) revealed two singlets at 1.90 and 1.87 
ppm respectively, each integrating for three hydrogens, indicating the presence of the acetyl 
group in the compounds.  
 
The examination of the 13C NMR spectra of compounds (137)-(148) showed an increase in the 
number of carbon signals in the aromatic region in comparison with those of the starting 
materials (107) and (109). The 13C NMR spectra of (139) and (140) showed two distinct carbon 
signals at 20.80  and 20.78 ppm respectively, supporting the 1H NMR, suggesting the presence of 
methyl groups on (139) and (140). Two carbon signals at 59.26 and 54.53 ppm suggesting the 
presence of methoxy groups were observed on the 13C NMR spectrum of (141) and the 
examination of the 13C NMR spectrum of (142) also revealed two distinct carbon signals at 60.41 
and 55.73 ppm, indicating the presence of methoxy groups on (142). Further examination of the 
13C NMR spectra of (143) and (144) showed two carbon signals at 55.41 and 55.79 ppm 
suggesting the presence of methoxy groups on (143) and (144) while the 13C NMR spectra of 
(145), (146), (147) and (148) showed distinct carbon signals at 192.00, 192.11, 203.89 and 
204.21 ppm respectively, which are characteristic of a carbonyl groups. The 13C NMR spectra of 
(147) and (148) also showed two distinct carbon signals at 30.14 and 30.11 ppm which is 
indicative of the presence of methyl groups on (147) and (148). The results of the formation of 
(145), (146), (147) and (148) were further supported by the information from infrared 
spectroscopy. The infrared spectra of (145), (146), (147) and (148) showed strong absorption 
peaks at 1693, 1681, 1685 and 1690 wavenumbers respectively, confirming the presence of 
carbonyl groups of the products. 
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After the successful synthesis of compounds (137)-(148), the next step was to remove the 
phenylsulfonyl protecting group of these compounds. This would be achieved as before by 
treating the solutions of compounds (137)-(148) in methanol with potassium carbonate under 
reflux followed by treatment with 10% hydrochloric acid and subjection to column 
chromatography afforded unprotected indoles (149)-(160) (Scheme 34). The envisaged 
unprotected indoles (149)-(160) were produced in good to excellent yields (Table 5) and their 
structures were confirmed by spectroscopic techniques. 
 
N
H
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R
K2CO3, MeOH,
reflux, 10% HCl
R = H (149, 151, 153, 155, 157 and 159)
R = OMe (150, 152, 154, 156, 158 and 160)
R = H (137, 139, 141, 143, 145, and 147)
R = OMe (138, 140, 142, 144, 146 and 148)
N
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R
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Scheme 34 
 
Table 5: The % yields of unprotected indoles (149)-(160) 
R =  Ar Product % yield δH 
ppm 
Melting point °C 
H Phenyl 149 81 8.17 86-89, lit. 8985 
OMe Phenyl 150 85 8.01 Oil, lit. 66-6786 
H o-Tolyl 151 64 8.17 Oil, li. Oil56 
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OMe o-Tolyl 152 86 8.11 Oil, lit. Oil56 
H 3,4,5-Trimethoxyphenyl 153 65 8.35 Oil 
OMe 3,4,5-Trimethoxyphenyl 154 72 8.46 Oil 
 
H 
p-Methoxyphenyl 155 79 8.13 130-134, lit. 
131-13387 
OMe p-Methoxyphenyl 156 72 8.10 Oil, lit. 151.2-
15288 
H 2-Formylphenyl 157 72 8.61 Oil 
OMe 2-Formylphenyl 158 95 8.51 Oil 
H 2-Acetylphenyl 159 92 8.61 Oil 
OMe 2-Acetylphenyl 160 82 8.56 116-120 
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Figure 19 
 
The formation of compounds (149)-(160) was confirmed by the 1H NMR spectra in which the 
singlet between 8.00 and 8.65 ppm (Table 5) accounting for one hydrogen indicating the 
presence of the indole NH group. The results were further confirmed by 1H NMR spectra of the 
compounds when they showed a decrease in number of hydrogens in the aromatic region 
suggesting the removal of the phenylsulfonyl protecting group. When the 13C NMR spectra of 
(149)-(160) were examined, a decrease in the number of carbon signals in the aromatic region 
was noted further suggesting the removal of the phenylsulfonyl protecting group. The infrared 
spectra of these compounds further supported the results by showing medium to strong 
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absorption in the range of 3200-3480 wavenumbers suggesting the presence of NH group in 
these compounds.  
 
 2.2.4 Suzuki-Miyaura cross-coupling of dibromindole (108) followed by deprotection 
 
The next step was to attempt the synthesis of 2,3-disubstituted indoles by using the 2,3-
dibromoindole (108) as the starting material with the hope of producing 2,3-diaryl substituted 
indoles. 
N
S OO
Br
Br
N
S OO
B(OH)2
112
108
161
[Pd(PPh3)4], DME, EtOH,
aq. Na2CO3, reflux, 56%
 
Scheme 35 
 
Compound (108) was successfully synthesized and characterized as described in section 2.1.4 of 
this project.  After the synthesis of (108), the next step required was to perform the Suzuki-
Miyaura cross-coupling reaction with the boronic acids (112)-(116) (Table 1), however only 
phenylboronic acid (112) shown in Scheme 35 was successfully utilized in the cross-coupling 
reaction. Presumably the other boronic acids were not successful as a result of steric factors, 
Heck trapping or electron withdrawing groups for (114) and (115) in placing two substituted aryl 
substituents in adjacent positions on the indole nucleus. Compound (108) was treated with 
boronic acid (112) in the presence of catalytic amounts of [Pd(PPh3)4
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carbonate and dimethoxyethane/ethanol under reflux to afford the desired cross-coupling product 
(161) in 56% yield (Scheme 35) as a cream white solid with melting point 173-175 °C with 
literature melting point of 174-176 °C69. The formation of (161) was confirmed by spectroscopy. 
The 1H NMR spectrum showed that the number of hydrogens in the aromatic region has 
increased, suggesting the presence of extra aromatic systems in comparison with the starting 
material (108). This was further supported by the 13C NMR spectrum which also showed that the 
number of carbon signals in the aromatic region has increased.  
 
N
H
162
K2CO3, MeOH, 
reflux, 10% HCl, 60%N
S OO
161
 
Scheme 36 
 
The next step was to remove the protecting group of (161).  This was be achieved by treating the 
solution of compound (161) in methanol with potassium carbonate under reflux followed by 
treatment with 10% hydrochloric acid and subsequent column chromatography to afford (162) in 
60% yield as a yellow solid with melting point 224-227 °C (Scheme 36). The formation of (162) 
was verified by spectroscopic techniques. The examination of the 1H NMR spectrum of (162) 
showed a decrease in number of hydrogens in the aromatic region which is indicative of the 
removal of the phenylsulfonyl protecting group and a singlet at 8.21 ppm integrating for one 
hydrogen, indicating the presence of the indole NH group. This was further supported by the 13C 
NMR spectrum which showed that the number of carbon signals in the aromatic region has 
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decreased in comparison with that of the starting material (161). The infrared spectrum of (162) 
showed a medium-intensity absorption peak at 3461 wavenumbers, indicating the presence of the 
indole NH group of (162). 
 
2.3 Synthesis of 2-arylindoles via one-pot synthesis 
 
The next step in the preparation of 2-arylsubstituted indoles was to attempt their construction 
without first preparing the 2-halogenated indoles. This would remove the need to form 
halogenated precursors. Fewer steps would then be needed in the synthesis and the use of 
reagents used for the introduction of a halogen would no longer be necessary. This can be 
important as often these reagents are toxic and especially from an industrial point of view their 
elimination is highly desirable. 
 
2.3.1 Synthesis of 2-(4-bromo-2,5-dimethoxyphenyl)-1-(phenylsulfonyl)-1H-
indole (164) and 2-(4-bromo-2,5-dimethoxyphenyl)-5-methoxy-1-
(phenylsulfonyl)-1H-indole (165) followed by deprotection 
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Scheme 37 
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As shown in Scheme 37, 2-substituted indoles were successfully synthesized via 
organomagnesium intermediate, made by treating the indole with magnesium amide base. Either 
previously prepared (36) or (104) was treated with isopropylmagnesium chloride and a catalytic 
amount of diisopropylamine in tetrahydrofuran at room temperature. The reaction mixture was 
stirred for 16 hours before being treated with 1,4-dibromo-2,5-dimethoxybenzene (163) in the 
presence of palladium(0) catalyst (Pd(PPh3)4) and the reaction mixture was left to stir for another 
48 hours. After this time, the reaction mixture was quenched by the addition of saturated solution 
of aqueous ammonium chloride and then worked up. Following the work up, the excess solvent 
was removed, resulting in a black oil that was subjected to column chromatography and 
recrystallized from the mixture of dichloromethane and diethyl ether which gave white solids for 
both (164) and (165) in low yields with melting points of 181-183 °C and 159-162 °C 
respectively. 
 
The 1H NMR spectrum of (164) was characterized by two singlets at 7.13 and 6.77 ppm each 
integrating for one hydrogen belonging to hydrogens on the newly introduced benzene ring of 
(164). The spectrum also showed a singlet at 6.58 ppm integrating for one hydrogen, which 
belongs to the 3-position of the indole nucleus (164).  The identity of the product was further 
proved by the presence of two singlets at 3.82 and 3.68 ppm, each accounting for three 
hydrogens, indicating the presence of methoxy group of (164). The 13C NMR spectrum of (164) 
also proved the results by showing two distinctive carbons signals at 57.36 and 56.54 ppm 
indicating the presence of methoxy groups supported by their respective quaternary carbons at 
153.08 and 149.63 ppm.  
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The formation of (165) was confirmed by the 1H NMR spectrum where two singlets each 
integrating for one hydrogen at 7.13 and 6.78 ppm were observed. The presence of a singlet at 
6.52 ppm accounting for one hydrogen belongs to the hydrogen on the 3-position of indole (165). 
One singlet at 3.82 ppm accounting for six hydrogens and another singlet at 3.69 ppm accounting 
for three hydrogens indicating the presence of three methoxy groups on (165). The 13C NMR 
spectrum further confirmed the results by showing three carbon signals at 57.36, 56.56 and 56.05 
ppm supported by their respective quaternary carbons at 157.24, 152.97 and 149.62 ppm 
indicating the presence of the three methoxy groups on (165).  
After the synthesis of (164) and (165) (Scheme 37), we then attempted to remove the 
phenylsufonyl protecting group. This was done by treating the solutions of the compounds (164) 
and (165) in methanol with potassium carbonate under reflux followed by treatment with 10% 
hydrochloric acid solution and subjection to column chromatography to afford the unprotected 
compounds (166) and (167) (Scheme 38).  The envisaged unprotected compounds were 
produced in moderate yields. 
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Scheme 38 
 
The formation of (166) and (167) was also confirmed by spectroscopy. The 1H NMR spectra of 
(166) and (167) showed a decrease in the number of hydrogens in the aromatic region, 
suggesting that the phenylsulfonyl group was removed. The spectra further supported the 
formation of (166) and (167) by showing one singlet for each at ~9.00 ppm. The peak positions 
were 9.63 ppm for (166) and 9.54 ppm for (167), indicating the presence of NH groups of the 
indole. The 13C NMR spectra of (166) and (167) further agreed with the results from 1H NMR 
spectra by showing that the number of carbons in the aromatic region has decreased, suggesting 
that the phenylsulfonyl group was no longer present. The infrared spectroscopy of (166) showed 
a medium-sized signal at 3450 wavenumbers and that of (167) showed a signal at 3397 
wavenumbers, both suggesting the presence of the NH group. 
 
2.4 Synthesis of indolopyrans 
 
Substituted pyrans are ubiquitous structural elements in natural products, and some have 
important biological activity71.  Their derivatives are often important intermediates in the 
synthesis of many natural products72. Apart from their biological activity, pyrans such as diaryl-
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benzopyrans and naphthopyrans display highly desirable photochromic properties73. We wished 
to construct the pyran ring onto the 2- and 3-position of the indole nucleus using the 
methodology developed in our laboratories. This would represent a novel pyran fused to an 
indole nucleus. 
 
2.4.1 Synthesis of 2-allyl-1-(phenylsulfonyl)-1H-indole (169) and 2-Allyl-1-(phenylsulfonyl)-
1H-indole-3-carbaldehyde (171) 
 
In order to construct the desired indolopyrans, substituents needed to be introduced at both the 2- 
and 3- position. Metallation at the 2-position of indole, for example using lithiation as a synthetic 
route to 2-substituted indoles, has been studied extensively. Owing to the low temperatures 
required for lithiating reagents and their instability including that of their intermediates, methods 
have been developed that use reagents that are more stable. Recently metallation of indoles using 
magnesium amide bases and their extension has been reported27, 28. In our laboratories, when 
(36) was treated with isopropylmagnesium chloride and allyl bromide (168) in the presence of 
catalytic amount of diisopropylamine, followed by quenching with saturated solution of aqueous 
ammonium chloride it gave a brown oil (Scheme 39). The oil was then subjected to column 
chromatography and the resultant solid recrystallized from a mixture of dichloromethane and 
diethyl ether to give (169) as a white solid in poor yield of 31% with melting point 88-91 °C. 
The formation of (169) was confirmed by the 1H NMR spectrum which showed a distinct singlet 
at 6.40 ppm accounting for one hydrogen which belongs to the 3-position of (169). This was 
further confirmed by a multiplet at 6.08-5.96 ppm accounting for one hydrogen, another 
multiplet at 5.22-5.16 ppm accounting for two hydrogens and a triplet at 3.78-3.76 ppm 
integrating for two hydrogens, indicating the presence of an allyl group. The 13C NMR spectrum 
further confirmed the results by showing two distinct carbon signals in the aromatic region at 
134.06 and 118.22 ppm and one at 33.78 ppm which also indicate the presence of allyl group of 
(169).  
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Scheme 39 
 
As we wished to synthesise 2,3-disubstituted indoles and, in this particular case assemble a fused 
pyran ring onto the indole after the synthesis of the above mentioned 2-allyl indole (169), the 
next step was its formylation at the 3-postion of the indole nucleus using titanium(IV) chloride 
and dichloro(methoxy)methane (170). Compound (169) was added to mixture of titanium(IV) 
chloride and (170) in dichloromethane at –78 °C and the reaction mixture stirred for 2 hours. 
After the reaction mixture was allowed to warm up to room temperature, it was neutralized by 
water and worked up according to literature74 and gave (171) as a brown oil. The literature 
reported (171) isolated as solid with melting point 157-158.5 °C75. The formation of (171) was 
supported by a singlet accounting for one hydrogen at 10.31 ppm in the 1H NMR spectrum of 
(171) and carbon signal at 186.18 ppm suggesting the presence of a carbonyl from the 13C NMR 
spectrum. This indicated the presence of the aldehyde (171). The infrared spectrum of (171) 
showed strong absorption at 1666 wavenumbers which clearly suggests the presence of a 
carbonyl group on (171). 
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2.4.2 Synthesis of (2-allyl-1-(phenylsulfonyl)-1H-indol-3-yl) methanol (172) 
 
After the successful synthesis of (171), the next step was to reduce the aldehyde to alcohol. Due 
to the reactivity of aldehydes, sodium borohydride is usually employed in this regard. The 
reduction with sodium borohydride should be carried out at lower temperatures due the heat 
released during the reaction and requires that sodium borohydride be added in portions76. 
Compound (171) was treated with sodium borohydride at 0 °C in ethanol and the reaction 
mixture was stirred for 6h. After this time, the solvent was removed under reduced pressure and 
the resulting white solid shaken up with 5% aqueous solution of sodium hydroxide and extracted 
with dichloromethane to give (172) as a yellow oil in 71% yield.  
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Scheme 40 
 
The literature reported that (172) was isolated as solid with melting point 82-83 °C76. The 1H 
NMR spectrum of (172) showed that the aldehyde peak had disappeared and the appearance of 
new broad singlet at 1.96 ppm suggesting the presence of the OH group on the desired product. 
This was further confirmed by the presence of another new singlet at 4.62 ppm, suggesting the 
presence of the methylene of the desired product. An investigation of the 13C NMR spectrum 
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showed that the carbonyl peak had disappeared, and there was a new carbon signal at 53.82 ppm 
again indicating the presence of the methylene substituent bearing oxygen. The infrared 
spectrum showed a broad absorption at 3406 wavenumbers which clearly suggests the presence 
of OH group on the desired product (172). 
 
2.4.3 Synthesis of 1-(2-allyl-1-(phenylsulfonyl)-1H-indol-3-yl) ethanol (173) 
 
After the successful synthesis of (172), we wanted to attempt the synthesis of similar alcohols. 
When (172) was synthesized, NaBH4 was used as a source of hydrogen for the reduction of the 
aldehyde. We attempted the synthesis of alcohol (173) using a Grignard reagent to added to the 
aldehyde (171) and in this case, methylmagnesium iodide in THF was used. 
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Scheme 41 
 
Methylmagnesium iodide was prepared in situ from dry magnesium turnings and methyl iodide 
in ether. The resulting solution was then treated with the solution of (171) in ether. The reaction 
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mixture was left to stir overnight before being quenched with saturated aqueous ammonium 
chloride solution followed by work up to give alcohol (173) as a yellow oil in 76% yield.  
 
The 1H NMR spectrum of (173) showed that the aldehyde peak that was at 10.31 ppm for (171) 
had disappeared. The 1H NMR also showed a multiplet at 5.04-4.92 ppm accounting for one 
hydrogen, a doublet at 1.56-1.54 ppm suggesting the presence of a methyl substituent on (173) 
and a broad singlet at 1.91 ppm accounting for one hydrogen suggesting the presence of OH 
group on (173). This was further confirmed by infrared spectrum which showed a broad peak at 
3567 wavenumbers suggesting the presence of OH group. An examination of the 13C NMR 
spectrum showed two distinctive carbon signals, one at 64.56 ppm which suggests the presence 
of methylene related substituent and another at 30.44 ppm which suggests the presence of a 
methyl substituent.  
 
2.4.4 Synthesis of 3-methyl-5-(phenylsulfonyl)-1,3,4,5-tetrahydropyrano[4,3-b]indole (174) 
and 1,3-dimethyl-5-(phenylsulfonyl)-1,3,4,5-tetrahydropyrano[4,3-b]indole (175) 
 
After the successful synthesis of alcohols (172) and (173), the next step was to perform the ring 
closure reaction to afford a novel compound, a pyran-fused indole. The two alcohols were treated 
with mercury acetate in tetrahydrofuran at room temperature. The reaction mixture was left to 
stir for 38 hours after which it was quenched with mixture of aqueous sodium hydroxide and 
sodium borohydride whilst stirring and the reaction mixture was stirred for further 1h before the 
addition of aqueous solution of sodium carbonate (Scheme 42). The reaction mixture was 
allowed to stand and worked up according to literature procedures77. This gave (174) as clear 
solid with melting point 145-148 °C and (175) as a clear oil.  
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Scheme 42 
 
The formation of (174) was confirmed by 1H NMR spectroscopy which showed that the broad 
singlet has disappeared. It also showed a multiplet at 5.19-5.04 ppm integrating for two 
hydrogens, a multiplet at 4.17-4.10 ppm accounting for one hydrogen, a multiplet at 3.56-3.50 
accounting for one hydrogen, another multiplet at 3.16-3.07 ppm accounting for one hydrogen 
and finally a doublet at 1.78-1.74 ppm accounting for three hydrogens. The identity of the 
product was further confirmed by 13C NMR spectrum which showed the alkene carbons that 
previously were in the aromatic region had disappeared. It also showed two carbon signals at 
69.81 and 62.15 ppm which suggests the presence of carbons that are bonded to oxygen, another 
two carbon signals at 31.78 and 20.38 ppm which probably suggests the presence of methyl and 
methylene groups on (174).  
 
The 1H NMR of (175) also showed the disappearance of the broad singlet peak. It also showed 
multiplets at 5.10-5.04 ppm, 4.14-4.08 ppm, 3.26-3.16 and 2.85-2.69 ppm, each accounting for 
one hydrogen and finally two doublets at 1.56-1.54 and 1.40-1.38 ppm which clearly suggest the 
presence of two methyl substituents on the desired product (175). The 1H NMR also suggested 
the presence of the two isomers, with one isomer more than the other but this has to be correctly 
determined. Further confirmation of the results was obtained from the 13C NMR spectrum of 
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(175) which showed that alkene carbons that were observed in the aromatic region disappeared. 
It also showed two carbon signals at 67.55 and 64.04 ppm which suggests the presence of 
carbons that are bonded to oxygen, one carbon signal at 32.54 ppm which suggests the presence 
of a methylene substituent and two carbon signals at 21.19 and 19.98 ppm which suggest the 
presence of two methyl substituents on (175). The two compounds (174) and (175) were 
obtained in low yields. I was later found that the compounds stick to the silica during the 
filtration of mercury and purification stage. One should take care and make sure more solvent is 
used to get the product especially during the filtration process. 
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Figure 21 
 
In summary, we managed to synthesis 2-allylindoles using isopropylmagnesium chloride and 
isopropylamine. The synthesis of 2-allyindole was followed by the formylation to afford 2-allyl-
3-formylindoles which were later reduced to afford the respective alcohols was a success. In 
addition to the alcohols, we managed to cyclize the alcohols to construct indolo-fused pyrans, a 
novel class of compounds.  
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Chapter 3: Conclusion and Future Work 
 
During the course of this MSc we managed to synthesis 2-arylindoles (128)-(136) in fair to 
excellent yields. The 2-arylindoles (128)-(136) were synthesized in three steps starting from 2-
iodo-1-(phenylsulfonyl)-1H-indole (105) or 2-iodo-5-methoxy-1-(phenylsulfonyl)-1H-indole 
(106) while (166) and (167) were synthesized in two steps starting from (36) and (104) 
respectively in a one-pot synthesis to the removal of the phenylsulfonyl protecting group. The 
future work on this will include improving the yields of the protected compounds (120), (121), 
(123), (125)-(127) and unprotected compounds (129), (131), (132), and (134)-(136). We will be 
submitting the compounds (128)-(136) for testing against cancer cells and malarial cell lines. 
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Also, we managed to synthesize the 3-arylindoles (149)-(160) in fair to excellent yields. The 3-
arylindoles (149)-(160) were synthesized in three steps starting from 3-bromo-1-
(phenylsulfonyl)-1H-indole (107) and 3-bromo-5-methoxy-1-(phenylsulfonyl)-1H-indole (109). 
The future work in this section will involve submitting the compounds (149)-(160) for testing 
against cancer and malarial cell lines. Infact, (149) has been tested and showed promising results 
against bacterial and fungal cell lines. Also in the future work of this section will be to improve 
the yields in the reactions leading to the desired products (139), (141), (151) and (153). 
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We also successfully synthesized 2,3-dibromo-1-(phenylsulfonyl)-1H-indole (108) by treating 
(36) with bromine in carbon tetrachloride in acceptable yield of 47%. After synthesizing (108), 
we managed to synthesise 2,3-diphenyl-1-(phenylsulfonyl)-1H-indole (161) in a fair yield of 
56% which was successfully deprotected using potassium carbonate in methanol to give 2,3-
diphenyl-1H-indole (162) in a fair yield of 60%. The future work in this section will include 
submitting (162) for testing against cancer and malarial cell lines and as well improving the 
yields of (108), (161) and (162). Other future work will involve reacting (108) with other boronic 
acids such as (114), (115) and others to give a range of 2,3-diarylindoles (176) (Scheme 43) 
because boronic acid such as (113), (117) and (118) have been generated. However, there was no 
success in synthesizing these 2,3-diarylindoles with these boronic acids. Instead, 3-arylindoles 
were obtained and we attributed this to steric effects. 
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Scheme 43 
 
Using methodology developed in our laboratories, we also managed to synthesize compounds 
(174) and (175) in four steps starting from the allylation of (36), formylation of (169) to 
cyclization of (172) and (173) using mercury acetate in tetrahydrofuran at room temperature. 
Compounds (174) and (175) were synthesized successfully in poor yields of 31% and 25% 
respectively. The future work in this section will include improving the yield of (169) which was 
obtained at the highest yield of 31% and the yields of (174) and (175) will also need to be 
improved. Further future work will involve taking (174) and (175) and treating them with 
potassium carbonate in methanol in an attempt to remove the phenylsulfonyl protecting group to 
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give unprotected compounds (177) and (178) (Scheme 44). If compounds (176) and (177) can be 
successfully obtained, they will be submitted for biological testing. Other future work will 
include treating (171) with different arylmagnesium halides followed by cyclization reaction 
using mercury acetate to give cyclized compound (180) which can be deprotected to give 
compound (181) (Scheme 45). 
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Chapter 4: Experimental Procedures 
 
4.0 General Experimental Procedures 
 
4.0.1 Purification of Solvents and Reagents 
 
All solvents used for reactions and preparative chromatography were distilled prior to use. 
Where necessary, they were also dried by standard methods as recommended by Perrin et al78. 
Tetrahydrofuran was distilled from the sodium benzophenone ketyl radical, dichloromethane, 
triethylamine from calcium hydride and toluene from sodium. Where necessary, solvents were 
stored over activated molecular sieves (4 Å) under nitrogen atmosphere. Unless otherwise noted, 
other reagents were obtained from commercial sources and used without further purification. 
 
4.0.2 Chromatographic Separations 
 
Thin layer chromatography (TLC) was carried out on aluminum-backed Macherey-Nagel 
Alugram Sil G/UV254 plates pre-coated 0.25 mm silica gel 60.  Detection was done by under 
ultra violet light at 254 nm. Preparative column chromatography was carried out on dry-packed 
columns using Macherey-Nagel Kieselgel 60 silica gel 60 (particle size 0.063-0.200 mm) as the 
adsorbent. Mixtures of EtOAc and hexane were used as the mobile phase.  
 
4.0.3 Spectroscopic and Physical Data 
 
All melting points were obtained on a Reichert hot-stage microscope and are uncorrected. 
The 1H NMR (nuclear magnetic resonance) spectra were recorded on a Bruker AVANCE 300 
(300.13 MHz) or a Bruker AVANCE 400 (400.13 MHz) spectrophotometer. Spectra were 
Chapter 4                                    Experimental Procedures 
80 
 
recorded in deuterated chloroform (CDCl3) or deuterated acetone (acetone-d6) and chemical 
shifts are reported in parts per million (ppm) downfield from tetramethylsilane (TMS), the 
internal standard; coupling constants are given in Hertz (Hz). Splitting patterns are designated as 
“s”, “d”, “t”, “q”, and “m”; and these symbols indicate “singlet”, “doublet”, “triplet”, “quartet” 
and “multiplet” respectively. The 13C NMR (1H decoupled) spectra were recorded on a Bruker 
AVANCE 300 (75.47 MHz) or Bruker DRX 400 (100.63 MHz) spectrometer. Spectra were 
recorded in deuterated chloroform (CDCl3) or deuterated acetone (acetone-d6) and chemical 
shifts are reported in parts per million (ppm) relative to the central signal of deuterated 
chloroform, taken as δ 77.00 
 
IR (infrared) spectra were recorded on a Bruker IFS-25 Fourier Transform spectrometer or on a 
Bruker Vector-22 Fourier Transform spectrometer. Liquid samples were recorded as thin films 
between sodium chloride plates while solid samples were recorded as solutions in 
dichloromethane in sodium chloride cells. The signals were reported on the wavenumber scale 
(v/cm-1). Signals were designated as “s”, “m”, “w” and “b”; these symbols indicate “strong”, 
“medium”, “weak” and “broad” respectively. 
 
Mass spectra were recorded on Thermo Fisher LXQ, Thermo Fisher DFS or VG 70 SEQ mass 
spectrometer. 
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4.1 Protection of the indole nucleus 
 
4.1.1 1-(Phenylsulfonyl)-1H-indole (36) 
 
To an ice-cold mixture of aqueous NaOH (4.10 g, 102 mmol, 3 eq) and 
tetra-n-butylammonium bromide (0.29 g, 0.89 mmol, 0.026 eq) in 
dichloromethane (20.0 ml) under N2, was added solid indole (9) (4.00 g, 
34 mmol) in one portion followed by slow addition of phenylsulfonyl 
chloride (5.3 ml, 43 mmol, 1.25 eq).The light pink mixture was stirred at 
rt under N2 for 18 h over which time it turned milky white. Water was 
added and the reaction mixture was then extracted with CH2Cl2 (3 × 20 
ml). The organic extracts were combined, dried over MgSO4, filtered with the celite plug and the 
solvent removed on a rotary evaporator. The resulting brown oil was dried further on a high 
vacuum line. When it was left to stand, it became a cream white solid (36) (8.74g, 100%) 
Melting point: 75-78 °C, lit. value 76.5-77 °C64; vmax (Solid)/cm-1  3065 (w, CH), 1481 (m), 1448 
(m), 1362 (m), 1264 (m), 1177 (s), 1092 (m), 726 (m); δH (300 MHz; CDCl3; Me4Si) 7.99 (1H, 
d, J = 8.20, ArH), 7.87 (2H, d, J = 7.50, 2 × ArH), 7.56 (1H, d, J = 3.70, ArH), 7.53-7.19 (6H, m, 
6 × ArH), 6.65 (1H, d, J = 3.7, ArH); δC (75 MHz; CDCl3) 138.70 (C), 135.30 (C), 134.20 (CH), 
131.20 (C), 129.70 (2 × CH), 127.10 (2 × CH), 126.70 (CH), 125.10 (CH), 123.80 (CH), 121.80 
(CH), 113.90 (CH), 109.70 (CH); m/z 257 (M+, 100%), 141 (19%), 116 (85%), 89 (21%), 77 
(43%) (Found: M+, 257.0521. C14H11SO2N requires 257.0511). 
 
4.1.2 1-(Phenylsulfonyl)-5-methoxy-1H-indole (104) 
 
To an ice-cold mixture of sodium hydroxide (0.57 g, 14.30 
mmol, 3 eq) and tetra-n-butylammonium bromide (0.04 g, 0.12 
mmol, 0.026 eq) in dichloromethane (20.0 ml) under N2, was 
added solid 5-methoxyindole (102) (0.70 g, 4.77 mmol) in one 
N
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portion followed by slow addition of phenylsulfonyl chloride (0.77 ml, 6.00 mmol, 1.25 eq).The 
light pink mixture was stirred at rt under N2 for 18 h over which time it turned milky white. 
Water was added and the reaction mixture was then extracted with CH2Cl2 (3 × 20 ml). The 
organic extracts were combined, dried over magnesium sulphate, filtered with the celite plug and 
the solvent removed on a rotary evaporator. The resulting light brown oil was dried further on a 
high vacuum line. When it was left to stand, it became a cream white solid (104) 1.37 g, (100%). 
Melting point: 96-99 °C, lit. value 97-98 °C34; vmax (Solid)/cm-1 3002 (w, C-H), 1613 (m), 15384 
(m), 1471 (s), 1372 (s), 1226 (m, C-O), 1150 (m), 1092 (m), 940 (w), 844 (w), and 755 (m); δH 
(300 MHz; CDCl3; Me4Si) 7.90-7.82 (3H, m, 3 × ArH), 7.52-7.37 (4H, m, 4 × ArH), 6.96-6.91 
(2H, m, 2 × ArH), 6.58 (1H, d, J = 3.60, ArH),  3.79 (3H, s, CH3O); δC (300 MHz; CDCl3) 
156.50 (C), 138.20 (C), 133.70 (CH), 129.60 (C), 129.40 (C), 129.20 (2 × CH), 126.90 (CH), 
126.70 (2 × CH), 114.40 (CH), 113.80 (CH), 109.40 (CH), 103.70 (CH), 55.60 (CH3O); m/z 287 
(M+, 61%), 218 (3%), 147 (11%), 146 (100%), 125 (8%), 103 (10%), 77 (16%), 51 (9%), 49 
(3%). 
 
4.2 Iodination of indoles (36) and (104) 
 
4.2.1 2-Iodo-1-(phenylsulfonyl)-1H-indole (105) 
 
To 1-(phenylsulfonyl)-1H indole (36) (1.00 g, 3.89 mmol) in a dry flask 
was added isopropyl magnesium chloride solution in THF (~0.8 M in 
excess) and isopropyl amine (1.0 ml). The reaction mixture was 
maintained at rt under N2 atmosphere for 16 h. Iodine (2.50 g, 9.73 
mmol, 2.5 eq) was added and the mixture was stirred at rt for 1 h. The 
reaction mixture was quenched by the addition of saturated aqueous 
solution of ammonium chloride. The mixture was extracted with CH2CH2 (3 × 30 ml), the 
organic layers combined and dried over MgSO4, then filtered though celite plug and excess 
solvent removed on a rotary evaporator. This resulted in a brown oil that was subjected to 
column chromatography to give cream white solid (105) 1.18 g, (79%). Melting point: 96-99 °C, 
N
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lit. value 96-98 °C66; vmax (Solid)/cm-1 2924 (w, CH), 1449(w), 1430 (s), 1372 (s), 1215 (s), 1182 
(s), 1123 (s), 1090 (s), 1013 (s), 812 (s), 761 (m), 725 (s), 684 (s), 646 (s); δH (300 MHz; CDCl3; 
Me4Si) 8.27 (1H, d, J = 8.32 ArH), 7.90-7.87 (2H, m, 2 × ArH), 7.56-7.51 (1H, m, ArH), 7.44-
7.38 (3H, m, 2 × ArH), 7.29-7.20 (2H, m, 2 × ArH), 6.99 (1H, s, ArH); δC (75MHz; CDCl3) 
141.80 (C), 137.22 (C), 136.94 (C), 132.74 (CH), 130.43 (C), 127.84 (CH), 125.85 (CH), 123.65 
(CH), 123.36 (CH), 122.52 (CH), 118.44 (CH), 114.14 (CH); m/z 383 (M+, 5%), 263 (31%), 219 
(100%), 150 (5%), 131 (55%), 69 (95%), (Found: 382.9471. C21H17NSO3I requires 382.9477). 
 
4.2.2 2-Iodo-5-methoxy-1-(phenylsulfonyl)-1H-indole (106) 
 
To 5-methoxy-1-(phenylsulfonyl)-1H-indole (104) (0.50 g, 1.74 
mmol) in a dry flask was added isopropyl magnesium chloride 
solution in THF (~0.8M in excess) and isopropyl amine (1.0 ml). 
The reaction mixture was maintained at rt under N2 atmosphere 
for 16 h. Iodine (0.88 g, 3.48 mmol, 2.5 eq) was added and the 
mixture was stirred at rt for 1 h. The reaction mixture was 
quenched by the addition of saturated aqueous solution of 
ammonium chloride. The mixture was extracted with CH2CH2 (3 × 30 ml), organic layers 
combined and dried over MgSO4, then filtered though celite plug and excess solvent removed on 
a rotary evaporator. The resulting brown oil was subjected to column chromatography to give 
cream white solid (106) 0.61 g, (85%). Melting point: 127-130 °C; vmax (Solid)/cm-1 2936 (w, 
CH), 1611 (m), 1446 (s), 1374 (s), 1226 (m), 1179 (s), 1146 (s), 1082 (s), 1023 (m), 840 (m), 
800 (s), 756 (m), 724 (s), 687 (s), 621 (s); δH (300 MHz; CDCl3; Me4Si) 8.18 (1H, d, J = 9.14, 
ArH), 7.87 (2H, d, J = 7.49, 2 × ArH), 7.58-7.53 (1H, m, ArH), 7.46-7.41 (2H, m, 2 × ArH), 6.93 
(1H, s, ArH), 6.89 (1H, d, J = 2.59, ArH), 6.85 (1H, d, J = 2.47, ArH), 3.83 (3H, s, CH3O); δC 
(75MHz; CDCl3) 156.94 (C), 138.47 (C), 134.56 (CH), 133.66 (C), 133.05 (C), 129.49 (2 × CH), 
127.48 (2 × CH), 124.81 (CH), 116.79 (CH), 114.20 (CH), 102.39 (CH), 76.39 (C), 56.02 
(CH3O); m/z 412 (M+, 88%), 397 (100%), 330 (18%), 272 (12%), 257 (20%), 191 (3%), 117 
(3%), (Found: 412.1070. C15H12INO3 requires 412.9583). 
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4.3 Bromination of indoles (36) and (104) 
 
4.3.1 3-Bromo-1-(phenylsulfonyl)-1H-indole (107) 
 
To a mixture of 1-phenylsulfonylindole (36) (1.00 g, 3.9 mmol) and 
sodium acetate (0.32 g, 3.9 mmol, 1eq) in acetic acid (20.0 ml) at 0 °C, 
bromine (0.50 ml, and 3.9 mmol, 1 eq) was added dropwise. The 
reaction mixture was then allowed to warm up to rt before being refluxed 
under N2 for 14 h over which time it turned from brown to light yellow. 
After being allowed to cool to rt, the mixture was filtered and the acetic 
acid from the reaction mixture was removed on the rotary evaporator. 
The resultant oil was partitioned between water (20 ml) and CH2Cl2 and extracted with CH2Cl2 
(3 × 20 ml). The organic extracts were combined, dried over MgSO4, then filtered with celite 
plug and excess solvent removed on rotary evaporator. The resulting oil was purified by column 
chromatography using 10% EtOAc/Hexane as an eluent and this gave the product in 80% yield 
as a white solid (107). Melting point: 120-124 °C, lit. value 122-124 °C68; vmax (Solid)/ cm-1 3139 
(w, CH), 1446 (m), 1376 (m), 1176 (s), 1091 (m), 1032 (w), 932 (w), 728 (s); δH (300 MHz; 
CDCl3; Me4Si) 8.00 (1H, d, J = 8.21, ArH), 7.88 (2H, d, J = 7.62, 2 × ArH), 7.62 (1H, s, ArH), 
7.57-7.21 (6H, m, 6 × ArH); ) δC (75 MHz; CDCl3) 138.21 (C), 134.72 (C), 134.5 (CH), 130.23 
(C), 129.80 (2 × CH), 127.30 (2 × CH), 126.34 (CH), 125.25 (CH), 124.40 (CH), 120.56 (CH), 
113.93 (CH), 99.80 (C); m/z 336 (79Br-M+, 63%), 334 (57%), 257 (11%), 196 (98%), 194 (10%), 
193 (100%), 141 (18%), 116 (14%), 115 (27%), 88 (12%), 77 (53%), 51 (17%) (Found: 79Br-M+, 
336.9650. C14H10SO2N79Br requires 334.9616). 
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4.3.2 2,3-Dibromo-1-(phenylsulfonyl)-1H-indole (108) 
 
1-(Phenylsulfonyl)-1H-indole (36) (3.00 g, 11.7 mmol) was dissolved 
in dry DMF (10.0 ml) and bromine (1.6 ml, 12.9 mmol, 1.1 eq) was 
added dropwise at rt. The red solution was then stirred at rt for 18 h. 
The resulting reaction mixture was poured into a saturated solution of 
aqueous NaHCO3 (20 ml). The layers were separated, and extracted 
with CH2Cl2 (3 × 20 ml), washed successively with aqueous Na2S2O3 
(20.0 ml) and then finally washed with brine (20.0 ml). The organic 
extracts were dried over MgSO4, filtered with the celite plug and solvent removed on a rotary 
evaporator. This gave a crude brown solid which was purified by column chromatography using 
10% EtOAc/Hexane as an eluent. After the chromatography, the product was recrystallized from 
ethyl acetate and gave 47% yield of the product as a cream white solid (108). Melting point: 141-
144 °C, lit. value 141-143 °C70; vmax (Solid)/cm-1 3071 (w, CH), 1443 (m), 1383 (s),1194 (s), 
1092 (m), 1038 (m), 909 (s), 739 (s), 570 (m); δH (300 MHz; CDCl3; Me4Si) 8.30 (1H, d, J = 
8.31 ArH), 7.88 (2H, d, J = 7.52, 2 × ArH), 7.62-7.31 (6H, m, 6 × ArH); δC (75 MHz; CDCl3) 
138.21 (C), 137.0 (C), 134.82 (CH), 129.43 (2 × CH), 127.74 (2 × CH), 127.55 (C), 127.26 
(CH), 125.17 (CH), 120.08 (CH), 115.79 (CH), 111.60 (C), 107.11 (C); m/z 416 ( 81Br-M+, 
30%), 415 (79Br-M+, 10%), 414 (58%), 412 (27%), 336 (17%), 275 (49%), 273 (100%), 271 
(47%), 195 (24%), 193 (27%), 141 (41%), 114 (40%), 77 (58%), 51 (18%) (Found: 79Br-M+, 
415.8816. C14H9SO2NBr2 requires 412.8721 79Br). 
 
4.3.3 3-Bromo-5-methoxy-1-(phenylsulfonyl)-1H-indole (109) 
 
A mixture of N-bromosuccinimide (0.060 g, 0.35 mmol, 1.01 
eq), 5-methoxy-1 (phenylsulfonyl)-1H-indole (104) (0.10 g, 0.35 
mmol) and benzoyl peroxide (0.01g) in dry CCl4 (5 ml), was 
gently refluxed for 18 h. The reaction mixture was allowed to 
cool to rt, cooled in ice bath before the succinimide was 
N
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separated by filtration. The last traces of succinimide were removed by shaking the filtrate in a 
separating funnel with an ice cooled aqueous sodium hydroxide (5%) solution followed by 
shaking with water. The organic layer was dried over MgSO4 before being evaporated on a 
rotary evaporator to afford a white solid (109) 0.11 g (85%). Melting point: 129-132 °C, lit. 
value 131-133 °C56; vmax (Solid)/cm-1 3146 (m, CH), 1612 (m), 1474 (s), 1445 (s), 1361 (s), 1313 
(m), 1275 (s), 1211 (s), 1159 (s), 1136 (s), 1089 (s), 1034 (s), 963 (s), 835 (m), 819 (m), 800 (m), 
765 (s), 749 (s), 722 (s), 683 (s), 650 (s); δH (300 MHz; CDCl3; Me4Si) 7.90-7.85 (3H, m, 3 × 
ArH), 7.58-7.53 (2H, m, 2 × ArH), 7.47-7.42 (2H, m, 2 × ArH), 6.98 (1H, d, J = 9.03, ArH), 6.89 
(1H, d, J = 1.79, ArH), 3.84 (3H, s, CH3O); δC (75MHz; CDCl3) 155.92 (C), 136.60 (C), 132.93 
(CH), 129.65 (C), 128.24 (2 × CH), 126.70 (C), 125.65 (2 × CH), 124.22 (CH), 114.33 (CH), 
113.56 (CH), 100.69 (CH), 98.69 (C), 54.59 (CH3O); 
 
4.4 Typical procedure for the synthesis of 2-aryl-1-(phenylsulfonyl)-1H-indole 
and 2-aryl-5-methoxy-1-(phenylsulfonyl)-1H-indole 
 
To Pd(PPh3)4 (10 mol%) under N2 was added a deoxygenated mixture of 2-iodo-1-
(phenylsulfonyl)-1H-indole or 2-iodo-5-methoxy-1-(phenylsulfonyl)-1H-indole in DME (5 ml) 
and arylboronic acid in ethanol (3 ml). The reaction mixture was stirred for about 10 min 
followed by the addition of a deoxygenated 2 M solution of Na2CO3 in water. The resulting 
reaction mixture was stirred for further 10 min at rt before being heated to reflux for 8 h. The 
reaction mixture was allowed to cool to room temperature, quenched with water (10.0 ml) and 
the organic extracts extracted with CH2Cl2 (3 × 30 ml). The organic fractions were combined, 
dried over MgSO4, filtered through a celite plug and then the excess solvent was removed using 
a rotary evaporator. The resulting black oils were purified by column chromatography using 10% 
EtOAc/Hexane as an eluent. 
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(a) 2-Phenyl-1-(phenylsulfonyl)-1H-indole (119)  
 
Pd(PPh3)4 (0.35 g, 10%), 2-iodo-1-(phenylsulfonyl)-1H-indole 
(105) (1.00 g, 3.04 mmol) phenyl boronic acid (0.56 g, 4.56 mmol, 
1.5 eq), Na2CO3 (2.73 g, 25.8 mmol, 8.5 eq) in water (12.9 ml). This 
gave white solid (119) (0.89 g, 82%). Melting point: 100-104 °C, lit 
value 104-105 °C64; vmax (Solid)/cm-1 3055 (w, CH), 1585 (w), 1479 
(m), 1434 (s), 1372 (s), 1248 (m), 1171 (s), 1115 (m), 1089 (s), 
1049 (s), 1026 (s), 976 (s), 837 (m), 754 (s), 732 (s), 682 (s), 635 (s); δH (300 MHz; CDCl3; 
Me4Si) 8.31 (1H, d, J = 8.28, ArH), 7.48-7.35 (9H, m, 9 × ArH), 7.27-7.18 (4H, m, 4 × ArH), 
6.52 (1H, s, ArH); δC (75MHz; CDCl3) 142.54 (C), 138.73 (C), 137.94 (C), 133.99 (CH), 132.73 
(C), 130.79 (CH), 129.15 (CH), 129.02 (CH), 127.99 (CH), 127.17 (CH), 125.32 (CH), 124.88 
(CH), 121.22 (CH), 117.07 (CH), 115.79 (C), 114.19 (CH); m/z 333 (M+, 80%), 277 (35%), 219 
(96%), 192 (100%), 164 (53%), 131 (37%), 69 (80%), (Found: 333.0826. C21H17NSO3 requires 
333.0824). 
 
(b) 5-Methoxy-2-phenyl-1-(phenylsulfonyl)-1H-indole (120) 
 
Pd(PPh3)4 (0.11 g, 10%), 2-iodo-5-methoxy-1-
(phenylsulfonyl)-1H-indole (106) (0.40 g, 0.97 mmol), 
phenylboronic acid (0.18 g, 1.46 mmol, 1.5 eq), Na2CO3 
(0.87 g, 8.23 mmol, 8.5 eq) in water (4.1 ml). This gave a 
brown oil (120), 0.21 g (60%); vmax (Liquid)/cm-1 3061 
(w, CH), 1609 (m), 1468 (s), 1446 (s), 1386 (s), 1207 (m), 
1175 (s), 1145 (s), 1089 (m), 1028 (m), 909 (m), 849 (m), 
809 (s), 759 (m), 725 (s), 685 (s), 635 (m); δH (300 MHz; CDCl3; Me4Si) 8.19 (1H, d, J = 9.08, 
ArH), 7.51-7.45 (2H, m, 2 × ArH), 7.43-7.39 (4H, m, 4 × ArH), 7.36-7.33 (2H, m, 2 × ArH), 
7.26-7.21 (2H, m, 2 × ArH), 6.96 (1H, dd, J = 2.57 and 2.50, ArH), 6.87 (1H, d, J = 2.53, ArH), 
6.48 (1H, s, ArH), 3.18 (3H, s, CH3O); δC (75MHz; CDCl3) 157.14 (C), 143.06 (C), 137.22 (C), 
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133.43 (CH), 132.82 (C), 132.29 (C), 131.72 (C), 130.20 (2 × CH), 128.68 (CH), 128.49 (2 × 
CH), 127.53 (2 × CH), 126.74 (2 × CH), 117.70 (CH), 113.96 (CH), 113.50 (CH), 103.22 (CH), 
55.57 (CH3O); m/z 364 (M+, 48%), 279 (6%), 223 (100%), 208 (2%), 149 (2%), (Found: 
363.1920. C21H17NO3S requires 363.0929). 
 
(c) 1-(Phenylsulfonyl)-2-o-tolyl-1H-indole (121) 
 
Pd(PPh3)4 (0.24 g, 10%), 2-iodo-1-(phenylsulfonyl)-1H-indole 
(105) (0.50 g, 1.31 mmol), o-tolyl boronic acid (0.41 g, 3.10 
mmol, 1.5 eq), Na2CO3 (1.84 g, 17.30 mmol, 8.5 eq) in water 
(8.7 ml). This gave a brown oil (121), 0.20 g (44%); vmax 
(Liquid)/cm-1 3063 (w, CH), 1585 (w), 1485 (s), 1369 (s), 1247 
(m), 1220 (m), 1174 (s), 1121 (s), 1090 (s), 1064 (s), 995 (m), 
822 (m), 747 (s), 724 (s), 684 (s), 641 (s); δH (300 MHz; CDCl3; 
Me4Si) 8.37 (1H, d, J = 8.33, ArH), 7.50-7.42 (4H, m, 4 × ArH), 7.39-7.33 (2H, m, 2 × ArH), 
7.30-7.24 (3H, m, 3 × ArH), 7.21-7.16 (1H, m, ArH), 7.11-7.03 (2H, m, 2 × ArH), 6.46 (1H, s, 
ArH), 2.19 (3H, s, CH3); δC (75MHz; CDCl3) 140.67 (C), 139.79 (C), 138.97 (C), 137.81 (C), 
134.09 (CH), 132.35 (C), 131.42 (CH), 130.52 (C), 130.10 (CH), 129.61 (CH), 129.22 (2 × CH), 
127.30 (2 × CH), 125.15 (CH), 124.40 (CH), 121.21 (CH), 116.14 (CH), 115.35 (C), 112.90 
(CH), 20.89 (CH3); m/z 348 (M+, 100%), 297 (3%), 222 (3%), 207 (80%), 141 (2%), (Found: 
347.246. C21H17NO2S requires 347.098). 
 
(d) 5-Methoxy-1-(phenylsulfonyl)-2-o-tolyl-1H-indole (122) 
 
Pd(PPh3)4 (0.10 g, 0.078 mmol, 10%), 2-iodo-5-methoxy-
1-(phenylsulfonyl)-1H-indole (106) (0.33 g, 0.78 mmol), 
o-tolylboronic acid (0.16 g, 1.18 mmol, 1.5e q), Na2CO3 
(0.71 g, 6.66 mmol, 8.5 eq) in water (3.3 ml). This gave a 
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yellow oil (122), 0.23 g (78%); vmax (Liquid)/cm-1 2930 (w, CH), 1611 (m), 1464 (s), 1446 (s), 
1367 (s), 1201 (s), 1175 (s), 1144 (s), 1089 (m), 1038 (s), 995 (m), 854 (m), 807 (m), 753 (s), 
722 (s), 684 (s);  δH (300 MHz; CDCl3; Me4Si) 8.14 (1H, d, J = 8.97, ArH), 7.36 (3H, d, J = 
7.71, 3 × ArH), 7.28-7.17 (5H, m, 5 × ArH), 7.11 (1H, t, J = 14.82, ArH), 6.98 (1H, d, J = 7.50, 
ArH), 6.92-6.87 (2H, m, 2 × ArH), 6.32 (1H, s, ArH), 3.76 (3H, s, CH3O), 2.13 (3H, s, CH3); δC 
(75MHz; CDCl3) 157.24 (C), 141.55 (C), 139.67 (C), 138.78 (C), 133.95 (CH), 132.39 (C), 
132.34 (C), 131.57 (C), 131.27 (CH), 130.08 (CH), 129.53 (CH), 129.12 (2 × CH), 127.23 (2 × 
CH), 125.11 (CH), 117.13 (CH), 113.87 (CH), 113.12 (CH), 103.57 (CH), 56.05 (CH3O), 20.87 
(CH3). 
 
(e) 1-(Phenylsulfonyl)-2-(3,4,5-trimethoxyphenyl)-1H-indole (123) 
 
Pd(PPh3)4 (0.24 g, 10%), 2-iodo-1-(phenylsulfonyl)-1H-
indole (105) (0.50 g, 1.31 mmol), 3,4,5-trimethoxy-
phenyl boronic acid (0.66 g, 3.10 mmol, 1.5 eq), Na2CO3 
(1.84 g, 17.30 mmol, 8.5 eq) in water (8.7 ml). This gave 
a cream white oil (123), 0.20 g (56%); vmax (Liquid)/cm-1 
3066 (w, CH), 1584 (m), 1481 (m), 1447 (s), 1359 (s), 
1263 (s), 1203 (s), 1175 (s), 1113 (s), 1091 (s), 1022 (m), 
991 (s), 878 (s), 764 (s), 754 (s), 741 (s), 724 (s), 709 (s), 983 (s), 654 (s); δH (300 MHz; CDCl3; 
Me4Si) 7.80 (1H, d, J = 8.24, ArH), 7.87 (1H, d, J = 7.58, ArH), 7.56 (1H, d, J = 3.64, ArH), 
7.53-7.47 (2H, m, 2 × ArH). 7.42-7.37 (2H, m, 2 × ArH), 7.33-7.28 (1H, m, ArH), 7.24-7.19 
(1H, m, ArH), 6.65 (1H, d, J = 3.61, ArH), 6.57 (1H, d, J = 8.40, ArH), 3.85 (9H, s, 3 × CH3O); 
δC (75MHz; CDCl3) 155.10 (C), 139.83 (C), 136.41 (C), 135.35 (CH), 132.31 (C), 130.80 (2 × 
CH), 128.28 (2 × CH), 127.86 (CH), 126.20 (CH), 125.20 (2  × C), 124.93 (CH), 122.97 (CH), 
115.07 (CH), 110.79 (CH), 106.84 (CH), 62.38 (CH3O), 57.63 (2 × CH3O).  
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(f) 5-Methoxy-1-(phenylsulfonyl)-2-(3,4,5-trimethoxyphenyl)-1H-indole (124) 
 
Pd(PPh3)4 (0.10 g, 0.078 mmol, 10%), 2-iodo-5-
methoxy-1-(phenylsulfonyl)-1H-indole (106) 
(0.33 g, 0.78 mmol), 3,4,5-
trimethoxyphenylboronic acid (0.20 g, 1.00 mmol, 
1.5 eq), Na2CO3 (0.71 g, 6.66 mmol, 8.5 eq) in 
water (3.3 ml). This gave a brown oil (124), 0.20 
g (77%); vmax (Liquid)/cm-1 2936 (w, CH), 1608 
(w), 1581 (m), 1501 (w), 1470 (m), 1447 (m), 1411 (m), 1367 (m), 1336 (m), 1232 (m), 1173 
(m), 1144 (m), 1121 (m), 1087 (m), 1029 (m), 998 (m), 909 (m), 840 (m), 803 (m), 754 (m), 721 
(m), 685 (m); δH (300 MHz; CDCl3; Me4Si) 8.21 (1H, d, J = 9.08, ArH), 7.44 (1H, t, J = 14.49, 
ArH), 7.36 (2H, d, J = 7.91, 2 × ArH), 7.28-7.23 (2H, m, 2 × ArH), 6.97 (1H, d, J = 9.11, ArH), 
6.89 (1H, s, ArH), 6.66 (2H, s, 2 × ArH), 6.48 (1H, s, ArH), 3.94 (3H, s, CH3O), 3.87 (6H, s, 2 × 
CH3O), 3.83 (3H, s, CH3O); δC (75MHz; CDCl3) 156.48 (C), 151.65 (2 × C), 142.21 (C), 137.93 
(C), 136.73 (C), 132.84 (CH), 132.26 (C), 130.85 (C), 127.82 (2 × CH), 126.71 (C), 126.16 (2 × 
CH), 117.12 (CH), 112.85 (2 × CH), 107.21 (2 × CH), 102.49 (CH), 60.39 (CH3O), 55.58 (2 × 
CH3O), 54.93 (CH3O).  
 
(g) 2-(4-Methoxyphenyl)-1-(phenylsulfonyl)-1H-indole (125) 
 
Pd(PPh3)4 (0.24 g, 10%), 2-iodo-1-(phenylsulfonyl)-1H-
indole (105) (0.79 g, 2.06 mmol), 4–methoxy-phenyl 
boronic acid (0.47 g, 3.09 mmol, 1.5 eq), Na2CO3 (1.86 
g, 17.51 mmol, 8.5 eq) in water (8.9 ml). This gave a 
cream white solid (125), 0.40 g (60%). Melting point 
209-212 °C; vmax (Solid)/cm-1 3066 (w, CH), 1614 (m), 
1566 (m), 1503 (s), 1442 (s), 1353 (s), 1300 (m), 1249 (s), 1224 (m), 1172 (s), 1151 (m), 1121 
(m), 1069 (m), 1027 (m), 998 (m), 833 (s), 809 (s), 772 (m), 732 (s), 698 (m), 660 (s); δH (300 
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MHz; CDCl3; Me4Si) 8.25 (1H, d, J = 8.27, ArH), 7.90 (1H, d, J = 7.42, ArH), 7.56 (1H, d, J = 
7.51, ArH), 7.38-7.26 (4H, m, 4 × ArH), 7.11-7.01 (4H, m, 4 × ArH), 6.67 (2H, d, J = 8.53, 2 × 
ArH), 6.53 (1H, s, ArH), 3.80 (3H, s, CH3O); δC (75MHz; CDCl3) 160.30 (C), 142.95 (C), 
142.71 (CH), 140.39 (C), 139.76 (C), 133.91 (CH), 132.46 (2 × CH), 131.89 (CH), 129.22 (C), 
127.94 (CH), 124.74 (CH), 123.82 (CH), 121.09 (CH), 116.96 (CH), 113.33 (2 × CH), 111.49 
(CH), 92.39 (C), 55.75 (CH3O); m/z 364 (M+, 82%), 347 (28%), 328 (4%), 267 (2%), 127 (2%), 
(Found: 362.2600. C21H17NO3S requires 363.0929). 
 
(h) 5-Methoxy-2-(4-methoxyphenyl)-1-(phenylsulfonyl)-1H-indole (126) 
 
Pd(PPh3)4 (0.10 g, 0.078 mmol, 10%), 2-iodo-5-
methoxy-1-(phenylsulfonyl)-1H-indole (106) 
(0.33 g, 0.78 mmol), 4-methoxy-phenylboronic 
acid (0.18 g, 1.18 mmol, 1.5 eq), Na2CO3 (0.71 g, 
6.66 mmol, 8.5 eq) in water (3.3 ml). This gave a 
yellow oil (126), 0.19 g (61%); vmax (Liquid)/cm-1 
2933 (w, CH), 1609 (m), 1505 (m), 1467 (s), 1446 
(m), 1366 (m), 1248 (m), 12074 (m), 1172 (m), 1144 (m), 1088 (m), 1061 (m), 990 (m), 946 (m), 
832 (m), 805 (m), 789 (m), 753 (m), 724 (m), 684 (m), 629 (m), 611 (m); δH (300 MHz; CDCl3; 
Me4Si) 8.11 (1H, d, J = 9.04, ArH), 7.32 (3H, d, J = 8.58, 3 × ArH), 7.26 (2H, d, J = 8.00, 2 × 
ArH), 7.18-7.13 (2H, m, 2 × ArH), 6.88-6.84 (3H, m, 3 × ArH), 6.78 (1H, d, J = 2.31, ArH), 6.69 
(2H, s, × ArH), 6.33 (1H, s, ArH), 3.79 (3H, s, CH3O), 3.73 (3H, s, CH3O); δC (75MHz; CDCl3) 
159.75 (C), 156.79 (C), 142.67 (C)136.95 (C), 133.08 (CH), 132.40 (C), 131.53 (C), 131.22 (2 × 
CH), 128.16 (2 × CH), 126.42 (2 × CH), 124.31 (C), 117.41 (CH), 115.71 (CH), 114.51 (CH), 
112.87 (CH), 112.72 (2 × CH), 102.80 (CH), 55.26 (CH3O), 55.00 (CH3O). 
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(i) 2-(Naphthalen-1-yl)-1-(phenylsulfonyl)-1H-indole (127) 
 
Pd(PPh3)4 (0.24 g, 10%), 2-iodo-1-(phenylsulfonyl)-1H-indole 
(105) (0.50 g, 1.31 mmol), naphthalen-1-ylboronic acid (0.34 g, 
1.97 mmol, 1.5 eq), Na2CO3 (1.84 g, 17.30 mmol, 8.5 eq) in 
water (8.7 ml). This gave a brown oil (127), 0.30 g (60%); vmax 
(Liquid)/cm-1 3061 (w, CH), 1575 (w), 1480 (m), 1423 (s), 1349 
(s), 1263 (m), 1184 (s), 1119 (m), 1081 (s), 1043 (s), 1021 (s), 
979 (s), 833 (m), 756 (s), 739 (s), 687 (s), 639 (s); δH (300 
MHz; CDCl3; Me4Si) 8.00 (1H, d, J = 8.26, ArH), 7.93 (1H, d, 
J = 8.06, ArH), 7.85 (2H, d, J = 7.75, 2 × ArH), 7.63 (1H, d, J = 8.46, ArH), 7.55 (1H, d, J = 
3.64, ArH), 7.51-7.12 (10H, m, 10 × ArH), 6.65-6.62 (1H, m, ArH); δC (75MHz; CDCl3) 140.22 
(C), 139.64 (C), 139.01 (C), 136.25 (C), 135.18 (CH), 134.92 (CH), 134.46 (C), 132.14 (C), 
130.98 (CH), 130.74 (CH), 130.62 (2 × CH), 130.02 (CH), 129.45 (CH), 128.21 (CH), 128.09 (2 
× CH), 127.69 (CH), 127.45 (CH), 127.25 (CH), 126.29 (CH), 126.03 (CH), 125.84 (CH), 
125.46 (CH), 124.77 (CH), 122.27 (CH), 117.17 (CH), 115.28 (C), 114.91 (CH), 110.64 (CH); 
m/z 382 (M-, 60%), 257 (20%), 242 (100%), 213 (10%), 141 (10%), 116 (21%), 88 (8%), 77 
(25%) (Found: 383.9120. C24H17NSO2 requires 383.4623). 
 
4.5 Typical procedure for removing of phenylsulfonyl protecting group on 2-
aryl-1-(phenylsulfonyl)-1H-indoles and 2-aryl-5-methoxy-1-(phenylsulfonyl)-
1H-indoles 
 
The substrate was dissolved in methanol (20 ml) at rt under N2 atmosphere, K2CO3 was added to 
the solution and the reaction mixture was heated to reflux under N2 for 18 h. The reaction 
mixture was then allowed to cool to rt and filtered through a celite plug and then the filtrate 
concentrated under reduced pressure. Water was added to the crude material and slowly acidified 
to pH 2-4 with aqueous 10% HCl. The aqueous portion was saturated with solid NaCl and the 
organic material extracted with CH2Cl2 (3 × 30 ml). The combined organic extracts were washed 
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two times with water (20 ml), brine (20 ml), dried over MgSO4 and concentrated under reduced 
pressure. This resulted in brown oils that were subjected to column chromatography using 10% 
EtOAc/Hexane as an eluent. 
 
(a) 2-Phenyl-1-H-indole (128) 
 
2-Phenyl-1-phenylsulfonylindole (119) (0.79 g, 2.37 mmol), 
K2CO3 (62.30 g, 450 mmol, 190 eq). Column chromatography 
gave a cream white solid (128) 0.36 g (78%). Melting point 182-
186 °C, lit. value 182-184 °C79; vmax (Solid)/cm-1 3441 (s, NH), 3050 (w, CH), 1601 (w), 1542 
(m), 1480 (s), 1446 (s), 1403 (m), 1352 9s), 1298 (s), 1230 (m), 1184 (s), 1075 (m), 907 (s), 797 
(m), 763 (s), 738 (s), 687 (s); δH (300 MHz; CDCl3; Me4Si) 8.36 (1H, s, NH), 7.70 (3H, d, J = 
7.31, 3 × ArH), 7.51-7.35 (4H, m, 4 × ArH), 7.28-7.16 (2H, m, 2 × ArH), 6.88 (1H, s, ArH); δC 
(75MHz; CDCl3) 138.33 (C), 137.27 (C), 132.81 (C), 129.71 (C), 129.45 (2 × CH), 128.14 (CH), 
125.56 (2 × CH), 122.79 (CH), 120.71 (CH), 111.36 (CH), 100.43 (CH); m/z 194 (M+, 100%), 
167 (4%), 116 (4%), (Found: 193.2140. C14H10N requires 193.0892). 
 
 
(b) 5-Methoxy-2-phenyl-1H-indole (129) 
 
5-Methoxy-2-phenyl-1-(phenylsulfonyl)-1H-indole (120) 
(0.15 g, 0.41 mmol), K2CO3 (10.83 g, 79 mmol, 190 eq). 
Column chromatography gave a cream white solid (129) 
0.055 g (61%). Melting point 162-165 °C; vmax 
(Solid)/cm-1 3427 (m, NH), 2999 (w, CH), 1621 (m), 1476 (s), 1448 (s), 1301 (m), 1215 (s), 1150 
(s), 1116 (m), 1026 (s), 945 (w), 840 (s), 801 (s), 763 (s), 736 (s), 692 (s); δH (300 MHz; CDCl3; 
Me4Si) 8.21 (1H, s, NH), 7.64 (2H, d, J = 8.31, 2 × ArH), 7.45-7.40 (2H, m, 2 × ArH), 7.33-7.25 
(2H, m, 2 × ArH), 7.09 (1H, s, ArH), 6.85 (1H, dd, J = 2.37 and 2.34, ArH), 6.76 (1H, s, ArH), 
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3.86 (3H, s, CH3O); δC (75MHz; CDCl3)  154.93 (C), 139.01 (C1), 132.85 (C1), 132.43 (C), 
130.15 (C), 129.40 (2 × CH), 128.03 (CH), 125.45 (2 × CH), 113.04 (CH), 112.01 (CH), 102.71 
(CH), 100.26 (CH), 56.26 (CH3O); m/z 224 (M+, 100%), 209 (6%), 143 (2%), (Found: 223.2430. 
C15H13NO requires 223.0997). 
 
(c) 2-o-Tolyl-1H-indole (130) 
 
1-(phenylsulfonyl)-2-o-tolyl-1H-indole (121) (0.19 g, 0.55 
mmol), K2CO3 (14.37 g, 104 mmol, 190 eq). Column 
chromatography gave a cream white solid (130) 0.09 g (82%). 
Melting point 81-85 °C, lit. value 92-93 °C80; vmax (Solid)/cm-1 
3396 (s, NH), 3050 (w, CH), 1485 (m), 1452 (s), 1400 (m), 1345 (s), 1301 (s), 1230 (m), 1118 
(m), 797 (s), 742 (s), 719 (s), 677 (m); δH (300 MHz; CDCl3; Me4Si) 8.04 (1H, s, NH), 7.63 (1H, 
d, J = 7.65, ArH), 7.44-7.41 (1H, m, ArH), 7.35 (1H, d, J = 7.87, ArH), 7.27-7.24 (3H, m, 3 × 
ArH), 7.19-7.10 (2H, m, 2 × ArH), 6.59 (1H, s, ArH), 2.47 (3H, s, CH3); δC (75MHz; CDCl3) 
137.89 (C), 136.61 (C), 136.55 (C), 133.09 (C), 131.51 (CH), 129.44 (CH), 129.31 (C), 128.41 
(CH), 126.53 (CH), 122.50 (CH), 120.98 (CH), 120.50 (CH), 111.23 (CH), 103.42 (CH), 21.55 
(CH3); m/z 208 (M+, 100%), 193 (4%), 130 (2%), (Found: 207.2320. C15H13N requires   
207.1048).  
 
(d) 5-methoxy-2-o-tolyl-1H-indole (131) 
 
5-Methoxy-2-o-tolyl-1-(phenylsulfonyl)-1H-indole (122) 
(0.19 g, 0.50 mmol), K2CO3 (13.21 g, 96 mmol, 190 eq). 
Column chromatography gave a yellow oil (131) 0.080 g 
(67%); vmax (Liquid)/cm-1 3408 (m, NH), 2918 (m, CH), 
1621 (w), 1585 (w), 1479 (s), 1436 (s), 1275 (w), 1215 (s), 1150 (m), 1117 (m), 1032 (m), 844 
(m), 798 (m), 752 (s), 722 (m); δH (300 MHz; CDCl3; Me4Si) 8.03 (1H, s, NH), 7.46 (1H, t, J = 
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8.31, ArH), 7.28-7.25 (4H, m, 4 × ArH), 7.11 (1H, s, ArH), 6.87 (1H, dd, J = 10.56, ArH), 6.55 
(1H, s, ArH), 3.87 (3H, s, CH3O), 2.50 (3H, s, CH3); δC (75MHz; CDCl3) 154.43 (C), 138.24 
(C), 136.07 (C), 132.71 (C), 131.32 (C), 131.08 (CH). 129.30 (C), 128.90 (CH), 127.93 (CH), 
126.10 (CH), 112.36 (CH), 111.48 (CH), 102.86 (CH), 102.25 (CH), 55.94 (CH3O), 21.13 
(CH3). 
 
(e) 2-(3,4,5-Trimethoxyphenyl)-1H-indole (132) 
 
1-(phenylsulfonyl)-2-(3,4,5-trimethoxyphenyl)-1H-indole 
(123) (0.15 g, 0.35 mmol), K2CO3 (9.18 g, 67 mmol, 190 
eq). Column chromatography gave a white solid (132) 
0.05 g (51%). Melting point 206-209 °C, lit. value 205-
206.5 °C81; vmax (Solid)/cm-1 3321 (m, NH), 3000 (w, 
CH), 1593 (s), 1501 (m), 1445 (m), 1427 (m), 1364 (m), 1286 (m), 1234 (s), 1126 (s), 996 (s), 
836 (m), 784 (s), 728 (s), 693 (m), 633 (s); δH (300 MHz; CDCl3; Me4Si) 8.42 (1H, s, NH), 7.62 
(1H, d, J = 7.68, ArH), 7.40 (1H, d, J = 7.95, ArH), 7.25-7.10 (2H, m, 2 × ArH), 6.86 (2H, s, 2 × 
ArH), 6.75 (1H, s, ArH), 3.93 (6H, s, 2 × CH3O), 3.90 (3H, s, CH3O); δC (75MHz; CDCl3) 
154.13 ( 2 × C), 138.54 (C), 137.22 (C), 129.65 (C), 128.82 (C), 122.71 (CH), 120.95 (CH), 
120.71 (CH), 111.30 (CH), 103.20 (2 × CH), 100.31 (CH), 93.33 (C), 61.43 (CH3O), 56.66 (2 × 
CH3O); m/z 284 (M+, 100%), 253 (4%), 155 (2%), 118 (2%), (Found: 283.2900. C17H17NO3 
requires 283.1208). 
 
(f) 5-Methoxy-2-(3,4,5-trimethoxyphenyl)-1H-indole (133) 
 
5-Methoxy-1-(phenylsulfonyl)-2-(3,4,5-
trimethoxyphenyl)-1H-indole (124) (0.22 g, 0.49 
mmol), K2CO3 (12.70 g, 92 mmol, 190 eq). 
Column chromatography gave a white solid (133) 
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0.12 g (86%). Melting point 152-155 °C; vmax (Solid)/cm-1 3366 (m, NH), 2917 (m, CH), 1610 
(w), 1583 (s), 1461 (s), 1354 (m), 1297 (s), 1227 (m), 1124 (s), 1001 (s), 804 (s), 765 (s), 727 (s); 
δH (300 MHz; CDCl3; Me4Si) 8.38 (1H, s, NH), 7.30-7.26 (1H, m, ArH), 7.08 (1H, s, ArH), 6.85 
(2H, s, 2 × ArH), 7.72-6.66 (2H, m, 2 × ArH), 3.93 (6H, s, 2 × CH3O), 3.90 (3H, s, CH3O), 3.86 
(3H, s, CH3O); δC (75MHz; CDCl3) 154.88 (C), 154.09 (2 × C), 153.78 (C), 139.29 (C), 132.40 
(C), 130.11 (C), 128.87 (C), 112.86 (CH), 112.04 (CH), 103.03 (2 × CH), 102.59 (CH), 100.12 
(H), 66.43 (CH3O), 56.63 (2 × CH3O), 56.25 (CH3O). 
 
(g) 2-(4-Methoxyphenyl)-1H-indole (134) 
 
2-(4-Methoxyphenyl)-1-(phenylsulfonyl)-1H-indole 
(125) (0.40 g, 1.10 mmol), K2CO3 (28.40 g, 209 mmol, 
190 eq). Column chromatography gave a cream white 
solid (134) 0.13 g (52%). Melting point 228-230 °C, lit. value 227-231 °C82; vmax (Solid)/cm-1 
3428 (m, NH), 2837 (w, CH), 1543 (m), 1431 (s), 1350 (m), 1287 (m), 1242 (m), 1114 (m), 1026 
(s), 933 (w), 834 (s), 782 (s), 738 (s), 659 (m); δH (300 MHz; DMSO; Me4Si) 11.40 (1H, s, NH), 
7.79 (2H, d, J = 8.65, 2 × ArH), 7.49 (1H, d, J = 7.71, ArH), 7.37 (1H, d, J = 7.96, ArH), 7.08-
6.95 (4H, m, 4 × ArH), 6.76 (1H, s, ArH), 3.81 (3H, s, CH3O); δC (75MHz; DMSO) 160.96 (C), 
139.93 (C), 139.09 (C), 130.99 (C), 128.53 (2 × CH), 127.08 (C), 123.19 (CH), 121.81 (CH), 
121.38 (CH), 116.52 (2 × CH), 113.22 (CH), 99.50 (CH), 57.38 (CH3O); m/z 224 (M+, 100%), 
209 (4%), 141 (2%), (Found: 223.2450. C15H13NO requires 223.0997). 
 
(h) 5-Methoxy-2-(4-methoxyphenyl)-1H-indole (135) 
 
5-Methoxy-2-(4methoxyphenyl)-1-
(phenylsulfonyl)-1H-indole (126) (0.16 g, 0.41 
mmol), K2CO3 (10.67 g, 77 mmol, 190 eq). 
Column chromatography gave a white solid (135) 
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0.051 g (51%). Melting point 116-120 °C; vmax (Solid)/cm-1 3444 (w, NH), 2931 (w, CH), 1609 
(m), 1504 (m), 1467 (s), 1352 (m), 1249 (m), 1210 (m), 1171 (s), 1143 (m), 1089 (m), 1067 (s), 
946 (w), 829 (m), 800 (m), 790 (s), 764 (m), 678 (s), 624 (s); δH (300 MHz; acetone-d6; Me4Si) 
10.22 (1H, s, NH), 7.64-7.61 (2H, m, 2 × ArH), 7.13 (1H, d, J = 8.71, ArH), 6.91-6.89 (2H, m, 2 
× ArH), 6.89 (1H, s, ArH), 6.60 (1H, d, J = 2.46, ArH), 6.58 (1H, d, J = 2.41, ArH), 6.55 (1H, s, 
ArH), 3.71 (3H, s, CH3O), 3.66 (3H, s, CH3O); δC (75 MHz; acetone-d6) 160.26 (C), 155.29 (C), 
139.60 (C), 133.40 (C), 130.92 (C), 127.18 (2 × CH), 126.47 (C), 115.20 (2 × CH), 112.45 (CH), 
112.36 (CH), 102.55 (CH), 98.67 (CH), 55.82 (CH3O), 55.66 (CH3O); 
 
(i) 2-(Naphthalen-1-yl)-1H-indole (136) 
 
2-(naphthalen-1-yl)-1-(phenylsulfonyl)-1H-indole (127) (0.30 
g, 0.78 mmol), K2CO3 (20.57 g, 147 mmol, 190 eq). Column 
chromatography gave a cream white solid (136) 0.10 g (52%). 
Melting point 96-100 °C, lit. value 99-102 °C83; vmax 
(Solid)/cm-1 3344 (m, NH), 3048 (w, CH), 1595 (w), 1508 (w), 
1453 (m), 1394 (m), 1344 (m), 1299 (m), 1107 (w), 783 (s), 773 (s), 737 (s), 693 (s), 656 (m); δH 
(300 MHz; CDCl3; Me4Si) 8.30-8.27 (1H, m, ArH), 8.19 (1H, s, NH), 7.90-7.84 (2H, m, 2 × 
ArH), 7.69 (1H, d, J = 7.60, ArH), 7.57 (1H, d, J = 6.23, ArH), 7.58-7.45 (3H, m, 3 × ArH), 7.37 
(1H, d, J = 7.85, ArH), 7.24-7.14 (2H, m, 2 × ArH), 6.77 (1H, s, ArH); δC (75MHz; CDCl3) 
137.67 (C), 137.34 (C1), 134.89 (C), 132.51 (C), 132.07 (C1), 129.84 (C), 129.53 (CH), 129.43 
(CH), 128.15 (CH), 127.63 (CH), 127.12 (CH), 126.66 (CH), 126.29 (CH), 123.15 (CH), 121.58 
(CH), 1231.14 (CH), 111.84 (CH), 104.66 (CH); m/z 244 (M+, 100%), 217 92%), 155 (2%), 105 
(2%), (Found: 243.2380. C18H13N requires 243.1048). 
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(j) 2-(4-Bromo-2,5-dimethoxyphenyl)-1H-indole (166) 
 
2-(4-Bromo-2,5-dimethoxyphenyl)-1-phenylsulfonylindole 
(164) (0.38 g, 0.806 mmol), K2CO3 (20.73 g, 150 mmol, 
190 eq). Column chromatography gave a cream white solid 
(166) 0.14 g (52%). Melting point 158-161 °C; vmax 
(Solid)/cm-1 3450 (m, NH), 2938 (w, CH), 1531 (m), 1482 
(s), 1415 (m), 1325 (m), 1211 (s), 1178 (m), 1028 (m), 930 (w), 853 (w), 785 (s), 753 (s), 672 
(m); δH (300 MHz; CDCl3; Me4Si) 9.63 (1H, s, NH), 7.63 (1H, d, J = 7.79, ArH), 7.41 (1H, d, J 
= 8.03, ArH), 7.32 (1H, s, ArH), 7.24-7.17 (2H, m, 2 × ArH), 7.14-7.08 (1H, m, ArH), 6.88 (1H, 
s, ArH), 3.94 (3H, s, CH3O), (3H, s, CH3O); δC (75MHz; CDCl3) 151.12 (C), 150.51 (C), 136.65 
(C1), 135.51 (C), 128.27 (C), 122.68 (CH), 120.96 (CH), 120.75 (C), 120.45 (CH), 118.04 (CH), 
111.81 (C), 111.46 CH), 111.12 (CH), 100.56 (CH) 57.31 (CH3O), 57.19 (CH3O); m/z 331 (M+, 
78%), 316 (22%), 264 (26%), 219 (100%), 131 (44%), 69 (90%), (Found: 331.0234. 
C21H17NSO3 requires 331.0208). 
 
(k) 2-(4-Bromo-2,5-dimethoxyphenyl)-5-methoxy-1H-indole (167) 
 
2-(4-Bromo-2,5-dimethoxyphenyl)-5-methoxy-1-
(phenylsulfonyl)-1H-indole (165) (0.070 g, 0.14 
mmol), K2CO3 (3.67 g, 27 mmol, 190 eq). Column 
chromatography gave a yellow solid (167) 0.020 g 
(40%). Melting point 166-170 °C; vmax (Solid)/cm-1 
3397 (m, NH), 2919 (m, CH), 1623 (w), 1531 (w), 1497 (m), 1464 (m), 1438 (m), 1413 (m), 
1275 (m), 1204 (s), 1181 (w), 1149 (m), 1023 (s), 948 (w), 843 (m), 825 (m), 750 (s), 618 (w); 
δH (300 MHz; CDCl3; Me4Si) 9.54 (1H, s, NH), 7.33-7.26 (2H, m, 2 × ArH), 7.21 (1H, s, ArH), 
7.08 (1H, s, ArH), 6.88-6.82 (2H, m, 2 × ArH), 3.97 (3H, s, CH3O), 3.94 (3H, s, CH3O), 3.86 
(3H, s, CH3O); δC (75MHz; CDCl3) 154.41 (C), 150.77 (C), 150.10 (C), 135.69 (C), 131.57 (C), 
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128.32 (C), 120.66 (C), 117.67 (CH), 112.82 (CH), 111.80 (CH), 111.41 (CH), 110.63 (C), 
101.73 (CH), 99.89 (CH), 56.95 (CH3O), 56.81 (CH3O), 55.85 (CH3O);  
 
4.6 General procedure for the synthesis of 3-aryl-1-(phenylsulfonyl)indole and 
3-aryl-5-methoxy-1-(phenylsulfonyl)indole  
 
To Pd(PPh3)4 (10 mol%) under N2 was added a deoxygenated mixture of 3-bromo-1-
(phenylsulfonyl)-1H-indole or 3-bromo-5-methoxy-1-(phenylsulfonyl)-1H-indole in DME (5 ml) 
and arylboronic acid in ethanol (3 ml). The reaction mixture was stirred for about 10 min 
followed by the addition of deoxygenated solution of Na2CO3 in water. The resulting reaction 
mixture was stirred for further 10 mins at rt before being heated to reflux for 8 h. 
 
The reaction mixture was allowed to cool to rt, quenched with water (10.0 ml) and the organic 
extracts extracted with CH2CH2 (3 × 30 ml). The organic fractions were combined, dried over 
MgSO4, filtered through a celite plug and then the excess solvent was removed on a rotary 
evaporator. The resulting black oil was purified by column chromatography using 10% 
EtOAc/Hexane as an eluent. 
 
(a) 3-Phenyl-1-(phenylsulfonyl)-1H-indole (137) 
 
Pd(PPh3)4 (0.16 g, 10%), 3-bromo-1-(phenylsulfonyl)-1H-indole (107) 
(0.45 g, 1.34 mmol), phenylboronic acid (0.25 g, 2.01 mmol, 1.5 eq), 
Na2CO3 (1.21 g, 11.4 mmol, 8.5 eq). This gave a yellow oil (137) that 
solidified on standing in 89% yield. Melting point: 139-142 °C, lit. 
value 141-143 °C64; vmax (Solid)/cm-1 3067 (m, CH), 1607 (w), 1447 (s), 
1373 (s), 177 (s), 1132 (s), 1015 (m), 909 (s), 733 (s); δH (300 MHz; 
CDCl3; Me4Si) 8.07 (1H, d, J = 8.21, ArH), 7.92 (2H, d, J = 7.52, 2 × 
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ArH), 7.77 (1H, d, J = 7.83, ArH) 7.70 (1H, s, ArH), 7.61-7.24 (10H, m, 10 × ArH); δC (75 
MHz; CDCl3) 138.61 (C), 135.92 (C), 134.30 (CH), 133.43 (C),129.74 (2 × CH), 129.62 (C), 
129.48 (2 × CH), 128.39 (2 × CH), 128.06 (CH), 127.27 (2 × CH), 125.40 (CH), 124.55 (C), 
124.11 (CH), 123.38 (CH), 120.94 (CH), 114.30 (CH); m/z 333 (M+, 42%), 193 (18%), 192 
(100%), 165 (13%) and 77 (7%) (Found: 333.0830. C20H15SO2N requires 333.0824). 
 
(b) 5-Methoxy-3-phenyl-1-(phenylsulfonyl)-1H-indole (138) 
 
Pd(PPh3)4 (0.10 g, 0.055 mmol, 10%), 3-bromo-5-methoxy-1-
(phenylsulfonyl)-1H-indole (109) (0.20 g, 0.55 mmol), 
phenylboronic acid (0.10 g, 0.82 mmol, 1.5 eq), Na2CO3 (0.49 g, 
4.70 mmol, 8.5 eq) in water (2.3 ml). This gave a yellow oil (138), 
0.17 g (86%); vmax (Liquid)/cm-1 3004 (w, CH), 1607 (m), 1470 
(s), 1448 (s), 1364 (s), 1262 (s), 1211 (s), 1171 (s), 1143 (s), 1129 
(s), 1086 (s), 1029 (s), 997 (w), 958 (m), 850 (m), 836 (m), 801 
(s), 750 (s), 723 (s), 682 (s), 650 (m); δH (300 MHz; CDCl3; 
Me4Si) 7.96 (1H, d, J = 8.64, ArH), 7.89 (2H, d, J = 7.69, 2 × 
ArH), 7.65 (1H, s, ArH), 7.57 (2H, d, J = 7.68, 2 × ArH), 7.51-7.37 (6H, m, 6 × ArH), 7.19 (1H, 
s, ArH), 6.98 (1H, d, J = 9.13, ArH), 3.80 (3H, s, CH3O); δC (75MHz; CDCl3) 156.23 (C), 
137.49 (C), 133.26 (CH), 132.46 (C), 129.77 (C), 128.72 (2 × CH), 128.41 (2 × CH), 127.24 (2 × 
CH), 127.03 (CH), 126.35 (C), 126.19 (2 × CH), 123.72 (C), 123.20 (CH), 114.18 (CH), 113.37 
(CH), 102.39 (CH), 55.17 (CH3O). 
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(c) 3-ortho-Tolyl-1-(phenylsulfonyl)-1H-indole (139) 
 
Pd(PPh3)4 (0.17g, 10%), 3-bromo-1-(phenylsulfonyl)-1H-indole (107) 
(0.50 g, 1.49 mmol), o-tolylboronic acid (0.30 g, 2.23 mmol, 1.5 eq), 
Na2CO3 (1.34 g, 12.7 mmol, 8.5 eq) in water (6.3 ml). This gave a 
brown oil (139) that did not solidify on standing (0.35g, 68%) 
literature reported (139) as a light orange oil56; vmax (Liquid)/cm-1 3069 
(w, CH), 1600 (m), 1448 (m), 1376 (m), 1186 (m), 1014 (w), 909 (s), 
and 731 (s); δH (300 MHz; CDCl3; Me4Si) 8.07 (1H, d, J = 8.21, ArH), 
7.98-7.87 (2H, m, 2 × ArH), 7.52-7.22 (11H, m, 11 × ArH), 2.21 (3H, 
s, CH3); δC (75 MHz; CDCl3) 138.60 (C), 137.91 (C), 137.33 (C), 
135.42 (C), 134.23 (CH), 130.94 (CH), 129.96 (C), 129.78 (2 × CH), 128.45 (CH), 127.20 (2 × 
CH), 126.25 (CH), 125.36 (CH), 124.57 (CH), 123.90 (CH), 121.23 (CH), 114.29 (CH), 120.50 
(CH), 100.38 (C), 20.85 (CH3); m/z 347 (M+, 9%), 336 (37%), 334 (36%), 258 (16%), 257 
(100%), 206 (13%), 195 (52%), 193 (55%), 141 (31%), 117 (13%), 116 (88%), 89 (29%), 88 
(10%), 77 (84%), 63 (11%), 51 (28%) (Found: 347.0979. C21H17SO2N requires 347.0980). 
 
(d) 5-Methoxy-1-(phenylsulfonyl)-3-o-tolyl-1H-indole (140) 
 
Pd(PPh3)4 (0.10 g, 0.055 mmol, 10%), 3-bromo-5-methoxy-1-
(phenylsulfonyl)-1H-indole (109) (0.20 g, 0.55 mmol), o-
tolylboronic acid (0.11 g, 0.82 mmol, 1.5 eq), Na2CO3 (0.49 g, 
4.70 mmol, 8.5 eq) in water (2.3 ml). This gave a cream white 
solid (140), 0.20 g (95%). Melting point 111-114 °C, lit. value 
127-128 °C56; vmax (Solid)/cm-1 3198 (w, CH), 1606 (m), 1470 
(s), 1445 (s), 1362 (s), 1257 (s), 1213 (m), 1172 (s), 1134 (s), 
1085 (s), 1030 (s), 985 (m), 855 (s), 804 (m), 755 (s), 720 (s), 
682 (s), 652 (s), 630 (s); δH (300 MHz; CDCl3; Me4Si) 7.96 (1H, 
d, J = 9.02, ArH), 7.87 (2H, d, J = 8.47, 2 × ArH), 7.56-7.41 (4H, m, 4 × ArH), 7.32-7.24 (4H, 
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m, 4 × ArH), 6.96 (1H, dd, J = 2.12 and 2.16, ArH), 6.73 (1H, d, J = 2.04, ArH), 3.73 (3H, s, 
CH3O), 2.19 (3H, s, CH3); δC (75MHz; CDCl3) 157.17 (C), 138.44 (C), 137.28 (C), 134.18 (CH), 
132.31 (C), 132.22 (C), 130.95 (CH), 130.78 (CH), 130.07 (C), 129.63 (2 × CH), 128.04 (CH), 
127.13 (2 × CH), 126.28 (CH), 125.30 (CH), 124.38 (C), 115.20 (CH), 114.48 (CH), 103.29 
(CH), 56.10 (CH3O), 20.78 (CH3). 
 
(e) 1-(Phenylsulfonyl)-3-(3,4,5-trimethoxyphenyl)-1H-indole (141) 
 
Pd(PPh3)4 (0.10 g, 0.060 mmol, 10%), 3-bromo-1-
(phenylsulfonyl)-1H-indole (107) (0.20 g, 0.60 mmol), 3,4,5-
trimethoxyphenylboronic acid (0.10 g, 0.89 mmol, 1.5 eq), 
Na2CO3 (0.53 g, 5.06 mmol, 8.5 eq) in water (2.5 ml). This gave a 
yellow oil (141), 0.19 g (83%); vmax (Liquid)/cm-1 2935 (w, CH), 
1587 (m), 1502 (m), 1446 (m), 1415 (m), 1359 (s), 1268 (m), 
1238 (s), 1173 (s), 1123 (s), 1090 (s), 999 (m), 969 (m), 908 (m), 
837 (m), 724 (s), 684 (s), 657 (m); δH (300 MHz; CDCl3; Me4Si) 
8.07 (1H, d, J = 8.16, ArH), 7.93 (2H, d, J = 7.62, 2 × ArH), 7.77 
(1H, d, J = 7.75, ArH), 7.67 (1H, s, ArH), 7.38-7.31 (2H, m, 2 × 
ArH), 7.11-7.06 (3H, m, 3 × ArH), 6.80 (2H, s, × x ArH), 3.91 (9H, s, 3 × CH3O); δC (75MHz; 
CDCl3) 151.91 (3 × C), 136.33 (C), 133.71 (C), 132.77 (CH), 132.23 (CH), 128.97 (C), 128.26 
(CH), 127.63 (2 × CH), 125.94 (CH), 125.11 (2 × CH), 124.86 (C), 123.36 (CH), 122.45 (C), 
121.99 (CH), 120.98 (CH), 118.66 (CH), 112.15 (CH), 103.31 (2 × CH), 59.26 (CH3O), 54.53 (2 
× CH3O); m/z 424 (M+, 10%), 371 (4%), 295 (2%), 273 (26%), 231 (51%), 213 (89%), 173 
(100%), 133 (10%), 119 (2%) (Found: 423.3420. C23H21NO5S requires 423.1140). 
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(f) 5-Methoxy-1-(phenylsulfonyl)-3-(3,4,5-trimethoxyphenyl)-1H-indole (142) 
 
Pd(PPh3)4 (0.10 g, 0.055 mmol, 10%), 3-bromo-5-
methoxy-1-(phenylsulfonyl)-1H-indole (109) (0.20 g, 0.55 
mmol), 3,4,5-trimethoxyphenylboronic acid (0.17 g, 0.82 
mmol, 1.5 eq), Na2CO3 (0.49 g, 4.70 mmol, 8.5 eq) in 
water (2.3 ml). This gave a cream white solid (142), 0.15 g 
(60%). Melting point 132-136 °C; vmax (Solid)/cm-1 2934 
(w, CH), 1576 (m), 1503 (m), 1445 (m), 1364 (m0, 1276 
(m), 1240 (m), 1221 (m), 1170 (s), 1122 (s), 1031 (m), 997 
(m), 976 (m), 903 (m), 833 (m), 815 (m), 751 (s), 725 (m), 
691 (m), 643 (m); δH (300 MHz; CDCl3; Me4Si) 7.96 (1H, 
d, J = 905, ArH), 7.90 (2H, d, J = 7.62, 2 × ArH), 7.64 (1H, s, ArH), 7.57-7.52 (1H, m, ArH), 
7.47-7.42 (2H, m, 2 × ArH), 7.20 (1H, d, J = 2.12, ArH), 6.99 (1H, dd, J = 2.14 and 2.22, ArH), 
6.77 (2H, s, 2 × ArH), 3.94 (3H, s, CH3O), 3.91 (6H, s, 2 × CH3O), 3.90 (3H, s, CH3O); δC 
(75MHz; CDCl3) 156.20 (C), 153.10 (C), 152.82 (2 × C), 137.47 (C), 137.09 (C), 137.02 (C), 
133.31 (CH), 129.75 (C), 129.55 (C), 128.76 (2 × CH), 128.02 (C), 126.22 (2 × CH), 123.68 (C), 
122.97 (CH), 114.23 (CH), 113.33 (CH), 104.39 ( 2 × CH), 104.03 (2 × CH), 102.41 (CH), 60.41 
(CH3O), 55.73 (2 × CH3O), 55.69 (CH3O). 
 
(g) 3-(4-Methoxyphenyl)-1-(phenylsulfonyl)-1H-indole (143) 
 
Pd(PPh3)4 (0.34 g, 10%), 3-bromo-1-(phenylsulfonyl)-1H-indole (107) 
(1.00 g, 2.98 mmol), 4-methoxyphenylboronic acid (0.68 g, 5.84 mmol, 
1.5 eq), Na2CO3 (2.68 g, 33.10 mmol, 8.5 eq) in water (2.5 ml). This 
gave a white solid (143) (0.89 g, 82%). Melting point: 132-137 °C, 
literature reported (143) as an oil84; vmax (Solid)/cm-1 2964 (w, CH), 
1610 (m), 1501 (m), 1446 (m), 1361 (m), 1242 (m), 1131 (s), 1018 
(m), 998 (m), 832 (m), 774 (s), 684(m); δH (300 MHz; CDCl3; Me4Si) 
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8.06 (1H, d, J = 8.20, ArH), 7.91 (2H, d, J = 7.58, 2 × ArH), 7.74 (1H, d, J = 7.65, ArH), 7.63 
(1H, s, ArH), 7.53-7.51 (3H, m, 3 × ArH), 7.30-7.25 (2H, m, 2 × ArH), 7.14 (1H, d, J = 8.72, 
ArH)7.03-6.98 (2H, m, 2 × ArH), 6.82-6.76 (1H, m, ArH), 3.85 (3H, s, CH3O); δC (75MHz; 
CDCl3) 159.67 (C), 138.19 (C), 133.87 (CH), 133.41 (CH), 130.92 (CH). 129.59 (C), 129.33 (2 
× CH), 129.08 (2 × CH), 126.84 (2 × CH), 125.38 (C), 125.05 (CH), 123.61 (CH), 120.49 (CH), 
119.93 (C), 116.33 (C), 114.41 (2 × CH), 55.41 (CH3O); m/z 363 (M+, 16%), 263 (24%), 219 
(100%), 131 (35%), 100 (15%), 69 (35%), (Found: 363.0931. C21H17NSO3 requires 363.0929). 
 
(h) 5-Methoxy-3-(4-methoxyphenyl)-1-(phenylsulfonyl)-1H-indole (144) 
 
Pd(PPh3)4 (0.10 g, 0.055 mmol, 10%), 3-bromo-5-methoxy-1-
(phenylsulfonyl)-1H-indole (109) (0.20 g, 0.55 mmol), 4-
methoxyphenylboronic acid (0.12 g, 0.82 mmol, 1.5 eq), 
Na2CO3 (0.49 g, 4.70 mmol, 8.5 eq) in water (2.3 ml). This gave 
a yellow oil (144), 0.18 g (83%); vmax (Liquid)/cm-1 2933 (w, 
CH), 1610 (m), 1589 (m), 1571 (m), 1507 (s), 1469 (s), 1445 
(s), 1366 (s), 1303 (s), 1244 (s), 1211 (s), 1172 (s), 1129 (s), 
1103 (s), 1087 (s), 1031 (s), 958 (m), 835 (s), 788 (s), 769 (s), 
751 (s), 722 (s), 684 (s), 665 (s); δH (300 MHz; CDCl3; Me4Si) 
7.95 (1H, d, J = 9.02, ArH), 7.88 (2H, d, J = 8.23, 2 × ArH), 
7.58-7.40 (5H, m, 5 × ArH), 7.15 (1H, s, ArH), 7.02-6.95 (3H, m, 2 × ArH), 6.77 (1H, s, ArH), 
3.86 (3H, s, CH3O), 3.81 (3H, s, CH3O); δC (75MHz; CDCl3) 159.60 (C), 157.14 (C), 138.49 
(C), 134.17 (CH), 131.01 (C), 130.61 (C), 129.66 (2 × CH), 129.37 (2 × CH), 127.16 (2 × CH), 
125.79 (C), 124.44 (C), 123.54 (CH), 116.42 (C), 115.15 (CH), 114.83 (2 × CH), 114.22 (CH), 
103.36 (CH), 56.15 (CH3O), 55.79 (CH3O). 
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(i) 3-(2-Formylphenyl)-1-(phenylsulfonyl)-1H-indole (145) 
 
Pd(PPh3)4 (10%, 0.34 g), starting material (107) (1.00 g, 2.98 
mmol), 2-formylphenylboronic acid (0.67g, 4.46 mmol, 1.5 eq), 
Na2CO3 (2.68 g, 25.3 mmol, 8.5 eq) in water (12.6 ml).  This gave 
a brown oil (145) that did not solidify on standing in 67% yield; 
vmax (Liquid)/cm-1 3065 (w, CH), 1693 (s, C=O), 1599 (m), 1447 
(s), 1374 (s), 1184 (s), 1131 (s), 1014 (m), 911 (m), 784 (s); δH 
(300 MHz; CDCl3; Me4Si) 9.90 (1H, s, CHO), 8.08 (2H, t, J = 
8.10, 2 × ArH), 7.95 (2H, d, J = 7.80, 2 × ArH) and 7.68-7.26 
(10H, m, 10 × ArH); δC (75 MHz; CDCl3) 192.00 (CHO), 141.61 
(C), 138.43 (C), 136.35 (C), 135.39 (C), 134.61 (CH), 134.43 (CH), 131.80 (CH), 129.97 (2 × 
CH), 129.22 (C),128.93 (CH), 128.46 (CH), 127.35 (2 × CH), 126.00 (CH), 125.92 (CH), 124.68 
(CH), 120.55 (CH), 120.39 (C), 114.34 (CH); m/z 361 (M+, 4%), 220 (11%), 210 (11%), 182 
(15%), 181 (100%), 165 (10%), 153 (13%), 152 (24%), 151 (7%), 83 (11%), 77 (7%), 76 (9%) 
(Found: 361.0789. C21H15SO3N requires 361.0773). 
 
(j) 2-(5-Methoxy-1-(phenylsulfonyl)-1H-indol-3-yl)benzaldehyde (146) 
 
Pd(PPh3)4 (0.10 g, 0.085 mmol, 10%), 3-bromo-5-methoxy-
1-(phenylsulfonyl)-1H-indole (109) (0.31 g, 0.85 mmol), 2-
formylphenylboronic acid (0.20 g, 1.27 mmol, 1.5 eq), 
Na2CO3 (0.76 g, 7.22 mmol, 8.5 eq) in water (3.6 ml). This 
gave a white solid (146), 0.25 g (76%); Melting point 129-
132 °C; vmax (Solid)/cm-1 2920 (w, CH), 1681 (s, C=O), 
1601 (m), 1468 (m), 1446 (m), 1364 (s), 1256 (m), 1214 
(m), 1173 (s), 1134 (s), 1086 (m), 1029 (m), 996 (m), 960 
(m), 838 (w), 810 (m), 750 (s), 723 (s), 683 (s), 628 (s); δH 
(300 MHz; CDCl3; Me4Si) 9.87 (1H, s, CHO), 8.07 (1H, d, J = 7.75, ArH), 7.98 (1H, d, J = 9.06, 
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ArH), 7.92 (2H, d, J = 7.77, 2 × ArH), 7.69 (1H, t, J = 14.83, ArH), 7.59-7.46 (6H, m, 6 × ArH), 
7.26 (1H, s, ArH), 7.01 (1H, d, J = 9.05, ArH), 6.76 (1H, s, ArH), 3.73 (3H, s, CH3O); δC 
(75MHz; CDCl3) 192.11 (C=O), 157.61 (C), 138.26 (C), 136.41 (C), 134.87 (C), 134.55 (CH), 
134.52 (CH), 132.24 (C), 131.64 (CH), 129.83 (2 × CH), 128.89 (CH), 128.37 (CH), 127.18 (2 × 
CH), 126.57 (CH), 120.40 (C), 115.25 (CH), 102.44 (CH), 56.10 (CH3O). 
 
(k) 1-(2-(1-(Phenylsulfonyl)-1H-indol-3-yl) acetophenone (147) 
 
Pd(PPh3)4 (0.14 g, 10%), 3-bromo-1-(phenylsulfonyl)-1H-indole 
(107) (0.40 g, 1.19 mmol), 2-acetylphenylboronic acid (0.29 g, 1.79 
mmol, 1.5 eq), Na2CO3 (1.61 g, 15.2 mmol, 8.5 eq) in water (7.6 
ml). This gave a brown oil (147), 0.38 g (84%); vmax (Liquid)/cm-1 
3063 (w, CH), 1685 (s, C=O), 1446 (s), 1370 (s), 1273 (m), 1242 
(m), 1175 (s), 1127 (s), 1089 (s), 1012 (s), 931 (m), 745 (s), 724 (s), 
684 (s), 636 (s); δH (300 MHz; CDCl3; Me4Si) 8.09 (1H, d, J = 
8.11, ArH), 7.92 (2H, d, J = 7.49, 2 × ArH), 7.61 (1H, d, J = 7.30, 
ArH), 7.55 (1H, s, ArH), 7.52 (2H, d, J = 7.34, 2 × ArH), 7.46-7.35 
(6H, m, 6 × ArH), 7.27-7.22 (1H, m, ArH), 1.90 (3H, s, CH3); δC (75MHz; CDCl3) 203.89 
(C=O), 141.77 (C), 138.61 (C), 135.52 (C), 134.42 (CH), 131.40 (CH), 131.37 (CH), 130.76 (C), 
130.53 (C), 129.78 (2 × CH), 128.56 (CH), 127.18 (2 × CH), 125.83 (CH), 124.91 (CH), 124.40 
(CH), 123.45 (C), 120.57 (CH), 114.37 (CH), 30.14 (CH3); m/z 376 (M+, 80%), 358 (2%), 248 
(3%), 235 (32%), 218 (2%), 163 (1%), 135 (4%), (Found: 375.1530. C22H17NO3S requires 
375.0929). 
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(l) 1-(2-(5-Methoxy-1-(phenylsulfonyl)-1H-indol-3-yl) acetophenone (148) 
 
Pd(PPh3)4 (0.10 g, 0.055 mmol, 10%), 3-bromo-5methoxy-
1-(phenylsulfonyl)-1H-indole (109) (0.20 g, 0.55 mmol), 2-
acetylphenylboronic acid (0.14 g, 0.82 mmol, 1.5 eq), 
Na2CO3 (0.49 g, 4.70 mmol, 8.5 eq) in water (2.3 ml). This 
gave a cream white solid (148), 0.17 g (77%). Melting point 
105-109 °C; vmax (Solid)/cm-1 2895 (w, CH), 1690 (s, C=O), 
1610 (w), 1478 (s), 1447 (m), 1363 (s), 1271 (m), 1246 (s), 
1212 (s), 1174 (s), 1134 (s), 1089 (s), 1030 (m), 961 (s), 
851 (m), 834 (m), 757 (m), 724 (s), 687 (m), 632 (m); δH 
(300 MHz; CDCl3; Me4Si) 7.98 (1H, d, J = 9.05, ArH), 7.89 (2H, d, J = 7.73, 2 × ArH), 7.62-
7.42 (8H, m, 8 × ArH), 6.99 (1H, dd, J = 1.95 and 1.96, ArH), 6.77 (1H, s, ArH), 3.74 (3H, s, 
CH3O), 1.87 (3H, s, CH3); δC (75MHz; CDCl3) 204.21 (C=O), 157.44 (C), 141.77 (C), 138.50 
(C), 134.35 (CH), 131.51 (CH), 131.21 (CH), 130.78 (C), 130.09 (C), 129.73 (2 × CH), 128.60 
(CH), 128.57 (CH), 127.11 (2 × CH), 125.50 (CH), 123.71 (C), 115.39 (CH), 115.21 (C), 102.50 
(CH), 56.05 (CH3O), 30.11 (CH3). 
 
4.7 Typical procedure for removing of phenylsulfonyl protecting group on 3-
aryl-1-(phenylsulfonyl)-1H-indoles and 3-aryl-5-methoxy-1-(phenylsulfonyl)-
1H-indoles 
 
The substrate was dissolved in methanol (20 ml) at rt under N2 atmosphere, K2CO3 was added to 
the solution and the reaction mixture was heated to reflux under N2 for 18 h. The reaction 
mixture was then allowed to cool down to rt and filtered through a celite plug and then the 
filtrate concentrated under reduced pressure. Water was added to the crude material and slowly 
acidified to pH 2-4 with aqueous 10% HCl. The aqueous portion was saturated with solid NaCl 
and the organic material extracted with CH2Cl2 (3 × 30 ml). The combined organic extracts were 
washed two times with water (20 ml), brine (20 ml), dried over MgSO4 and concentrated under 
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reduced pressure. This resulted in brown oils that were subjected to column chromatography 
using 10% EtOAc/Hexane as an eluent. 
 
(a) 3-Phenyl-1H indole (149) 
 
3-Phenyl-1-phenylsulfonylindole (137) (0.36 g, 1.08 mmol), K2CO3 
(28.35 g, 205.4 mmol, 190 eq). Column chromatography  gave a 
yellow oil that solidified on standing to yellow solid (149) in 81% 
yield. Melting point: 86-89 °C, li. value 89 °C85; vmax (Solid)/cm-1 
3412 (s, NH), 3055 (m, CH), 1602 (m), 1545 (m), 1457 (m), 1416 (m), 
1337 (m), 1264 (s), 1100 (m), 1014 (w), 960 (w), 823 (w), 741 (s); δH 
(300 MHz; CDCl3; Me4Si) 8.17 (1H, s, NH), 7.94 (1H, d, J = 7.70, ArH), 7.66 (2H, d, J = 7.10, 2 
× ArH), 7.46-7.18 (7H, m, 7 × ArH); δC (75 MHz; CDCl3) 137.15 (C), 136.00 (C), 129.23 (2 × 
CH), 127.98 (2 × CH), 126.43 (CH), 126.27 (C), 122.86 (CH), 122.34 (CH), 120.7 (CH), 120.20 
(CH), 118.71 (C), 111.90 (CH); m/z 193 (M+, 100%), 192 (9%), 191 (4%), 165 (21%), 164 (4%), 
163 (4%), 96 (6%), 95 (6%), 90 (3%) (Found: 193.0897. C14H10N requires 193.0892). 
 
(b) 5-Methoxy-3-phenyl-1H-indole (150) 
 
5-Methoxy-3-phenyl-1-(phenylsulfonyl)-1H-indole (138) (0.17 g, 
0.47 mmol), K2CO3 (12.30 g, 89 mmol, 190 eq). Column 
chromatography gave a brown oil (150) 0.085 g (85%), literature 
reported (150) as a solid with melting point 66-67 °C86; vmax 
(Liquid)/cm-1 3409 (s, NH), 2935 (w, CH), 1620 (m), 1601 (m), 
1581 (m), 1542 (s), 1477 (m), 1437 (m), 1310 (m0, 1293 (m), 
1268 (s), 1238 (s), 1207 (m), 1175 (m), 1154 (m), 1109 (s), 1071 (m), 1026 (m), 966 (m), 913 
(m), 834 (s), 797 (s), 762 (s), 697 (s), 679 (s); δH (300 MHz; CDCl3; Me4Si) 8.01 (1H, s, NH), 
7.56 (2H, d, J = 7.83, 2 × ArH), 7.39-7.34 (2H, m, 2 × ArH), 7.31 (1H, s, ArH), 7.23-7.16 (3H, 
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m, 3 × ArH), 6.83 (1H, d, J = 8.46, ArH), 3.77 (3H, s, CH3O); δC (75MHz; CDCl3) 154.14 (C), 
135.18 (C), 130.21 (C), 128.51 (C), 128.31 (2 × CH), 126.83 (2 × CH), 126.46 (C), 125.38 (CH), 
122.15 (CH), 112.12 (CH), 111.64 (CH), 55.46 (CH3O). 
 
(c) 3-ortho-Tolyl-1H-indole (151) 
 
3-ortho-olyl-1-phenylsulfonylindole (139) (0.21 g, 0.61 mmol), K2CO3 
(15.87 g, 115.0 mmol, 190 eq). Column chromatography a gave brown 
oil (151) that did not solidify on standing in 64% yield, literature 
reported (151) as an oil56; vmax (Liquid)/cm-1 3476 (s, NH), 3061 (w, 
CH), 1620 (w), 1551 (w), 1456 (m), 1344 (w), 1253 (w), 1094 (m), 
909 (s), 731 (s), 650 (m); δH (300 MHz; CDCl3; Me4Si) 8.17 (1H, s, 
NH), 7.52 (1H, d, J = 7.91, ArH), 7.43-7.39 (2H, m, 2 × ArH), 7.32-7.23 (4H, m, 4 × ArH), 7.14-
7.10 (2H, m, 2 × ArH), 2.31 (3H, s, CH3); δC (75 MHz; CDCl3) 137.30 (C), 136.35 (C), 134.93 
(C), 131.39 (CH), 130.85 (CH), 127.67 (C), 127.26 (CH), 126.12 (CH), 123.24 (CH), 122.68 
(CH), 120.60 (CH), 120.41 (CH), 117.97 (C), 111.63 (CH), 21.16 (CH3); m/z 207 (M+, 100%), 
206 (73%), 205 (7%), 204 (16%), 180 (7%), 179 (10%), 178 (15%), 103 (7%), 102 (8%), 89 
(6%) (Found: 207.1051. C15H13N requires 207.1048). 
 
(d) 5-Methoxy-3-o-tolyl-1H-indole (152) 
 
5-Methoxy-1-(phenylsulfonyl)-3-o-tolyl-1H-indole (140) (0.25 
g, 0.74 mmol), K2CO3 (19.5 g, 140 mmol, 190 eq). Column 
chromatography gave a yellow oil (152) 0.16 g (86%), literature 
reported (151) as an oil56; vmax (Liquid)/cm-1 3411 (m, NH), 
1622 (m), 1580 (m), 1478 (s), 1437 (s), 1261 (s), 1208 (s), 1175 
(s), 1122 (m), 1093 (s), 1026 (s), 916 (m), 790 (s), 763 (s), 745 
(s), 724 (m), 668 (m); δH (300 MHz; CDCl3; Me4Si) 8.11 (1H, s, NH), 7.43-7.40 (1H, m, ArH), 
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7.35-7.22 (3H, m, 3 × ArH), 7.12 (1H, d, J = 1.95, ArH), 6.94 (1H, s, ArH), 6.89 (1H, dd, J = 
1.81 and 1.92, ArH), 3.78 (3H, s, CH3O), 2.32 (3H, s, CH3); δC (75MHz; CDCl3) 154.63 (C), 
137.13 (C), 134.80 (C), 131.20 (C), 130.99 (CH), 130.60 (CH), 127.71 (C), 126.96 (CH), 125.90 
(CH), 123.81 (CH), 117.50 (C), 112.83 (CH), 112.18 (CH), 101.75 (CH), 56.12 (CH3O), 20.93 
(CH3). 
 
(e) 3-(3,4,5-Trimethoxyphenyl)-1H-indole (153) 
 
1-(Phenylsulfonyl)-3-(3,4,5-trimethoxyphenyl)-1H-indole (141) 
(0.19 g, 0.45 mmol), K2CO3 (11.80 g, 85 mmol, 190 eq). Column 
chromatography gave a brown oil (153) 0.085 g (65%); vmax 
(Liquid)/cm-1 3350 (m, NH), 2931 (m), CH), 1583 (s), 1498 (m), 
1456 (s), 1408 (m), 1361 (m), 1334 (m), 1120 (s), 999 (s), 836 (m), 
739 (s), 659 (m), 623 (m); δH (300 MHz; CDCl3; Me4Si) 8.35 (1H, s, 
NH), 7.92 (1H, d, J = 7.74, ArH), 7.44 (1H, d, J = 7.96, ArH), 7.35 
(1H, d, J = 2.34, ArH), 7.24-7.21 (2H, m, 2 × ArH), 6.88 (2H, s, 2 × ArH), 3.93 (6H, s, 2 × 
CH3O), 3.91 (3H, s, CH3O); δC (75MHz; CDCl3) 152.06 (2 × C), 151.94 (C), 135.17 (C), 129.87 
(C), 124.28 (C), 121.05 (CH), 120.19 (CH), 118.90 (CH), 118.17 (CH), 117.01 (C), 110.06 
(CH), 103.27 (2 × CH), 54.85 (CH3O), 54.74 (2 × CH3O);  
 
(f) 5-Methoxy-3-(3,4,5-trimethoxyphenyl)-1H-indole (154) 
 
5-Methoxy-1-(phenylsulfonyl)-3-(3,4,5-
trimethoxyphenyl)-1H-indole (142) (0.11 g, 0.24 mmol), 
K2CO3 (6.40 g, 46 mmol, 190 eq). Column 
chromatography gave a brown oil (154) 0.055 g (72%); 
vmax (Liquid)/cm-1 3348 (m, NH), 2937 (w, CH), 1586 (s), 
1481 (s), 1334 (m), 1212 (m), 1172 (s), 1118 (s), 994 (s), N
H
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798 (m), 725 (m); δH (300 MHz; CDCl3; Me4Si) 8.46 (1H, s, NH), 7.37-7.32 (3H, m, 3 × ArH), 
6.93 (1H, d, J = 8.82, ArH), 6.85 (2H, s, 2 × ArH), 6.10 (2H, s, 2 × ArH), 3.87 (3H, s, CH3O), 
3.78 (3H, s, CH3O), 3.77 (6H, s, 2 × CH3O); δC (75MHz; CDCl3) 154.20 (C), 153.33 (C), 153.13 
(2 × C), 131.47 (C), 131.27 (C), 125.74 (C), 122.26 (CH), 117.66 (C), 112.19 (CH), 111.96 
(CH), 101.14 (CH), 92.52 (2 × CH), 60.68 (CH3O), 55.81 (2 × CH3O), 55.60 (CH3O). 
 
(g) 3-(4-Methoxyphenyl)-1H-indole (155) 
 
3-(4-Methoxyphenyl)-1-(phenylsulfonyl)-1H-indole (143) (0.83 g, 2.39 
mmol), K2CO3 (62.40 g, 452 mmol, 190 eq). Column chromatography 
gave a cream white solid (155) (0.53 g, 79%). Melting point: 130-134 
˚C, lit. value 131-133 °C87; vmax (Solid)/cm-1 3427 (s, NH), 2955 (w, 
CH), 1611 (m), 1542 (m), 1440 (m), 1322 (m), 1241 (s), 1181 (m), 
1030 (s), 957 (w), 809 (m), 794 (m), 648 (s); δH (300 MHz; CDCl3; 
Me4Si) 8.13 (1H, NH), 7.89 (1H, d, J = 7.77, ArH), 7.58 (2H, d, J = 
8.68, 2 × ArH), 7.38 (1H, d, J = 7.90, ArH), 7.25-7.17 (3H, m, 3 × ArH), 6.99 (2H, d, J = 8.67, 2 
× ArH), 3.85 (3H, s, CH3); δC (75MHz; CDCl3) 158.49 (C), 136.98 (C), 131.30 (C), 129.01 (2 × 
CH), 128.52 (C), 122.69 (CH), 121.56 (CH), 120.53 (CH), 120.12 (CH), 114.66 (2 × CH), 
113.25 (C), 111.75 (CH), 55.76 (CH3); m/z 223 (M+, 32%), 219 (100%), 208 (21%), 131 (41%), 
100 (16%), 69 (80%), (Found: 223.0995. C21H17NO requires 223.0997). 
 
(h) 5-Methoxy-3-(4-methoxyphenyl)-1H-indole (156) 
 
5-Methoxy-3-(4-methoxyphenyl)-1-(phenylsulfonyl)-1H-indole 
(144) (0.15 g, 0.38 mmol), K2CO3 (10.00 g, 73 mmol, 190 eq). 
Column chromatography gave a yellow oil (156) 0.070 g 
(72%), literature reported (156) as a solid with melting point 
151.2-152 °C88; vmax (Liquids)/cm-1 3405 (m), NH), 2916 (w), 
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CH), 1612 (m), 1547 (m), 1503 (s), 1479 (s), 1438 (m), 1296 (m), 1276 (s), 1240 (s), 1207 (s), 
1173 (s), 1104 (s), 1027 (s), 968 (m), 916 (m), 833 (m), 790 (s), 750 (m), 638 (m); δH (300 MHz; 
CDCl3; Me4Si) 8.10 (1H, s, NH), 7.56 (2H, d, J = 8.49, 2 × ArH), 7.33-7.25 (3H, m, 3 × ArH), 
7.01 (2H, d, J = 8.50, 2 × ArH), 6.91 (1H, dd, J = 2.03 and 2.08, ArH), 3.86 (6H, s, 2 × CH3O); 
δC (75MHz; CDCl3) 158.43 (C), 154.99 (C), 132.12 (C), 128.93 (2 × CH), 126.68 (C), 122.45 
(CH), 118.21 (C), 116.43 (C), 115.22 (C), 114.71 (2 × CH), 112.99 (CH), 112.46 (CH), 101.86 
(CH), 56.40 (CH3O), 55.79 (CH3O)  
 
(i) 3-(2-Formylphenyl)-1H-indole (157) 
 
3-(2-formylphenyl)-1-phenylsulfonylindole (145) (0.36 g, 0.99 
mmol), K2CO3 (25.96 g, 188.1 mmol, 190 eq), Column 
chromatography gave a brown oil (157) that did not solidify on 
standing in 72% yield; vmax (Liquid)/cm-1 3461 (m, NH), 3055 (m, 
CH), 1687 (m, C=O), 1600 (w), 1545 (w), 1420 (m), 1265 (s), 
1196 (w), 1099 (w), 896 (m), 735 (s); δH (300 MHz; CDCl3; 
Me4Si) 10.10 (1H, s, CHO), 8.61 (1H, s, NH), 8.06 (1H, d, J = 1.10, ArH), 7.67-7.60 (3H, m, 3 × 
ArH), 7.47 (2H, d, J = 8.08, 2 × ArH), 7.26-7.19 (3H, m, 3 × ArH); δC (75 MHz; CDCl3) 193.63 
(CHO), 139.30 (C), 136.52 (C), 134.82 (C), 131.84 (CH), 128.09 (CH), 127.78 (C), 127.47 
(CH), 125.43 (CH), 123.44 (CH), 121.35 (CH), 119.73 (CH), 111.96 (CH); m/z 221 (M+, 98%), 
193 (100%), 165 (58%), 86 (24%), 84 (38%), 71 (15%), 57 (27%), 43 (25%) (Found: 221.2001. 
C15H11NO requires 221.0841). 
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(j) 2-(5-Methoxy-1H-indol-3-yl)benzaldehyde (158) 
 
2-(5-Methoxy-1-(phenylsulfonyl)-1H-indol-3-
yl)benzaldehyde (146) (0.50 g, 1.28 mmol), K2CO3 (33.50 
g, 240 mmol, 190 eq). Column chromatography gave a 
brown oil (158) 0.30 g (94%); vmax (Liquid)/cm-1 3359 (m, 
NH), 2830 (w, CH), 1680 (s, C=O), 1622 (m), 1597 (m), 
1537 (m), 1448 (s), 1438 (s), 1389 (s), 1290 (s), 1258 (s), 
1176 (m), 1117 (m), 1027 (s), 969 (s), 917 (s), 830 (m), 799 (s), 766 (s), 729 (s), 690 (s), 638 
(m); δH (300 MHz; CDCl3; Me4Si) 10.01 (1H, s, CHO), 8.51 (1H, s, NH), 8.06 (1H, d, J = 7.79, 
ArH), 7.70-7.62 (2H, m, 2 × ArH), 7.56-7.46 (2H, m, 2 × ArH), 7.35 (1H, d, J = 8.91, ArH), 7.21 
(1H, s, ArH), 7.02 (1H, s, ArH), 6.94 (1H, d, J = 8.87, ArH), 3.80 (H, s, CH3O); δC (75MHz; 
CDCl3) 194.29 (CHO), 156.15 (C), 140.05 (C), 135.26 (C), 134.91 (CH), 134.22 (C), 132.23 
(CH), 130.30 (C), 128.67 (CH), 127.93 (CH), 126.60 (CH), 114.46 (CH), 113.34 (CH), 101.55 
(CH), 56.85 (CH3O). 
 
(k) 1-(2-(1H-indol-3-yl) acetophenone (159) 
 
1-(2-(1-(Phenylsulfonyl)-1H-indol-3-yl) acetophenone (147) (0.21 
g, 0.56 mmol), K2CO3 (14.68 g, 106 mmol, 190 eq). Column 
chromatography gave a brown oil (159) 0.13 g (92%); vmax 
(Liquid)/cm-1 3329 (b, NH), 3057 (w, CH), 1670 (s, C=O), 1596 
(m), 1544 (m), 1456 (m), 1352 (m), 1277 (m), 1224 (m), 1098 (m), 
1009 (m), 739 (s); δH (300 MHz; CDCl3; Me4Si) 8.61 (1H, s, NH), 
7.66-7.50 (4H, m, 4 × ArH), 7.42-7.36 (2H, m, 2 × ArH), 7.27-7.14 (2H, m, 2 × ArH), 7.09 (1H, 
d, J = 2.44, ArH), 2.02 (3H, s, CH3); δC (75MHz; CDCl3) 206.60 (C=O), 142.03 (C), 136.68 (C), 
133.44 (C), 131.28 (CH), 131.12 (CH), 128.07 (CH), 127.09 (CH), 126.83 (C), 124.27 (CH), 
123.19 (CH), 120.98 (CH), 119.80 (CH), 116.72 (C), 111.94 (CH), 30.45 (CH3); m/z 236 (M+, 
100%), 218 (18%), 194 (3%), 143 (3%), (Found: 235.2560. C16H13NO require 235.0997). 
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(l) 1-(2-(5-Methoxy-1H-indol-3-yl) acetophenone (160) 
 
1-(2-(5-Methoxy-1-(phenylsulfonyl)-1H-indol-3-yl) 
acetophenone (148) (0.17 g, 0.42 mmol), K2CO3 (11.01 g, 
80 mmol, 190 eq). Column chromatography gave a cream 
white solid (160) 0.090 g (82%). Melting point 116-120 °C; 
vmax (Solid)/cm-1 3268 (m, NH), 2987 (w, CH), 1666 (s, 
C=O), 1592 (m), 1537 (m), 1486 (m), 1353 (m), 1281 (s), 
1214 (s), 1135 (m), 1031 (m), 920 (m), 842 (m), 805 (s), 764 (s), 701 (s), 645 (m); δH (300 MHz; 
CDCl3; Me4Si) 8.56 (1H, s, NH), 7.59-7.51 (3H, m, 3 × ArH), 7.42-7.37 (1H, m, ArH), 7.31-7.25 
(1H, m, ArH), 7.10 (1H, d, J = 2.36, ArH), 7.05 (1H, d, J = 1.72, ArH), 6.91 (1H, dd, J = 2.14 
and 2.11, ArH), 3.80 (3H, s, CH3O), 2.03 (3H, s, CH3); δC (75MHz; CDCl3) 204.82 (C=O), 
153.38 (C), 140.05 (C), 131.70 (C), 129.79 (C), 129.33 (CH), 129.20 (CH), 126.26 (CH), 125.34 
(C), 125.17 (CH), 122.87 (CH), 114.70 (C), 111.77 (CH), 110.81 (CH), 99.21 (CH), 55.33 
(CH3O), 28.49 (CH3). 
 
4.8 Synthesis of 2,3-Diphenyl-1-(phenylsulfonyl)-1H-indole (161) 
 
To Pd(PPh3)4 (10%, 0.17 g) was added a deoxygenated 
mixture of the 2,3-dibromo-1-(phenylsulfonyl)-1H-indole 
(108) (0.50 g, 1.49 mmol) in DME (5 ml) and 
phenylylboronic acid (123) (0.27 g, 2.23 mmol, 1.5 eq) in 
ethanol (3 ml). The reaction mixture was stirred at rt for 
about 10 min followed by the addition of deoxygenated 
solution Na2CO3 (1.34 g, 12.7 mmol, 8.5 eq) in water (6.3 
ml). The resulting reaction mixture was stirred for further 
10 min at rt before being heated to reflux for 8 h. The 
reaction mixture was allowed to cool to rt, quenched with water (10 ml) and the organic extracts 
extracted with CH2Cl2 (3 × 30 ml). The organic fractions were combined, dried over MgSO4, 
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filtered through a celite plug and the excess solvent was removed on a rotary evaporator. The 
resulting black oil was purified by column chromatography using 10% EtOAc/Hexane as an 
eluent. This gave a light red solid (161) which was recrystallized from CH2Cl2 to give a cream 
white solid in 56% yield. Melting point: 173-175 °C, lit. value 174-176 °C69; vmax (Solid)/cm-1 
3065 (m, CH), 1604 (w), 1447 (s), 1379 (s), 1184 (s), 1128 (m), 1087 (s), 910 (s), 733 (s); δH 
(300 MHz; CDCl3; Me4Si) 8.41 (1H, d, J = 8.42, ArH), 7.50-7.43 (5H, m,5 × ArH), 7.321-7.20 
(11H, m, 11 × ArH ), 7.09-7.06 (2H, m, 2 × ArH); δC (75 MHz; CDCl3) 138.20 (C), 137.45 (C), 
136.88 (C), 133.56 (CH), 132.60 (C), 132.19 (2 × CH), 130.87 (C), 130.44 (C), 129.83 (2 × CH), 
128.77 (2 × CH), 128.61 (CH), 128.50 (2 × CH), 127.34 (2 × CH), 127.01 (CH), 126.95 (2 × 
CH), 125.31 (CH), 124.93 (C), 124.38 (CH), 120.16 (CH), 116.33 (CH); m/z 409 (M+, 42%), 334 
(7%), 269 (29%), 268 (100%), 267 (58%), 266 (13%), 219 (21%), 213 (10%), 193 (12%), 190 
(7%), 165 (21%), 163 (10%), 77 (19%), 51 (7%) (Found: 409.1195. C26H19SO2N requires 
409.1137). 
 
4.9 Synthesis of 2,3-Diphenyl-1H indole (162) 
 
2,3-Diphenyl-1-(phenylsulfonyl)-1H-indole (161) (0.28 g, 
0.69 mmol) was dissolved in methanol (20 ml) at rt under N2 
atmosphere, K2CO3 (17.80 g, 131.1 mmol, 190 eq) was added 
to the solution and the reaction mixture was heated to reflux 
under N2 for 18 h. The reaction mixture was then allowed to 
cool to rt and filtered through a celite plug and then the 
filtrate concentrated under reduced pressure. Water was 
added to the crude material and slowly acidified to pH 2-4 with aqueous 10% HCl. The aqueous 
portion was saturated with solid NaCl and the organic material extracted with CH2Cl2 (3 × 30 
ml). The combined organic extracts were washed two times with water (20.0 ml), brine (20.0 
ml), dried over MgSO4 and concentrated under reduced pressure. This resulted in brown oils that 
were subjected to column chromatography using 10% EtOAc/Hexane as an eluent. Column 
chromatography gave a yellow oil (162) that solidified on standing in 60% yield. Melting point: 
224-227˚C; vmax (Solid)/cm-1 3461 (m, NH), 3062 (w, CH), 1603 (w), 1454 (m), 1330 (w), 1250 
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(w), 1184 (w), 1093 (w), 909 (s), 732 (s), 650 (m); δH (300 MHz; CDCl3; Me4Si) 8.21 (1H, s, 
NH), 7.68 (1H, d, J = 7.90 ArH), 7.45-7.37 (6H, m, 6 × ArH), 7.34-7.12 (7H, m, 7 × ArH); δC 
(75 MHz; CDCl3) 136.3 (C1), 135.5 (C1), 134.5 (C), 133.1 (C), 132.5 (C), 130.6 (2 × CH), 130.3 
(C), 129.1 (2 × CH), 128.9 (2 × CH), 128.6 (2 × CH), 128.1 (CH), 126.7 (CH), 123.1 (CH), 
120.9 (CH), 120.1 (CH), 111.3 (CH); m/z 269 (M+, 100%), 268 (17%), 267 (22%), 266 (5%), 
254 (4%), 241 (3%), 193 (18%), 165 (13%), 163 (3%), 134 (7%), 133 (10%), 132 (5%), 127 
(6%), 42 (4%) (Found: 269.1217. C20H15N requires 269.1205).  
 
4.10 Synthesis of a novel class compounds 
 
4.10.1 Synthesis of 2-arylindoles via one-pot synthesis 
 
4.10.1.1 2-(4-Bromo-2,5-dimethoxyphenyl)-1-(phenylsulfonyl)-1-H-indole (164) 
 
To 1-(phenylsulfonyl)-1H-indole (36) (1.00 g, 3.89 mmol) 
in a dry flask was added isopropylmagnesium chloride 
solution in THF (~0.8 M in excess) and diisopropylamine 
(1 ml). The reaction mixture was maintained at rt under N2 
atmosphere for 16 h. The reaction mixture was treated with 
1,4-dibromo-2,5-dimethoxybenzene (2.30 g, 7.78 mmol, 2 
eq) and Pd(PPh3)4 (0.23 g, 0.20 mmol, 0.050 eq). After 
stirring at rt for 48 h, the reaction mixture was quenched by the addition of a saturated aqueous 
solution of NH4Cl. The mixture was extracted with CH2Cl2 (3 × 30 ml), the organic layers 
combined and dried over MgSO4, filtered though celite plug and excess solvent removed on a 
rotary evaporator. This resultant black oil was subjected to column chromatography. The 
resultant light black oil was recrystallized from the mixture of CH2Cl2 and hexane to give white 
solid (164) (0.38 g, 21%). Melting point: 181-183 °C; vmax (Solid)/cm-1 2838 (w, CH), 1585 (w), 
1489 (s), 1439 (m), 1431 (m), 1367 (s), 1279 (m), 1213 (s), 1177 (s), 1118 (m), 1090 (m), 1068 
(s), 1034 (s), 999 (s), 850 (s), 810 (s), 752 (s), 730 (s), 686 (s), 639 (s);δH (300 MHz; CDCl3; 
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Me4Si) 8.25 (1H, d, J = 8.33, ArH), 7.51-7.44 (4H, m, 4 × ArH), 7.37-7.23 (4H, m, 4 × ArH), 
7.12 (1H, s, ArH), 6.78 (1H, s, ArH), 6.58 (1H, s, ArH), 3.82 (3H, s, CH3O), 3.68 (3H, s, CH3O); 
δC (75MHz; CDCl3) 153.08 (C), 149.63 (C), 139.05 (C), 137.99 (C), 137.04 (C), 133.85 (CH), 
130.14 (C), 129.06 (2 × CH), 127.13 (2 × CH), 125.25 (CH), 124.32 (CH), 121.25 (CH), 116.72 
(CH), 116.46 (CH), 113.13 (CH), 113.54 (CH), 57.36 (CH3O), 55.53 (CH3O); m/z 470 (M+, 
46%, 79Br), 472 (M+, 44%, 81Br), 392 (12%), 373 (100%), 332 (14%), 317 (6%), 219 (4%), 113 
(4%), (Found: 470.3100. C22H18NSO4Br requires 471.0140). 
 
4.10.1.2 2-(4-Bromo-2,5-dimethoxyphenyl)-5-methoxy-1-(phenylsulfonyl)-1H-indole (165) 
 
To 1-(phenylsulfonyl)-5-methoxy-1H-indole (102) 
(0.97 g, 3.89 mmol) in a dry flask was added 
isopropylmagnesium chloride solution in THF (~0.8 
M in excess) and diisopropylamine (1 ml). The 
reaction mixture was maintained at rt under N2 
atmosphere for 16 h. The reaction mixture was 
treated with 1,4-dibromo-2,5-dimethoxybenzene 
(1.93 g, 6.76 mmol, 2 eq) and Pd(PPh3)4 (0.20 g, 0.17 mmol, 0.050 eq). After stirring at rt for 48 
h, the reaction mixture was quenched by the addition of a saturated aqueous solution of NH4Cl. 
The mixture was extracted with CH2Cl2 (3 × 30 ml), the organic layers combined and dried over 
MgSO4, filtered though celite plug and excess solvent removed on a rotary evaporator. This 
resulted in a black oil that was subjected to column chromatography. The resultant light black oil 
was recrystallized from the mixture of CH2Cl2 and hexane to give white solid (165) (0.60 g, 
35%). Melting point: 159-162 °C; vmax (Solid)/cm-1 2941 (w, CH), 1611 (m), 1494 (m), 1382 
(m), 1207 (s), 1171 (s), 1027 (m), 1028 (m), 950 (w), 857 (m), 814 (s), 752 (s), 722 (m), 685 (s); 
δH (300 MHz; CDCl3; Me4Si) 8.14 (1H, d, J = 8.92, ArH), 7.45 (3H, d, J = 8.13, 3 × ArH), 7.31-
7.26 (2H, m, 2 × ArH), 7.13 (1H, s, ArH), 6.97-6.92 (2H, m, 2 × ArH), 6.77 (1H, s, ArH), 6.52 
(1H, s, ArH); δC (75MHz; CDCl3) 157.24 (C), 152.97 (C), 149.62 (C), 138.76 (C), 137.87 (C), 
133.80 (CH), 132.64 (C), 131.55 (C), 128.99 (2 × CH), 127.10 (2 × CH), 121.49 (C), 117.20 
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(CH), 116.75 (CH), 116.50 (CH), 114.08 (CH), 113.93 (CH), 113.29 (CH), 103.65 (CH), 57.36 
(CH3O), 56.56 (CH3O), 56.05 (CH3O); 
4.10.2 Synthesis of indolo-fused pyrans 
 
4.10.2.1 2-Allyl-1-(phenylsulfonyl)-1H-indole (169) 
 
To 1-(phenylsulfonyl)-1H-indole (36) (3.00 g, 12 mmol) in a dry 
flask was added isopropylmagnesium chloride solution in THF 
(~0.8 M in excess) and diisopropylamine (1 ml). The reaction 
mixture was maintained at rt under N2 atmosphere for 16 h. Allyl 
bromide (4.23 g, 35 mmol, 3.1 ml, 2.9 eq) was added and the 
mixture was stirred at rt for an hour. The reaction mixture was 
quenched by the addition of a saturated aqueous solution of NH4Cl. The mixture was extracted 
with CH2Cl2 (3 × 30 ml), the organic layers combined and dried over MgSO4, filtered though 
celite plug and excess solvent removed on a rotary evaporator. This resulted in brown oil that 
was subjected to column chromatography. The resultant light brown oil was recrystallized from 
the mixture of CH2Cl2 and hexane to give white solid (169) (1.1 g, 31%). Melting point: 88-91 
°C, literature reported (169) as an oil89; vmax (Solid)/cm-1 3083 (w, CH), 1591 (w), 1448 (s), 1366 
(s), 1270 (m), 1219 (m), 1170 (m), 1141 (s), 1092 (s), 1045 (s), 998 (s), 918 (m), 759 (s), 739 (s), 
721 (s), 684 (s), 651 (s), 623 (s); δH (300 MHz; CDCl3; Me4Si) 8.16 (1H, d, J = 7.87, ArH), 7.76 
(2H, d, J = 7.63, 2 × ArH), 7.54-7.38 (4H, m, 4 × ArH), 7.29-7.18 (2H, m, 2 × ArH), 6.40 (1H, s, 
ArH), 7.01-5.96 (1H, m, CH=C), 5.22-5.16 (2H, m, C=CH2), 3.78-3.76 (2H, m, CH2-C=C); δC 
(75MHz; CDCl3) 140.53 (C), 139.56 (C), 137.66 (C), 134.49 (CH), 134.06 (CH), 130.04 (C), 
129.63 (CH), 126.69 (CH), 124.49 (CH), 123.99 (CH), 120.69 (CH), 118.22 (CH2), 115.11 (CH), 
109.99 (CH), 33.80 (CH2); m/z 298 (M+, 100%), 223 (6%), 157 (42%), 141 (4%), (Found: 
297.0260. C17H15NO2S requires 297.0824). 
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4.10.2.2 2-Allyl-1-(phenylsulfonyl)-1H-indole-3-carbaldehyde (171) 
 
2-Allyl-1-(phenylsulfonyl)-indole (169) (0.7 g, 2.3mmol) in 
CH2CH2 (6 ml) was added to a solution of TiCl4 (0.51 ml, 4.7 
mmol, 2 eq) and Cl2CHOCH3 (0.47 ml, 4.7 mmol, 2 eq) in CH2Cl2 
(6 ml) at -78 °C, and the resulting reaction mixture was stirred at –
78 °C for 3 h. The reaction mixture was allowed to warm to rt and 
diluted with water. The reaction mixture was made basic with 10% 
aqueous Na2CO3 and then extracted with CH2Cl2 (3 × 30 ml). The 
organic extracts were combined, dried over MgSO4, filtered 
through celite plug and the excess solvent removed on a rotary evaporator to result in a brown oil 
residue. This oily residue was subjected to column chromatography using 10% EtOAc/Hexane as 
an eluent to give a brown oil (171) (0.61 g, 81%), literature reported (171) isolated as solid with 
melting point 157-158.5 °C75. vmax (Liquid)/cm-1 3063 (w, CH), 1666 (s, C=O), 1553 (m), 1448 
(s), 1372 (s), 1265 (w), 1172 (s), 1119 (m), 1087 (s), 1026 (m), 995 (s), 915 (s), 749 (s), 726 (s), 
683 (s); δH (300 MHz; CDCl3; Me4Si) 10.31 (1H, s, CHO), 8.32-8.29 (1H, m, ArH), 8.21-8.18 
(1H, m, ArH), 7.88 (2H, d, J = 8.14, 2 × ArH) 7.64-7.59 (1H, m, ArH), 7.52-7.46 (2H, m, 2 × 
ArH), 7.41-7.38 (2H, m, 2 × ArH), 6.15-6.02 (1H, m, HC=C), 5.17-5.06 (2H, m, C=CH2), 4.26-
4.24 (2H, m, CH2-C=C); δC (75MHz; CDCl3) 186.18 (CHO), 149.31 (C),  138.96 (C), 136.41 
(C), 134.90 (CH), 134.68 (CH), 129.94 (CH), 127.10 (CH), 126.53 (C), 126.17 (CH), 126.60 
(CH), 121.91 (CH), 119.99 (C), 118.12 (CH2), 114.83 (CH), 29.89 (CH2); m/z 325 (M+, 7%), 264 
(23%), 219 (100%), 184 (11%), 156 (7%), 131 (40%), 100 (15%), 69 (50%), (Found: 325.0771. 
C21H17NSO3 requires 325.0773). 
 
4.10.2.3 (2-Allyl-1-(phenylsulfonyl)-1H-indol-3-yl) methanol (172) 
 
2-Allyl-1-(phenylsulfonyl)-1H-indole-3-carbaldehyde (171) (0.50 
g, 1.54 mmol) was dissolved in ethanol. NaBH4 (0.12 g, 3.08 
mmol, 2 eq) was added during which time the temperature was not 
N
S OO
O
N
S OO
OH
Chapter 4                                    Experimental Procedures 
120 
 
allowed to rise above 20 °C. Stirring was then continued for 6 h at rt, before the solvent was 
removed in vacuo. The residual white solid in round bottom flask was shaken up with 80 ml of 
aqueous 15% NaOH and the alkaline solution was extracted with CH2Cl2 (3 × 30 ml). The 
combined organic extracts were dried over MgSO4, filtered with celite plug and the excess 
solvent removed on a rotary evaporator to give a yellow oil. The oil was subjected to column 
chromatography using 50% EtOAc/Hex as an eluent to get yellow oil (172) 0.36g (71%), 
literature reported (172) isolated as solid with melting point 82-83 °C76; vmax (Liquid)/cm-1 3406 
(b, OH), 2923 (w, CH), 1606 (w), 1448 (s), 1362 (s), 1217 (w), 1170 (s), 1089 (s), 993 (s), 778 
(s), 745 (s), 723 (s), 684 (s); δH (300 MHz; CDCl3; Me4Si) 8.47 (1H, d, J = 8.10, ArH), 8.04 ( 
2H, d, J = 8.04, 2 × ArH), 7.89 (1H, d, J = 7.54, ArH), 7.80-7.76 (1H, m, ArH), 7.69-7.63 (2H, 
m, 2 × ArH), 7.60-7.52 (2H, m, 2 × ArH), 7.38-6.25 (1H, m, C-CH=C), 5.33-5.26 (2H, m, C-
C=CH2), 5.01 (2H, s, CH2O), 4.17 (2H, d, J = 5.67, CH2-C=C), 1.96 (1H, s, OH); δC (75MHz; 
CDCl3) 139.45 (C), 136.93 (C), 136.90 (C), 136.06 (=CH-), 134.15 (CH), 129.61 (2 × CH), 
126.81 (2 × CH), 125.10 (CH), 124.16 (CH), 121.10 (C), 119.37 (CH), 116.70 (=CH2), 115.34 
(CH), 55.74 (CH2O), 30.38 (-CH2-); m/z 326 (M+, 24%), 310 (100%), 284 (5%), 185 (3%), 141 
(3%), 109 (2%), (Found: 326.1990. C17H18NO3S requires 327.0929). 
 
4.10.2.4 1-(2-Allyl-1-(phenylsulfonyl)-1H-indol-3-yl)ethanol (173) 
 
Magnesium turnings (0.030 g, 1.23 mmol, 4.0 eq) were placed in a 
two necked round bottom flask and dried in an oven. The flask 
fitted with a dropping funnel and cooled under N2. Dry ether was 
then placed into the round bottom flask and CH3I was added to the 
suspension. The mixture immediately started going cloudy with 
slight rise in temperature.  Once all the magnesium has reacted, the 
dropping funnel was charged with the solution of 2-allyl-1-
(phenylsulfonyl)-1H-indole-3-carbaldehyde (171) (0.10 g, 0.308 
mmol) in ether, and this was added dropwise to the cloudy Grignard solution. The resulting 
yellow solution was left to stir for 18 h under N2 over which time the solution turned milky 
orange. Water was added to the reaction mixture to quench the excess Grignard reagent and this 
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formed a white slurry of Mg(OH)2. The slurry was made soluble by adding an aqueous solution 
of NH4Cl and the mixture was transferred to the separating funnel and extracted with CH2Cl2 (3 
× 30 ml). The organic fractions were combined, dried over MgSO4, filtered through a celite plug 
and the excess solvent removed on a rotary evaporator. The resulting yellow oil was purified by 
column chromatography using 30% EtOAc/Hexane as an eluent to give yellow oil (173), 0.080 g 
(76%); vmax (Liquid)/cm-1 3567 (b, OH), 2977 (w, CH), 1603 (w), 1448 (s), 1364 (s), 1223 (w), 
1171 (s), 1150 (m), 1089 (m), 1022 (m), 960 (w), 913 (m), 730(s), 685 (s); δH (300 MHz; CDCl3; 
Me4Si) 8.19 (1H, d, J = 7.91, ArH), 7.81 (1H, d, J = 7.13, ArH), 7.73 (2H, d, J = 8.85, 2 × ArH), 
7.51-7.46 (1H, m, ArH), 7.40-7.35 (2H, m, 2 × ArH), 7.29-7.22 (2H, m, 2 × ArH), 6.03-5.93 
(1H, m, CH2CHCH2), 5.18-5.12 (1H, m, CH(OH)CH3), 5.04-4.92 (2H, m, CH2CHCH2), 3.93 
(1H, dd, J = 5.55 and 5.54, CH2CHCH2), 3.77 (1H, dd, J = 5.99 and 5.97, CH2CHCH2), 1.91 
(1H, s, OH), 1.55 (3H, d, J = 6.57, CH(OH)CH3); δC (75MHz; CDCl3) 1139. 48 (C), 137.29 (C), 
135.85 (CH), 134.16 (C), 134.06 (CH), 129.56 (2 × CH), 128.42 (C), 127.11 (C), 126.80 (2 × 
CH), 125.14 (C), 124.80 (CH), 123.82 (CH), 122.02 (CH), 116.55 (CH), 115.17 (CH), 64.56 
(CH(OH)CH3), 30.44 (CH2CHCH2), 23.57 (CH(OH)CH3); m/z 340 (M-, 10%), 324 (100%), 284 
(2%), 198 (4%), 183 (30%), 168 (6%), 109 (2%), (Found: 341.2530. C19H19NO3S requires 
341.1086). 
 
4.10.2.5 3-Methyl-5-(phenylsulfonyl)-1,3,4,5-tetrahydropyrano[4,3-b]indole (174) 
 
Hg(OAc)2 (2.34 g, 0.73 mmol, 1.5 eq) was added to (2-allyl-1-
(phenylsulfonyl)-1H-indol-3-yl) methanol  (172) (0.16 g, 0.49 
mmol) dissolved in dry THF (15 ml). The resulting yellow mixture 
was stirred under N2 for 20 h at rt. A further portion of Hg(OAc)2 
(0.23 g, 0.73 mmol, 1.5 eq) was added and the mixture was stirred 
at rt for further 18 h. A mixture of NaBH4 (0.042 g, 1.22 mmol, 2.5 
eq) in aqueous NaOH (5 ml, 2.5 M) was added whilst stirring. After 
stirring for further 1 h, a saturated solution aqueous Na2CO3 (5 ml) was added and the mixture 
was stirred for further 20 minutes. The reaction mixture was allowed to stand for 30 minutes and 
the THF removed under reduced pressure. Saturated aqueous brine solution (20 ml) and CH2Cl2 
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(20.0 ml) were added and the mixture was extracted with CH2Cl2 (3 × 30 ml). The organic 
fractions were combined, dried over MgSO4, filtered with the celite plug and silica to remove 
traces of Hg and the excess solvent was removed on a rotary evaporator. This gave clear oil that 
solidified on standing and it was dissolved in CH2Cl2 and subjected to column chromatography 
using 20% EtOAc/Hexane as an eluent to give a clear solid (174) 0.05 g (31%), melting point 
145-148 °C; vmax (Solid)/cm-1 3061 (w, CH), 1620 (m), 1449 (m), 1404 (s), 1363 (s), 1304 (m), 
1220 (s), 1201 (m), 1170 (s), 1119 (m), 1083 (s), 1049 (m), 1022 (m), 979 (m), 931 (s), 852 (s), 
794 (m), 759 (s), 725 (s), 687 (s), 664 (s); δH (300 MHz; CDCl3; Me4Si) 8.46 (1H, d, J = 8.18, 
ArH), 8.09 (1H, d, J = 8.61, 2 x ArH), 7.85-7.80 (1H, m, ArH), 7.74-7.69 (2H, m, 2 × ArH), 
7.63-7.52 (3H, m, 3 × ArH), 5.19-5.03 (2H, m, CH2O), 4.17-4.10 (1H, m, CH), 3.56-3.55 (1H, 
m, CH), 3.16-3.07 (1H, m, CH), 1.75 (3H, d, J = 6.20, CH3); δC (75MHz; CDCl3) 137.80 (C), 
135.18 (C), 132.69 (CH), 131.68 (C), 128.28 (2 × CH), 126.36 (C), 125.32 (2 × CH), 123.33 
(CH), 122.56 (CH), 116.99 (CH), 116.02 (C), 113.47 (CH), 69.81 (CH), 62.25 (CH2O), 31.78 
(CH2), 20.38 (CH3); m/z 328 (M+, 37%), 284 (100%), 220 (3%), 187 (13%), 143 (7%), 109 (2%), 
(Found: 327.1570. C17H18NO3S requires 327.0929). 
 
4.10.2.6 1,3-Dimethyl-5-(phenylsulfonyl)-1,3,4,5-tetrahydropyrano[4,3-b]indole (175) 
 
Hg(OAc)2 (0.12 g, 0.37 mmol, 1.5 eq) was added to 1-(2-allyl-1-
(phenylsulfonyl)-1H-indol-3-yl)ethanol (173) (0.080 g, 0.25 mmol) 
dissolved in dry THF (15 ml). The resulting yellow mixture was 
stirred under N2 for 20 h at rt. A further portion of Hg(OAc)2 (0.080 
g, 0.25 mmol, 1 eq) was added and the mixture was stirred at rt for 
further 18 h. A mixture of NaBH4 (0.023 g, 0.61 mmol, 2.5 eq) in 
aqueous NaOH (5 ml, 2.5 M) was added whilst stirring. After stirring 
for further 1 h, a saturated solution aqueous Na2CO3 (5 ml) was added and the mixture was 
stirred for further 20 minutes. The reaction mixture was allowed to stand for 30 minutes before 
the THF removed under reduced pressure. An aqueous saturated brine solution (20 ml) and 
CH2Cl2 (20.0 ml) were added and the reaction mixture was extracted with CH2Cl2 (3 × 30 ml). 
The organic fractions were combined, dried over MgSO4, filtered with the celite plug and silica 
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to remove traces of Hg and the excess was solvent removed on a rotary evaporator. This gave 
clear oil that solidified on standing and it was dissolved in CH2Cl2 and subjected to column 
chromatography using 20% EtOAc/Hexane as an eluent to give clear oil (175) 0.02 g (25%); vmax 
(Liquid)/cm-1 2920 (w, CH), 1615 (w), 1448 (s), 1369 (s), 1203 (m), 1171 (s), 1150 (s), 1090 (s), 
1028 (s), 975 (m), 885 (m), 777 (s), 744 (s), 723 (s), 684 (s); δH (300 MHz; CDCl3; Me4Si) 8.16 
(1H, d, J = 8.12, ArH), 7.78 (2H, d, J = 7.39, 2 × ArH), 7.55-7.750 (1H, m, ArH), 7.44-7.37 (2H, 
m, 2 × ArH), 7.31-7.22 (2H, m, 2 × ArH), 5.10-5.04 (1H, m, CH(O)CH3), 4.14-4.08 (1H, m, 
CH2CH(O)CH3), 3.26-3.16 (1H, m, CH2CH(O)CH3), 2.85-2.69 (1H, m, CH2CH(O)CH3), 1.60-
1.54 (3H, m, CH(O)CH3), 1.45-1.38 (3H, m, CH2CH(O)CH3); δC (75MHz; CDCl3) 138.86 (C), 
136.31 (C), 133.69 (CH), 132.28 (C), 129.29 (2 × CH), 127.49 (C), 126.35 (2 ×CH), 124.18 
(CH), 124.04 (C), 123.49 (CH), 120.97 (C), 119.18 (C), 118.43 (CH), 114.54 (CH), 67.55 
(CH(O)CH3), 64.04 (CH2CH(O)CH3), 32.54 (CH2CH(O)CH3), 21.19 (CH(O)CH3), 19.98 
(CH2CH(O)CH3); m/z 342 (M+, 66%), 298 (100%), 201(8%), 157 (10%), 130 (2%), (Found: 
341.1290. C19H19NO3S requires 341.1086). 
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Appendix 1: Selected 1H and 13C NMR spectra 
Compound Page 
5-Methoxy-2-phenyl-1H-indole (129) 130 
2-o-Tolyl-1H-indole (130) 131 
5-Methoxy-2-o-tolyl-1H-indole (131) 132 
2-(4-Methoxyphenyl)-1H-indole (134) 133 
5-Methoxy-3-o-tolyl-1H-indole (152) 134 
3-(4-Methoxyphenyl)-1H-indole (155) 135 
1-(2-(1H-indol-3-yl) acetophenone (159) 136 
1-(2-(5-Methoxy-1H-indol-3-yl) acetophenone (160) 137 
2-(4-Bromo-2,5-dimethoxyphenyl)-1-(phenylsulfonyl)-1-H-indole (164) 138 
2-(4-Bromo-2,5-dimethoxyphenyl)-5-methoxy-1-(phenylsulfonyl)-1H-indole (165) 139 
2-(4-Bromo-2,5-dimethoxyphenyl)-1H-indole (166) 140 
2-(4-Bromo-2,5-dimethoxyphenyl)-5-methoxy-1H-indole (167) 141 
2-Allyl-1-(phenylsulfonyl)-1H-indole (169) 142 
3-Methyl-5-(phenylsulfonyl)-1,3,4,5-tetrahydropyrano[4,3-b]indole (174) 143 
1,3-Dimethyl-5-(phenylsulfonyl)-1,3,4,5-tetrahydropyrano[4,3-b]indole (175) 144 
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Tlabo :  TLB92.1 : CDCl3 : 09/070/07 : 300K : 13C
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Tlabo : TLB56.1 : CDCl3 : 07/02/07 : 300K : 1H
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Tlabo : TLB56.1 : CDCl3 : 08/02/07 : 300K : 13C
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Tlabo : TLB105.03 : CDCl3 : 20/08/007 : 300K : 1H
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Tlabo : TLB105.03 : CDCl3 : 21/08/07 : 300K : 13C
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